MICROFLUIDIC DEVICES IN NANOTECHNOLOGY Applications Edited by CHALLA S. KUMAR
MICROFLUIDIC DEVICES IN NANOTECHNOLOGY
...
597 downloads
2319 Views
6MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
MICROFLUIDIC DEVICES IN NANOTECHNOLOGY Applications Edited by CHALLA S. KUMAR
MICROFLUIDIC DEVICES IN NANOTECHNOLOGY
MICROFLUIDIC DEVICES IN NANOTECHNOLOGY Applications Edited by CHALLA S. KUMAR
Copyright Ó 2010 by John Wiley & Sons, Inc. All rights reserved Published by John Wiley & Sons, Inc., Hoboken, New Jersey Published simultaneously in Canada No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 750-4470, or on the web at www.copyright.com. Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/permission Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no representations or warranties with respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives or written sales materials. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate. Neither the publisher nor author shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages. For general information on our other products and services or for technical support, please contact our Customer Care Department within the United States at (800) 762-2974, outside the United States at (317) 572-3993 or fax (317) 572-4002. Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic formats. For more information about Wiley products, visit our web site at www. wiley.com. Library of Congress Cataloging-in-Publication Data: Microfluidic devices in nanotechnology. Applications / edited by Challa S. Kumar. p. cm. Includes bibliographical references and index. ISBN 978-0-470-59069-0 (cloth) 1. Microfluidic devices. 2. Nanofluids. 3. Nanotechnology. 4. Fluidic devices. I. Kumar, C. S. S. R. (Challa S. S. R.) TJ853.4.M53M5325 2010 2009051009 620.10 06–dc22 Printed in the United States of America 10 9 8 7 6 5 4 3 2 1
CONTENTS
Preface
vii
Contributors
xi
1
1
Microfluidics For Nanoneuroscience Pamela G. Gross and Emil P. Kartalov
2
Nanoporous Membrane-Based Microfluidic Biosensors
47
Shalini Prasad, Yamini Yadav, Manish Bothara, Vindhya Kunduru, and Sriram Muthukumar
3
Nanoparticle-Based Microfluidific Biosensors
91
Giovanna Marrazza
4
Microfluidic Enzymatic Reactors Using Nanoparticles
125
Chunhui Deng and Yan Li
5
Microfluidic Devices for Nanodrug Delivery
187
Clement Kleinstreuer and Jie Li
6
Microchip and Capillary Electrophoresis Using Nanoparticles
213
Muhammad J. A. Shiddiky and Yoon-Bo Shim
7
Pillars and Pillar Arrays Integrated in Microfluidic Channels: Fabrication Methods and Applications in Molecular and Cell Biology
255
Jian Shi and Yong Chen
v
CONTENTS
vi
8
Nanocatalysis in Microreactor for Fuels
281
Shihuai Zhao and Debasish Kuila
9
Microfluidic Synthesis of Iron Oxide and Oxyhydroxide Nanoparticles
323
Ali Abou-Hassan, Olivier Sandre, and Valerie Cabuil
10
Metal Nanoparticle Synthesis in Microreactors
361
Peter Mike G€ unther, Andrea Knauer, and Johann Michael K€ ohler
Index
395
PREFACE
I hope you had an opportunity to go through the first volume. It gives me immense satisfaction in placing the second volume of the two-volume book series— Microfluidic Devices for Nanotechnology: Applications—in your hands. The second volume is the first book ever to be published that covers nanotechnology applications using microfluidics in a broad range of fields, including drug discovery, biosensing, catalysis, electrophoresis, enzymatic reactions, and synthesis of nanomaterials. While the first volume, Microfluidic Devices for Nanotechnology: Fundamental Concepts, in its combined form provides readers an up-to-date knowledge of the fluid and particle kinetics, spatiotemporal control, fluid dynamics, residence time distribution, and nanoparticle focusing within microfluidics, the second volume primarily captures upto-date applications. The book fills in a long-term gap that existed for the real-time measurement of biomolecular binding in biosensors and justification for incorporating nanoporous membranes into “lab-on-a-chip” biosensing devices. Focusing on lab-ona-chip systems for drug delivery (also called bio-MEMS), separating bioanalytes using electrophoresis, genomics, proteomics, and cellomics, the book is a must for biologists and biochemists. Highlighting the importance of nanoneuroscience, the book educates the reader on the discipline of microfluidics to study the nervous system at the single-cell level and decipher physiological processes and responses of cells of neural origin. For a nanomaterials chemist interested in novel approaches for synthesis of nanomaterials, this book is an excellent source of information covering a wide variety of microfluidic-based approaches for synthesis of metallic and nonmetallic nanomaterials. Finally, opening a window for the next-generation alternative energy portable power devices, nanocatalyst development for industrially useful reactions in silicon-based microreactors is discussed especially in the context of syngas conversion to higher alkanes, which could solve current difficulties of storage and transportation vii
viii
PREFACE
by converting natural gas into liquid fuels. Overall, the book contains reviews by world-recognized microfluidic and nanotechnology experts providing strong scaffolding for futuristic applications utilizing synergy between microfluidics and nanotechnology. Chapter 1 by Drs. Pamela G. Gross and Emil P. Kartalov focuses on the application of microfluidic devices to study the nervous system at single-cell level using nanotechnologies. This chapter describes various aspects of microfluidic chips used to decipher physiological processes and responses of cells of neural origin with examples of novel research not previously possible. Continuing on a similar theme, Chapter 2 by Professor Shalini Prasad et al. provides a detailed account of realtime biomolecular sensing through incorporation of nanoporous membranes, manmade as well as natural, into “lab-on-a-chip” biosensing devices. In addition to nanoporous membranes, simple spherical nanoparticles are finding novel applications when incorporated within the microchannels. Chapter 3 by Professor Giovanna Marrazza reviews the most recent applications of nanoparticles within microfluidic channels for electrochemical and optical affinity biosensing, highlighting some of their technical challenges and the new trends. Chapter 4 by Professors Chunhui Deng and Yan Li presents the recent advances in the field of immobilized microfluidic enzymatic reactors (IMERs), which constitutes a new branch of nanotechnology. In view of the increasing use of lab-on-a-chip systems in the healthcare industry, there is a growing demand for discovery, development, and testing of active nanodrug carriers within the microfluidic environment for controlled drug delivery. Chapter 5 by Professor Clement Kleinstreuer and Jie Li provides a comprehensive treatise on fundamentals and applications of microfluidics and bio-MEMS with respect to nanodrug targeting and delivery. Capillary electrophoresis (CE) and microchip electrophoresis (MCE) are two promising separation techniques for analyses of complex samples, in particular, biological samples. Not surprisingly, these techniques have been profoundly influenced by the advances in nanotechnologies. Chapter 6 by Muhammad J. A. Shiddiky and Professor Yoon-Bo Shim covers the recent developments and innovative applications of nanomaterials as stationary and/or pseudostationary phases in CE and MCE. This chapter illustrates the importance of various types of nanomaterials, including metal and metal oxide nanoparticles, carbon nanotubes, silica nanoparticles, and polymeric nanoparticles, in enhancing the separation of biological samples using CE and MCE. The examples we have seen so far involve externally fabricated nanomaterials, which are later on utilized for a number of applications within the microfluidic channels. Chapter 7 by Drs. J. Shi and Yong Chen discusses pillars and pillar arrays integrated into microfluidic chips in the fabrication process itself. This chapter demonstrates how such an approach provides a large variety of functionalities for molecule and cell biology studies. The applications we have seen so far in the first seven chapters range from biology to drug delivery. Chapter 8 by Shihuai Zhao and Professor Debasish Kuila is uniquely placed in the book as it brings out the recent recognition for microreactor as a novel tool for chemistry and chemical process industry, such as fuel industry. This chapter presents silicon-based microreactors for the development of nanocatalysts for
PREFACE
ix
industrially useful reactions. For example, methanol steam reformer to produce H2 and CO purifier is described in detail for potential microreactor applications in the next generation of alternative energy for portable power devices. The last example that the book provides is the application of microfluidic reactors for the synthesis of nanomaterials. With the increase in the demand for high-quality metal nanoparticles with narrow size, shape distribution, and homogeneous composition, the continuous-flow microfluidic processes are gaining attention as they are particularly suited for realizing constant mixing, reaction, and quenching conditions necessary for production of high-quality metallic nanomaterials. Chapter 9 by Dr. Ali Abou-Hassan et al. reviews the recent scientific literature concerning the use of microfluidics for the synthesis of the iron oxides nanomaterials. Chapter 10 by Professor J. Michael K€ ohler and coworkers is a fitting conclusion to the book delineating a number of promising opportunities and challenges for the application of microreaction technology for the synthesis and manipulation of metallic nanoparticles. In combination with the Chapter 9 in Volume 1, this will provide a strong platform from both theoretical and experimental perspectives on synergism between microfluidics and nanotechnology for automated microreactor-based controlled synthesis and engineering of nanomaterials for a number of applications. In conclusion, the two volumes bring out a clear understanding of theoretical and experimental concepts of microfluidics in relation to nanotechnology in addition to providing a seamless transition of knowledge between and micro- and nanofluidics. The contributors for both the volumes are world-renowned experts exploiting the synergy between microfluidics and nanotechnology. I am very much grateful to all of them for sharing my enthusiasm and vision by contributing high-quality reviews, on time, keeping in tune with the original design and theme of both the volumes. You will not be having this book in your hand but for their dedication, perseverance, and sacrifice. I am thankful to my employer, the Center for Advanced Microstructures and Devices (CAMD), who has been supporting me in all my creative ventures. Without this support, it would be impossible to make this venture of such magnitude a reality. No words can express the understanding of my family in allowing me to make my home a second office and bearing with my spending innumerable number of hours in front of the computer. It is impossible to thank everyone individually in this preface; however, I must make a special mention of the support from Wiley in general and the publishing editor Anita Lekhwani in particular, who has been working closely with me to ensure that this project becomes a reality. I am grateful for this support. Note: Additional color versions of selected figures are available on ftp://ftp.wiley. com/public/sci_tech_med/microfluidic_devices_concepts Baton Rouge, LA, USA November 15, 2009
CHALLA S. S. R. KUMAR
CONTRIBUTORS
Ali Abou-Hassan, Laboratoire de Physicochimie des Electrolytes Colloy¨des et Sciences Analytiques (PECSA), UMR 7195, Equipe Colloy¨des Inorganiques, ˜ Paris 6, Paris Cedex 5, France UniversitO Manish Bothara, Department of Electrical and Computer Engineering, Portland State University, Portland, OR, USA Vale´rie Cabuil, Laboratoire de Physicochimie des Electrolytes Colloy¨des et Sciences Analytiques (PECSA), UMR 7195, Equipe Colloı¨des Inorganiques, Universite Paris 6, Paris Cedex 5, France Yong Chen, Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, Japan Chunhui Deng, Department of Chemistry, School of Pharmacy, Fudan University, Shanghai, China Pamela G. Gross, Student Health and Wellness Center, University of Nevada at Las Vegas, Las Vegas, NV, USA Peter Mike Gu¨nther, Department of Physical Chemistry and Microreaction Technology, Institute of Micro- and Nanotechnologies, Ilmenau University of Technology, Ilmenau, Germany Emil P. Kartalov, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
xi
xii
CONTRIBUTORS
Clement Kleinstreuer, Department of Mechanical and Aerospace Engineering and Department of Biomedical Engineering, North Carolina State University, Raleigh, NC, USA Andrea Knauer, Department of Physical Chemistry and Microreaction Technology, Institute of Micro- and Nanotechnologies, Ilmenau University of Technology, Ilmenau, Germany Johann Michael Ko¨hler, Department of Physical Chemistry and Microreaction Technology, Institute of Micro- and Nanotechnologies, Ilmenau University of Technology, Ilmenau, Germany Debasish Kuila, Institute for Micromanufacturing, Louisiana Tech University, Ruston, LA, USA; Department of Chemistry, North Carolina A&T State University, Greensboro, NC, USA Vindhya Kunduru, Department of Electrical Engineering, Arizona State University, Tempe, AZ, USA Jie Li, Department of Mechanical and Aerospace Engineering, North Carolina State University, Raleigh, NC, USA Yan Li, Department of Chemistry, School of Pharmacy, Fudan University, Shanghai, China ´ di Firenze, Via della Giovanna Marrazza, Dipartimento di Chimica, UnivesitA Lastruccia, Sesto Fiorentino, Italy Sriram Muthukumar, Intel Corporation, Chandler, AZ, USA Shalini Prasad, Department of Electrical Engineering, Arizona State University, Tempe, AZ, USA Olivier Sandre, Laboratoire de Physicochimie des Electrolytes Colloı¨des et Sciences Analytiques (PECSA), UMR 7195, Equipe Colloı¨des Inorganiques, Universite Paris 6, Paris Cedex 5, France Jian Shi, Ecole Normale Superieure, Paris, France Muhammad J. A. Shiddiky, Department of Chemistry and Institute of Biophysio Sensor Technology, Pusan National University, Busan, South Korea Yoon-Bo Shim, Department of Chemistry and Institute of Biophysio Sensor Technology, Pusan National University, Busan, South Korea Yamini Yadav, Department of Electrical and Computer Engineering, Portland State University, Portland, OR, USA Shihuai Zhao, Institute for Micromanufacturing, Louisiana Tech University, Ruston, LA, USA; Tianjin University, Tianjin, China
1 MICROFLUIDICS FOR NANONEUROSCIENCE PAMELA G. GROSS Student Health and Wellness Center, University of Nevada at Las Vegas, Las Vegas, NV, USA
EMIL P. KARTALOV Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
1.1 INTRODUCTION The nervous system of an organism is like the information technology department of an organization. Each of the billions of building blocks of the nervous system, called neurons, is a multistate device similar to the transistors of a microprocessor. But while transistors are binary state devices, neurons are capable of being in many thousands of states, and this adds many orders of magnitude to the complexity of possible connections within a nervous system. In addition, each neuron has multiple connections with other neurons, and some of these connections are bundled into tracts and nerves that travel within brain and spinal cord, and out to peripheral locations. In computers, disconnection of one network cable, or disabling of the electronic circuits in the server, can seriously compromise the function of the organization. Similarly, traumatic injuries or neurodegenerative processes such as multiple sclerosis, Alzheimer’s disease, or Parkinson’s disease can significantly impair the functionality of an individual by damaging the neurons, tracts, and nerves. However, unlike computer systems, medical repair processes do not yet exist because we do not yet understand how the system operates in the healthy state. This may change in the near future as cell biologists pursue stem cell interventions to regenerate or remodel Microfluidic Devices in Nanotechnology: Applications, Edited by Challa S. Kumar Copyright 2010 John Wiley & Sons, Inc.
1
2
MICROFLUIDICS FOR NANONEUROSCIENCE
damaged areas of the nervous system. Simultaneously, engineers are teaming up with biologists to design electronic implants and prostheses that can interface with functioning tissue on either side of a damaged connection and act as a bridge to allow restoration of injured neuronal circuits. Pharmaceutical researchers are using nanotechnologies to create novel systems capable of delivering targeted drugs and other agents across the previously impenetrable blood–brain barrier,1,2 a feature of nervous systems that chemically separates the system from the rest of the organism. All these advances may be accelerated by knowledge derived from studies of cellular physiology using tools designed to study biological processes at the single cell level. As our ability to fabricate tools on the micro- and nanoscale levels has progressed, we can now study cellular processes at a scale compatible with cell size, and this is revealing new information about their operational responses, including how they respond to physical and chemical cues from their immediate environment. It is important that neuroscience researchers be aware of these new technologies, so that their use can be optimized. Recent advances in biological applications of micro- or nanotechnology have included novel micro- or nanoscaled carriers for drug delivery,3–6 quantum dots that operate as nanoscaled sensors at the cellular level,7–11 and nanoelectrodes.12 In addition, self-assembled monolayers and scaffolding, as well as carbon nanotubes, have been used as artificial nanotechnology matrices for cell culture.13–19 In neuroscience specifically, nanoparticles have been used for free radical scavenging in ischemic and neurodegenerative diseases.20 Scaffolds made of self-assembling nanofibers are being developed to enhance neuroregeneration.21 The blood–brain barrier has been successfully breached by drugs attached to special nanoparticles.22 High-resolution studies of the topography and material properties of live nervous system cells are being carried out by atomic force microscopy (AFM) (Figure 1.1).23,24 Single-molecule tracking using quantum dots has revealed details about the structure and function of membrane receptors.10,25,26 Finally, nanotubes, nanowires, and nanoneedles are being developed for use as relatively nontraumatic intracellular electrodes.12,27,28 On a slightly larger scale, microfabrication technology has been used to create microfluidic platforms that have been employed for a variety of nanoneuroscience studies, and these platforms will now be discussed. Microfluidics refers to a technology that utilizes microscale channels to manipulate fluid and suspended objects in a controlled manner at the nanoliter scale. Most microfluidic chips are designed and constructed using the same techniques as used in the development of microelectronic circuitry. Microfluidics has been advancing rapidly over the past decade and has progressed from basic devices, for example, a channel,29 a valve,30 and a pump,30 to large-scale two-dimensional integration of components,31 three-dimensional architectures,32 and nonlinear autoregulatory systems.32 Simultaneously, the development of the fundamental technology has enabled the advent of a plethora of specialized devices that have miniaturized important macroscale applications such as protein crystallization,33,34 DNA sequencing,35 and PCR (polymerase chain reaction), a technique for DNA detection and amplification.36,37 The same development has also enabled the advent of novel techniques to conduct fundamental research in a scale that was never previously possible.
INTRODUCTION
3
FIGURE 1.1 Atomic force microscopy images of neural lineage cells. (a) Three-dimensional rendering of an oligodendrocyte differentiated from a murine neural stem cell. Fixed sequentially with 100% ethanol and 4% PFA, air dried, and then imaged on an Asylum Research MFP 3D AFM using an Olympus AC160 cantilever in AC mode in air. Note the detailed process formation. Scan size is 90 mm 90 mm. (b) Three-dimensional rendering of a portion of a living astrocyte derived from a human embryonic stem cell on a polyornithine/laminin-coated substrate, imaged in media, in AC mode with an Olympus Biolever, and on an Asylum Research MFP 3D AFM. The image shows cytoskeletal fibrous elements visible through the cell membrane in the proximal thicker area of the cell as they enter a broad, flat attachment area. Scan size is 30 mm 30 mm (unpublished data, Pamela G. Gross).
More recently, some microfluidic chips incorporate other microtechnology and nanotechnology hardware, such as electrodes,38–44 magnetic coils,45,46 and surface-emitting lasers,47 to enhance their capabilities beyond fluid handling. Many of the first applications of microfluidic chips involved studying the physics of fluid dynamics at the microscale (characterized by low Reynolds numbers, laminar flow, and fast diffusion), which is quite different from the flow characteristics of bulk fluid at the macroscale (characterized by higher Reynolds numbers, turbulence, and slow diffusion). The unusual behavior of fluid traversing microchannels has allowed creation of new methodologies to manipulate molecules, in order to synthesize novel nanomaterials and chemical/pharmaceutical moieties, and this has been described in other chapters. For biologists, microfluidic platforms have emerged as invaluable tools to study biology at small scales, even down to the single cell level. For neuroscientists, these “lab-on-a-chip” platforms have enabled a novel approach for experiments on the cellular physiology of the nervous system. Their usefulness in deciphering the complicated interactions involved in the differentiation, growth, and maintenance of neurons in health and in disease has become increasingly apparent within the past 5 years, as more research in this field continues to be reported. As more neuroscientists become familiar with this technology, we anticipate a rapid evolution of the field. This chapter will review pertinent contributions in the use of microfluidics to study the physiology and pathophysiology of neurons and their support cells and will hopefully serve as a primer for neuroscientists unfamiliar with this technology, inspiring some to develop new applications of microfluidics to the field of neuroscience.
4
MICROFLUIDICS FOR NANONEUROSCIENCE
Microfluidic platforms typically contain a series of chambers and channels that each measure in the range of 1 mm to a few hundred microns and are used to process fluid at a microscopic scale. For in vivo applications, microfluidic technology has been integrated with neural implants for precise delivery of solutions.48 Three-dimensional electrodes with bundled microfluidic channels that can be implanted into severed nerves to guide and monitor their regeneration while allowing infusion of drugs are also under development.49 However, the most common biological application of microfluidics has been for in vitro studies, such as the delivery and processing of biochemical reactants for DNA sequencing35 and protein analysis,50 the sorting, counting, and analysis of cells by flow cytometry,51 the delivery of cell adhesives and cells for substrate micropatterning of cell populations,52,53 the development of biomimetic three-dimensional tissues, complete with stromal support molecules,18,19 and the isolation and nurtured maintenance of individual cells to study basic cell physiology and cell–cell interactions on a single (or near-single) cell basis.54–59 In addition, microfluidic platforms have been used to study the effect of laminar flow and shear forces on the function of endothelial and other types of cells,60,61 to provide artificial circulation through various organ-simulating cell culture chambers in order to determine the pharmacokinetics of prospective pharmaceutical agents,62 and to deliver test samples containing potential toxins to cells acting as biosensors (also known as “lab-in-a-cell” technology).63–65 Finally, microfluidics can be used to study physiology within small organisms, such as the effects of anesthetics on the regrowth of severed axons, or the recovery of axonal synapses after laser ablation in Caenorhabditis elegans nematodes that have been captured and immobilized in microfluidic chips.66,67 Microfluidic-based cell studies are a useful adjunct to conventional in vitro techniques or mini culture systems68 because microfluidic chambers have the ability to control both the amount of material (media, growth factors, etc.) used for cell study and their exact distribution over well-defined periods. This can permit better control of the experiment by limiting unanticipated extraneous factors and diffusion constraints that can occur in larger systems. The effects of cell population variability will also be more limited in smaller systems and therefore individual differences among similar cells will be less likely to influence results. From an economic standpoint, small culture volumes allow cost savings since the required volume of expensive media, hormones, and growth factors is orders of magnitude less than that used in typical culture flasks. These platforms can also be designed for high throughput and compatibility with automated laboratory equipment such as plate readers. In addition, the hardware is portable and it can be mass produced so inexpensively that it can be very cost-effective to perform massively parallel microfluidic platform-based experiments, in order to confirm results or test the effects of numerous agents simultaneously. These parallel experiments are necessary to verify results obtained on individual cells since it is known that there can be significant variation in the behavior of particular cells, even if they are cloned from the same precursor cell.69 Similarly, it will be imperative that the effect of microenvironment parameters such as mechanical forces, shear stress, effective culture volume, and material interfaces be well
INTRODUCTION
5
understood and controlled before interpreting single cell study results so that these factors do not contribute to misleading conclusions.70 Nevertheless, observations derived from studies of individual cells in a controlled microenvironment may be much more likely to reveal true cellular physiology responses than those derived from studying the responses of populations of cells simultaneously, as is done with conventional in vitro studies. Although the development of this technology has progressed significantly over the past 5–7 years, its utility as a tool is just beginning to be appreciated by biologists. There are many published reviews on the general topic of microfluidics for biological applications,69–85 but there have only been a few that have focused on microfluidic applications in neuroscience.80–82 This chapter will update the reader on the discipline of microfluidics to study the nervous system at the single cell level. Specifically, it will report on microfluidic chips used to decipher physiological processes and responses of cells of neural origin, and it will also focus on examples of systems that combine microfluidic chambers with other technologies for novel research not previously possible. Section 1.2 will begin with a description of current microfluidic chamber construction techniques, starting with a discussion of the characteristics of the PDMS polymer used in many microfluidic chambers and then moving on to cover stepby-step fabrication processes. Various architectural designs of use for cellular studies will then be introduced, followed by a description of alternative applications of PDMS to create tools that are useful in customizing the substrate of microfluidic chips for specific experiments. Practical limitations of microfluidic techniques will then be discussed to present a balanced view of the topic. In Section 1.3, gradient-generating designs will be reviewed, along with examples of how they have been used to study cellular responses. Methods of incorporating electrophysiological measurements into chip design, including patch clamping, will be examined and then use of other integrated micro- and nanoscaled analytical devices will be considered. The theory and methodology used for in vivo tissue simulation will be evaluated, since the natural behavior of cells is ultimately what most biological research is attempting to discern. Following this, a literature review of neuroscience research involving microfluidic platforms will be detailed in Section 1.4, starting with cell identification and separation tools, which is essential for researchers requiring specific subpopulations of neural lineage cells. Studies on microfluidic analysis of neuropeptide release will follow, which is of interest to individuals studying synapse formation and function. The use of microchips to study the effects of physical and chemical guidance cues on single cells will then be considered since this is a key to understanding how neural cells interact with their environment and with each other. Section 1.5 will focus on electrophysiology studies that use multielectrode arrays (MEAs) as microfluidic chamber substrates. This is a popular field of endeavor since these two technologies seem to be complementary and can allow studies on action potential characteristics and propagation in single axons. The effect of growth factors on neuronal responses of microfluidically cultured and isolated cells will be covered after this, given its significance in understanding cell differentiation and maturation.
6
MICROFLUIDICS FOR NANONEUROSCIENCE
The use of microfluidic chambers for gene therapy studies on neural cells will be subsequently discussed. Although this is a relatively new area of study, preliminary results are very promising and future research will likely take advantage of the unique capabilities that microfluidic chips offer to this field. The final area of research to be covered involves studies based on the microfluidic isolation of axons and neural cell bodies. This approach to neural research is gaining great interest, given the potential applications for those studying neural degeneration and regeneration processes, in addition to those interested in axonal transport mechanisms, and synapse formation and physiology. A general discussion with consideration of future perspectives will complete the chapter. It is hoped that the reader will gain an appreciation for the future potential of these platforms to uncover previously hidden cell-based interactions in the nervous system, and this will stimulate new applications of microfluidics for their specific research programs.
1.2 PDMS MICROFLUIDIC DESIGN AND FABRICATION 1.2.1 Characteristics of PDMS Initially, most microfluidic chambers were constructed on silicon wafers using “hard” lithography. Since those early studies, “soft” lithography has been developed and various polymers and fabrication techniques have been investigated.86 Now, softsided chambers made of polydimethylsiloxane (PDMS) are gaining increased popularity, especially for biological applications. PDMS is a silicon-type elastomer and can be purchased commercially as Sylgard 184 by Dow Corning or RTV by General Electric. It can be molded into many different shapes to form valves, chambers, and channels. PDMS is advantageous for biological studies since it is biocompatible, optically transparent down to wavelengths as low as 280 nm, permeable to gases needed for cellular respiration, autoclavable, and naturally inhibitory to cellular adhesion.87,88 PDMS has therefore proven very handy for cellular studies by allowing long-term cultures, optical microscopy, and fluorescent/chemiluminescent studies, while the cells are still in situ in the chip.64 A final advantage of this material for use with cell culture systems is that PDMS has been shown to be an excellent protective coating for on-chip solid-state analytical devices (such as surface-emitting lasers), since PDMS is optically transparent yet prevents the detrimental effects of ions migrating from the culture medium into sensitive electrical junctions.47 Native PDMS is hydrophobic, and this influences many of its surface properties, including its interactions with fluid and molecules that are in contact with it. These properties can be altered by physical and chemical treatments that can change the hydrophobicity of the surface of the PDMS channels and change its adhesive properties if this is desired.74 For example, the pretreatment of the PDMS channels with bovine serum albumin (BSA) will assist in blocking cell adhesion to its surface.54 Alternatively, PDMS can be made hydrophilic and supportive of cell growth by treatment with oxygen plasma,88 or UV/ozone,89 that acts by changing the moieties on the PDMS surface to increase the number of silanol groups and decrease the number
PDMS MICROFLUIDIC DESIGN AND FABRICATION
7
of siloxane groups. Polyethylene glycol (PEG) can also be used to alter the surface chemistry of PDMS.35 The surface interactions of PDMS with adjacent molecules will also depend on local flow conditions. Experimentally, proteins such as collagen and fibrinogen adhere to both hydrophobic and hydrophilic (oxygen plasma-treated) PDMS. But under flow conditions, the oxygen plasma-treated hydrophilic surfaces experienced only temporary adhesion, followed by rapid detachment of any adherent cells, whereas the hydrophobic PDMS channels became permanently clogged with protein and cells.88 Therefore, systems that are designed to have continuous exposure to protein-laden media and cells will likely benefit from pretreatment of the PDMS with oxygen plasma to increase the functional lifetime of the channels. 1.2.2 PDMS Chip Fabrication Protocol Microfluidic chip fabrication uses many of the same techniques used in electronic circuit production. The process begins with the creation of an architectural design using a computer-aided design (CAD) software program. The design is printed on a transparency using a high-resolution printer, since the feature size on the final chip will be determined by the resolution of features on the transparency. This transparency acts as a photomask during the next step, in which it is placed over a substrate (silicon wafer or glass) that is precoated with a thin layer of photoresist, a photocurable epoxy. UV exposure polymerizes exposed areas for photoresists such as SU-8, so the developer solution can strip away the unexposed areas because they are not polymerized, while the polymerized exposed structures remain. This type of photoresist is called negative photoresist because the result is the reverse, or “negative,” of the mask. On the other hand, photoresists such as 5740, SPR-220, and the AZ family are called “positive photoresists” because the result corresponds to the mask; that is, the result is “positive” to the mask. UV exposure makes a chemical change in positive photoresists that results in the material becoming more soluble, for example, in a strong base. Thus, the developer solution removes the material from the exposed areas, while the structures in the unexposed areas remain. In both cases, the result is a mold where the features are built in photoresist. Since photoresist is softer than silicon, the resulting mold is softer than traditional molds, and so the technique has been named “soft lithography.” In the next step, PDMS is combined with its catalyst in a 10:1 proportion and the mixture is degassed in a vacuum chamber to remove bubbles. It is then poured onto the master, allowed to cure, and then peeled off the mold. Access ports are punched after casting (or silicon tube ports are placed during casting) to create connections to input and drainage tubes. The PDMS slab is then placed onto a substrate such as a silicon wafer or a glass slide to create the final microfluidic platform. The PDMS forms a reversible conformal seal to the substrate, but optional treatment of the PDMS with plasma oxidation of the PDMS surface after curing will render the surface more hydrophilic and allow the PDMS to irreversibly bond to the substrate. After sterilization by means of autoclaving, UV treatment, or immersion in 70% ethanol, the system is ready for use.
8
MICROFLUIDICS FOR NANONEUROSCIENCE
Although PDMS can reproduce features down to 10 nm in size,75 actual fabricated channels in PDMS have not yet achieved a cross-sectional area smaller than 1 mm2.74 This is because the feature size of the PDMS is determined by the printed resolution on the photomask, which is determined by the printer used to create it. For example, standard printers that have a resolution of 5080 dpi can reproduce features on the photomask down to 25 mm resolution, whereas photoplotters that print at 20,000 dpi can achieve a resolution down to 8 mm.75,90 To reproduce smaller features, chrome masks may be used, which are created with e-beam or laser writing and are much more costly. In addition, the relative softness of PDMS makes it difficult to maintain uniformly high quality of the reproduced features when the linear scale is decreased below a few microns. 1.2.3 Architectural Designs of Microfluidic Platforms The physical behavior of a fluid flowing through microscale channels is very different from the flow characteristics of the same fluid flowing through larger channels. For example, fluid flow through microfluidic channels is laminar, so mixing does not occur between solutes placed at different locations in the channel cross section, except by the slow process of diffusion. Without turbulence, solute gradients will remain relatively intact as fluid traverses down channels of uniform width. If cells are localized at certain areas of this channel, their exposure to specific concentrations of solute can be tightly controlled. In fact, different parts of the cell can even be exposed to different and controlled concentrations of the solute. This laminar flow behavior can also be used to pattern and deposit specific solute concentrations onto the substrate or to pattern cell adhesives and repellents next to each other onto the substrate prior to introduction of cells. Alternatively, if mixed patterns are desired, deliberate oblique grooving of the floor of the channel can be employed to create turbulence in order to mix solutes,91–93 and nanotopographic features can also be added to the platform substrate to influence cell adhesion.94 Most microfluidic chips use some type of dynamic flow conditions, with flow achieved by the use of syringe pumps, gravity-driven reservoirs,95 electrokinetic control,96 or other more complicated functional PDMS valve structures. These valves are designed by layering “control channels” that act as bladders across flow channels. Application of pneumatic pressure in the “control channels” can then cause controlled collapse of the underlying fluidic lumen, and this controlled deformation of the flow channel’s lumen creates a functional valve.30 Digital control and sequential coordination of these valves can create peristaltic pumps. Rotary pumps based on similar mechanisms have been designed and used for applications that require repeated cycling of fluid for mixing, such as on-chip PCR, used in amplification and identification of DNA strands in genetic engineering.97 Various structures have been devised to immobilize cells within microfluidic chips. These architectures must be able to catch and retain a cell from a passing stream of media, while minimizing damage to the cell. Sieves have been used within the culture chamber to retain cells while also producing a nutrient gradient.98 Channel walls can be constructed at partial height to create a dam that allows flow from one channel to
PDMS MICROFLUIDIC DESIGN AND FABRICATION
9
another while gently transporting and immobilizing cells for later analysis.99 Inverted T junctions that have small docks with tiny drain channels at the junction have been used to immobilize single cells and then perform rapid on-chip calcium flux assays.54 Curved docking areas that can balance the forces exerted on cells (fluid flow versus gravitation) have also been used to isolate individual cells for culture and study of calcium mobilization.56,57 Gravity-induced flow has been combined with dielectrophoresis to trap and sort cells without physically contacting them.100 For the capture of cells with variable dimensions such as pancreatic islets (used in diabetes research), designs have combined one semiellipsoidal wall and one movable wall to create an adjustable holding area that will allow studies on the regional effect of infused glucose and drugs.59 Studies on pairs of cells have used intersecting channels that have been designed to trap pairs of cells from different populations to study intercellular communication via gap junctions between their cell membranes.55 Finally, the surface of PDMS has been microstructured with arrays of wells and coupled to a microfluidic system to create a test platform for parallel experiments on single cells or small groups of cells.101 As described above, a significant advantage of microfluidic chambers is that the architectural design and the dimensions of the channels and chambers can be customized for the morphology of the cells to be studied and to the task to be accomplished. As new researchers enter this field, we expect to see a wealth of new designs for novel applications. 1.2.4 PDMS Tools In many cases, it is desirable to have a microfluidic chip substrate that is patterned with different molecules prior to assembly of the chip. This can be easily achieved by creating a separate PDMS tool that contains the substrate pattern and can be used as a stencil or a stamp. This tool is fabricated using the same techniques as outlined above. After completion of the tool, it can be used for microcontact printing by dipping the patterned area into a fluid with the desired concentration of solute molecules and then transferring this pattern to the substrate. PDMS can also be formed into a twodimensional stencil sheet that allows patterned deposition of selected proteins or agents onto the underlying substrate, and this PDMS stencil has the advantage of being useful on irregular or curved substrate surfaces. Once the protein pattern has been created on the substrate, the remaining platform can be constructed by applying the matched PDMS chip so that its channels are complementary to it. With this arrangement, future cell attachment and differentiation can be guided, and cocultures can be created in controlled geometric patterns.102–104 Since this technique can help control the exact position of neurons on a substrate, the resultant controlled neuronal patterns can be very helpful in studying neural networks and interactions occurring within synapses.69,102,103,105 These techniques have also been combined with selective oxygen plasma treatment to create long-term and short-term cell repellent areas to coculture cells in controlled geometric patterns.104 In this case, cell repellent polymers were homogeneously deposited on a substrate, and a PDMS stencil was used to selectively protect the repellent from plasma treatment in certain areas. Unprotected areas lost their repellent nature and could then be treated with adhesives like
10
MICROFLUIDICS FOR NANONEUROSCIENCE
fibronectin and short-term repellents like BSA to create patterns of relative adhesivity over time that could then be seeded as desired with different cell types. 1.2.5 Practical Considerations and Limitations As with all new technologies, there are certain practical design considerations and limitations that must be recognized before planning a microfluidic chamber for cell studies. Cell viability has definitely been correlated with channel size and proportions, closed versus open-channel configurations, and static versus dynamic media flow. For example, it has been shown that in contrast to cells grown in conventional tissue culture flasks, the proliferation rates of cells grown in microfluidic channels without media flow depend on the height of the channel.106 This is likely due to loss of convective movement of cell-expressed inhibitory factors away from cells, rather than lack of nutrients or change in osmolarity or pH of the culture medium. In a static system where there is no flow of media or connection of the media in the channels to a bulk container, secreted factors can only be dissipated by diffusion, and this can be insufficient to remove their often deleterious effects.106 If continuous or intermittent flow is designed into the system, the flow rate must be optimized to provide nutrients and remove wastes, without producing excessive shear stress that can change morphology or migration of the cells or even detach the cells.98,107 Similarly, certain secreted factors may be essential for cellular health, and if the flow is too high, then these factors may be washed out. Pretreatment of the PDMS prior to the introduction of cells can have significant effects on cell culture success. For example, Matsubara et al. showed that different treatments to make the PDMS hydrophilic affected both the morphology and the density of mast cells.64 Similarly, Prokop et al. found that extracellular matrix deposition and plasma treatment of the PDMS improved subsequent cell cultures.98 Other important considerations include recognition of the fact that the tiny volume of microfluidic culture systems confers a much less stable homeostatic system in terms of temperature, carbon dioxide concentration, and humidity control compared to standard Petri or tissue culture flasks. These chips equilibrate much more rapidly with their environment than larger systems given their larger surface area to volume ratio, so each time these chips are removed from the incubator, they are prone to more rapid alteration of their temperature, atmosphere, and humidity. Temperature alone is known to directly influence gene expression, biochemical reactions, and diffusion speed. To maintain a stable system, steps must be taken to minimize losses of environmental stability. Similarly, if media is fed into these chips via tubing that is outside the incubator (i.e., if connected to a syringe pump), or if the tubing is part of a “mini” culture system, it is important that media temperature and CO2 content do not change during transport through the tubing.68 Therefore, although these microscale systems are technically portable, control systems for their ambient environment may be necessary if they require transport outside the incubator for time lapse imaging or other interventions. We witnessed this effect directly when an isolated axon in a microfluidic chip was observed to shrink back significantly within a few minutes of removal from the incubator and placement onto the cold microscope stage
PDMS MICROFLUIDIC DESIGN AND FABRICATION
11
(unpublished data). Control of humidity is also critical because water diffuses into PDMS according to Fick’s law of diffusion.108 From there, it can evaporate and lead to increased osmolarity of the cell culture medium and premature cell death. Methods to minimize evaporation, such as coating the PDMS with a thin layer of parylene, have been successfully implemented and shown to prolong cell viability.108 The last practical consideration in using PDMS as a culture chamber in microfluidic systems involves the high ratio of chamber surface area to the volume of culture medium and number of cells compared to standard culture flasks. This increased surface area to volume ratio can lead to increased interactions between chamber contents (media, cells) and chamber walls. For example, it is known that small hydrophobic molecules may partition into the PDMS and therefore be less bioavailable when studying their effects on cells.109 This extraction of media solutes by the PDMS can significantly change the concentration of some agents in media within microfluidic channels by many orders of magnitude. The magnitude of this change depends on the partition coefficient of the substance, the pH of the culture medium, and the counterion pairing in the media. Major decreases in the media concentration of neurotransmitters, hormones, and growth factors could change experimental outcomes, and the cost savings for using small volumes of these agents in microfluidic platforms can be lost if much larger quantity of the substance has to used to achieve the same effect. Therefore, many individuals are now experimenting with different surface treatments to decrease the porosity of the PDMS and avoid some of these effects. In addition to taking up biomolecules, the PDMS may also release potentially toxic agents from its polymer matrix.110 These can then be concentrated in a proportionally smaller volume of culture medium and may affect more sensitive cells. Certainly, neurons from different sources vary in their hardiness, and culturing sensitive neurons at low density and in serum-free conditions can be difficult, even in the most tightly controlled environments. For example, we have personally had difficulty maintaining the viability of human neural stem cells in PDMS chips, whereas rat dorsal root ganglion cells thrived in the same conditions (unpublished data). One possible explanation of this phenomenon may be found in the work of Millet et al., who hypothesized that there might be seepage of toxins from the PDMS.110 In their research, they tried to improve neuron survival in open- and closed-channel microfluidic chips by treating the PDMS with serial solvent-based extraction processes (to remove potentially cytotoxic uncross-linked oligomers and residual platinum catalyst in the PDMS) or with autoclaving (to drive cross-linking and outgas solvents). They found that treatment with extraction improved neuron survival, increased the development of neurites, and lowered platinum levels in the PDMS more than did autoclaving. Specifically, the ratio of neuron survival was 3:28:51 for native PDMS, autoclaved PDMS, and extracted PDMS, respectively. Overall cell viability in low density, small volume, serum-free studies in closed-channel devices was improved from less than 2 days in native PDMS to over 7 days for extracted PDMS. If gravity-driven flow was added, survival could be further increased to over 11 days by improving nutrient delivery and waste removal compared to static systems. These extraction processes will be imperative for future studies on
12
MICROFLUIDICS FOR NANONEUROSCIENCE
individual cells or cell-to-cell interactions in low-density cultures in microscale culture volumes. Perhaps the biggest impediment to the general acceptance of microfluidic platforms as tools for biological investigation will be the initial need for interdisciplinary teams of researchers that include both engineers who can devise and fabricate the chips and biologists who know when and where to best apply the technology. As with all new technology, the developers may not be able to recognize its most useful niche, and the users may not be aware of the technology or have the auxiliary tools and expertise to operate it correctly. However, as more individuals take the steps to experiment with the technology, it would become more commonplace and better utilized. On the other hand, the novelty of the underlying technology and of the general approach of combining neuroscience with microfluidics offers unique and exciting opportunities to address fundamental problems with new tools in new ways. These technologies thereby carry the immense promise of important breakthroughs and new insights both in fundamental neuroscience and in its extensions to biomedical practice in improving the treatment of many neurological diseases.
1.3 DESIGNS AND DEVICES FOR NEUROSCIENCE APPLICATIONS 1.3.1 Gradient-Generating Designs As discussed above, the laminar flow that occurs in microscale channels can be used advantageously to create high-resolution gradients of solutes and special factors within the cell culture chamber, in order to assess the effects of these gradients on the behavior of individual cells. These designs employ two or more inputs—one for the studied factor and one for the diluting medium, with each connected to its own syringe pump. The inputs connect to a network of serpentine, interconnected channels that repeatedly split and remix, with each generation of splitting channels increasing in number, until they finally coalesce back into a single larger channel (Figure 1.2). At each branch point, some mixing occurs so that there is a gradient of concentrations of the studied factor(s) that is oriented perpendicular to the flow direction at the final exit channel, and this gradient has a range of resolution spanning from several microns to hundreds of microns. After exiting the gradient-generating device, the established gradient is maintained by laminar flow. By varying the flow rate into one input, dynamic and asymmetric gradients of variable shape (smooth, step, or multiple peaks) can also be created.52,111,112 These devices have been used to study the effects of IL8 (interleukin 8) on neutrophil chemotaxis,113EGF (epidermal growth factor) on breast cancer cell chemotaxis,114 and various growth factors on neural stem cells.115 These gradient-generating devices are commonly used for research on the physiology of neural lineage cells since the devices provide precise control over exposure of growth and inhibitory factors to these cells. In addition, these same devices have been used to etch a controlled gradient into the surface topology of chip substrates by injecting etching reagents, or to lay down gradients of adhesives, self-assembled monolayers (SAMs), and dyes.111 Finally, these gradient generators have been
DESIGNS AND DEVICES FOR NEUROSCIENCE APPLICATIONS
13
FIGURE 1.2 (a) Photograph showing a microfluidic device used for generating gradients of green and red dyes in solution. The three incoming channels (top part of the photograph) were connected to syringes via tubings (not visible). After combining the streams into a single, wide channel (bottom of the photograph shown in (a)), a gradient was formed across the channel, perpendicular to the direction of flow. (b) Schematic explaining the nomenclature used for the mathematical description of the network. (c) Schematic demonstrating the application of the formulas governing the splitting ratios at the branching points. The dotted lines indicate the boundary between the two combined streams. The concentrations at the end of the serpentine channels can be calculated by multiplying the concentration of the incoming streams (cp, cq, cr) with the corresponding numbers of the splitting ratio (Vp þ 1)/B, (B Vq)/B, (Vq þ 1)/B, and (B Vr)/B, as indicated). Reprinted with permission from Ref. 112. Copyright 2001 American Chemical Society.
combined with large chip-based arrays of cell culture chambers (10 10) to simultaneously perform 100 parallel tests on the effect of an agent’s various dilutions.116 Since these chambers each had four individual access ports, repeated growth/passage cycles of the cells could be performed on-board by microfluidic control, so the cell cultures could be maintained over long periods. As demonstrated with the studies described above, these gradient devices are very useful tools for investigations into cellular responses to varying concentrations of specific factors, whether these factors are substrate bound or dissolved in media.
14
MICROFLUIDICS FOR NANONEUROSCIENCE
1.3.2 Integrated Electrophysiology For electrically active cells such as neurons and muscle cells, integrated electrical recording is a very valuable addition to microfluidic platforms. An early example of this was a unique system that was designed as a self-contained, portable unit for field use as a cell-based biosensor. The unit incorporated a hybrid glass/PDMS/silicon chamber for cell culture with integrated microfluidics, a microelectrode array substrate modified with fibronectin and gelatin for cell growth, a temperature regulation system, on-chip electronics for acquisition, analysis and display of action potentials, and a transparent cover that makes the unit amenable to microscopic inspection.65 This approach of creating a stand-alone unit with its own environmental controls may eventually be required of many platforms in the future; however, most neuronal studies have employed much simpler hardware, typically using commercial MEAs as the substrate for a PDMS microfluidic chip. These will be discussed in more detail in Section 1.4.4. The “gold standard” for electrophysiological studies has always been patch clamping, and many microfluidic platforms incorporating arrays of patch clamp electrodes have been engineered and successfully demonstrated. Conventional patch clamps use suction to attach the tip of a glass micropipette to a cell membrane, and then break the membrane and record the intracellular potential using a conductive fluid in the micropipette. In early microfluidic designs, these systems used PDMS microfluidic channels to guide cells to pores micromachined into silicon wafers,117 or they used cell-trapping pores in a horizontal PDMS substrate.118–120 These pores simulated the tip of a conventional glass micropipette and were used to create a highresistance seal to the cell wall for subsequent electrical recording. Ionescu-Zanetti et al. improved on this design by incorporating pores on a vertical channel wall of the PDMS to facilitate the use of optical and fluorescent microscopy to monitor the procedure.121 This vertical approach allows both the cell and the capillary tube leading to the pore to be in the same plane of focus, and, therefore, it permits easier guidance of the selected cell to the pore (using a combination of flow in the cell chamber and suction from the pore). It also permits visual monitoring of the cell condition and position during the recording. Each pore is connected to a capillary tube that applies negative pressure (suction) to attach the cell and break the membrane and to a silver/silver chloride electrode that then connects to a multiplexer circuit to process the recorded signals. Using CHO (Chinese hamster ovary) cells, the seal resistance between pores and cells was an average of 300 megaohms, and the system was able to record currents down to 20 pA. Individual cell trapping could be achieved in less than 3 s, and the seal was stable for 20–40 min (Figure 1.3). This group further updated this system by raising the trapping pore above the chamber floor to avoid deformation of the trapped cell. They also opened the ceiling of main chamber to ensure rapid fluidic access for high-throughput drug profiling on the clamped cell. For these authors, this microfluidic approach to patch clamping represented a much more efficient system for pharmaceutical analysis than traditional patch clamp technology.122 Unfortunately, patch clamp resistance seals in the megaohm range as reported above are not ideal, and other groups have been modifying their techniques to
DESIGNS AND DEVICES FOR NEUROSCIENCE APPLICATIONS
15
FIGURE 1.3 Patch clamp array on a microfluidic platform. (a) Cell trapping is achieved by applying negative pressure to recording capillaries that open into a main chamber containing cells in suspension. Attached cells deform, protruding into the capillaries. Patch clamp recordings are obtained by placing AgCl electrodes in each of the capillaries, as well as in the main chamber. Signals are fed through a multiplexing circuit and into the data acquisition system. (Multiplexer setup and microscope objective are not to scale.) The device is bonded to a glass coverslip for optical monitoring. (b) Scanning electron micrograph of three recording capillary orifices as seen from the main chamber. The capillary dimensions are 4 mm 3 mm, with a site-to-site distance of 20 mm. (c) Dark-field optical microscope image of cells trapped at three capillary orifices. Trapping was achieved by applying negative pressure to the recording capillaries. The device consists of 12 capillaries arrayed 6 along each side of the main chamber fluidic channel along a 120 mm distance. Reprinted with permission from Ref. 121. Copyright 2005 National Academy of Sciences USA.
improve this. Chen and Folch used e-beam lithography to create a 1 mm cell attachment aperture in their patch clamp chip. This method was combined with standard photolithography using high-resolution photomasks to create larger suction channels. They also used O2 plasma treatment of their master and PDMS chip to smooth the edges on the aperture, and they achieved reliable gigaohm seals and signal quality that was similar to that obtained with traditional glass pipette patch clamps.123 Commercial forms of these microfluidic patch clamp technologies will likely be available in the near future. 1.3.3 Other Integrated Sensors and Microfluidic Capabilities Microfluidic chips have employed many other complementary microtechnologies in recent years for application to biological studies. Although they have not all been used specifically for neuroscience studies, they do have this potential and they are presented here for the interested and motivated reader. For example, as an alternative to using electrodes, charged membrane-permeable, potential-sensitive dyes have been used in a microfluidic device to determine the membrane potential of cells in a rapid, highly
16
MICROFLUIDICS FOR NANONEUROSCIENCE
sensitive manner, with minimal consumption of reagents.124 Various electrical parameters including amperometry, impedance measurement, and potentiometry have also been used to analyze cells and their ionic secretions in microfluidic chambers (see the excellent review on this topic by Bao, Wang, and Lu).85 The relative acidity of the contents of microfluidic channels has been monitored by pH-sensitive fluorescently tagged monolayers (SAMs) that are bound to the substrate of the microfluidic platform.125 An alternative pH meter with higher sensitivity has used a different technology in microliter flow chambers to measure pH changes down to 0.5 103 pH units. This device has been useful in the study of cellular processes that alter ATP levels, such as receptor activation and signal transduction.126 The oxygen content in microscale cell cultures is another important parameter that can be monitored by an on-chip oxygen sensor based on fluorescent quenching of ruthenium dye particles encapsulated in the PDMS of the microfluidic culture device.62 Silicon chips containing multiple microsensors for bulk detection of extracellular pH, oxygen consumption rates, and cell morphological alterations have also been developed.127 and although not yet applied to microfluidic single cell studies, it is reasonable to expect that they might be adaptable to this purpose in the future. More advanced technology has also been miniaturized for on-chip use. For example, single nonperfused neurons have been studied with NMR (nuclear magnetic resonance) microcoils, and NMR spectroscopy has been used to determine their metabolite content, but the need for continuous perfusion to prevent cell death was noted.45 To address this issue, planar NMR probes have been incorporated into microfluidic platforms and preliminary studies on their functionality are underway.46 Other advanced technologies such as surface-enhanced Raman scattering and confocal microscopy have been combined with microfluidics to study real-time intracellular chemical dynamics of single live cells with high spatial and temporal resolution.128 Apoptosis (programmed cell death) is an important cellular process that is well studied by both biologists and pharmaceutical companies since it is critical to understanding how to control cancer and cell growth in general. Microfluidics have been used to study the multiple morphologic and biochemical changes associated with apoptosis at the single cell level.72 Tamaki et al. noninvasively monitored the change in cytochrome c distribution that occurred during apoptosis of single neuroblastoma–glioma hybrid cells confined in quartz glass microfluidic chambers by using scanning thermal lens microscopy without the need for any labeling materials.129 Finally, on-chip single cell genetic evaluation and manipulation will be useful for neuroscience cellular studies. One successful technique for this involved a combined microfluidic/microelectroporation chip that could isolate and temporarily immobilize individual prostate cancer cells in a channel, prior to application of a 10 V, 100 ms electric pulse to puncture the cell membrane and insert green fluorescent protein genes into them.130 In more recent work, a lower applied voltage of only 0.8 V for 6.5 ms was focused at one location on the membrane of individually trapped HeLa cells and resulted in successful electroporation.131 Because of the lower voltage requirement and because this design was able to monitor the permeation of the membrane by recording accompanying jumps in electrical current across the cell membrane, it represented a definite improvement over previous technology.
DESIGNS AND DEVICES FOR NEUROSCIENCE APPLICATIONS
17
Another example of a platform for genetic studies used microfluidics to isolate cells and then lyse them prior to purifying and recovering their mRNA, the genetic instruction codes that cells use to synthesize proteins.132 Further development of this technology from this same laboratory has yielded chips capable of performing 72 parallel, 450 pL reverse-transcriptase PCR reactions that could detect mRNA levels down to 34 RNA templates.133 They have also used microfluidics to synthesize cDNA from subpicogram mRNA templates isolated from single cells134 and performed gene ligation with plasmids and successfully transformed the plasmid DNA into competent cells.135 This technology has potential utility for neuronal studies. 1.3.4 Simulating In Vivo Tissues with Microfluidics To draw reasonable conclusions about in vivo processes using data derived from our in vitro experimental models, these models must simulate real tissues as closely as possible. This is why many researchers have tried to consolidate multiple cell types and extracellular matrix proteins into a three-dimensional architecture. Otherwise, the data may be misleading and oversimplified. For example, most muscle cells grown in vitro have different morphology and function compared to those grown in vivo. However, one group of researchers found that they could culture cardiac muscle myocytes with more typical morphology if they cocultured fibroblasts alongside of them on linear, intersecting patterns of collagen deposited within microfluidic channels.136 Similarly, a perfused microfluidic platform built upon a substrate with alternating cell adhesive (matrigel on poly-D-lysine) and cell repellent stripes (polyacrylamide and polyethylene glycol) was used to grow and fuse myoblasts into realistic multinucleated myotubes.91 Based on studies such as these, it is now believed that many environmental parameters can directly influence a cell’s cytoskeleton and subsequently alter cell behaviors such as proliferation, motility, and migration, to name a few. To better understand these interactions, the effect of variably sized and shaped microfabricated cell culture wells has been studied. Preliminary work shows that these single cell wells (treated with cell adhesive material via PDMS microcontact printing) have been successful in altering the three-dimensional shape of the cell contained within them.137 Further study in this field may reveal how cell shape in vivo alters cell function. In addition to controlling individual cell shape, environmental cues from cell attachment matrices containing self-assembling proteins and gel-like substances have influenced the three-dimensional shape of a group of cells in vitro.17 Microfluidics have been used to build up realistic vascular tissue by sequentially depositing layers containing different cell types and extracellular matrices (collagen, matrigel, etc.) within a platform.18,19 These types of microfluidic platforms have the capability of creating more biomimetic in vitro systems, but they may also encounter the same type of limitations on study that using live tissue sections do. Rather than trying to simulate real tissue, it may be more important in the in vitro study of individual cell physiology to create a substrate with the right characteristics. For example, to be truly “physiologic,” in vitro substrates must re-create several characteristics of normal in vivo extracellular matrices, including mechanical properties (such as elasticity,
18
MICROFLUIDICS FOR NANONEUROSCIENCE
rigidity, and strain), chemical properties (such as ligand density and orientation), and topographic properties (such as surface curvature and fibrous contact guidance). These characteristics control cell distribution in tissues and guide cell morphology, behavior, gene expression, proliferation, differentiation, and apoptosis, presumably through interactions with transmembrane integrin receptors.17,138,139 This theory is reinforced by studies that show that neurons grow better on a “soft” bed of astrocytes than on glass.139 As research in this field progresses, we expect to see more physiologic substrates being incorporated into microfluidic systems. Researchers investigating neural prosthesis development are very interested in trying to optimize substrate topography and chemistry. Their goal is to find the best substrate that will prevent astrocytes from overgrowing the implanted electrodes since these cells can interfere with signal transmission by insulating the electrodes from the neurons. Results from research on microfluidic substrates for neural growth and on prosthesis optimization will likely benefit both fields. For example, studies have shown that certain cells do prefer certain nanotopographies, as demonstrated by the finding that astroglial cells preferentially attach to pillars over wells and respond to the topography by changing their expression of cytoskeletal proteins such as actin and vinculin.140 Independent chemical cues also have different effects on different cell types. For example, substrate-bound peptides with the amino acid sequence IKVAV preferentially promote neural adhesion, whereas the sequence RGD promotes fibroblast and glial cell adhesion.141 In contrast to the goals of prosthesis development to limit astrocyte attachments, neural stem cell researchers desire a controlled bed of astrocytes to generate a permissive environment for the differentiation of neural stem cells. Research shows that combining topographic cues (in the form of substrate grooves) with chemical cues (in the form of adsorbed laminin molecules) can orient over 85% of astrocytes in the direction of the grooves.142 This can help to control the differentiation of neural stem cells cultured over the astrocytic bed and hopefully will permit directed axon regeneration in future studies. A final limitation of developing truly three-dimensional cultures in vitro has been the difficulty of maintaining cell viability when cell density approaches the order of magnitude seen in live tissues. Cullen et al. theorized that this might be due to lack of adequate perfusion to supply nutrients and remove waste products.143 They used microfluidics to create a cylindrical PDMS culture plate that had multiple inlet ports at the base and peripheral (circumferential) outlet ports along the edge. The plate was covered with FEP (fluorinated ethylene propylene) membrane to minimize evaporative losses while allowing gas exchange, and the ports were connected to a syringe pump to keep the culture volume constant, while using forced interstitial convection at various perfusion rates. Cells were loaded into a 500 mm thick 3D matrigel matrix preloaded in the plate. The researchers were able to demonstrate that a perfusion rate of 10–11 mL min1 allowed greater than 90% viability in neuronal or neuronal/astrocyte cocultures, with cell densities that more closely matched the density of the brain than prior successful models (although still lower than that found in the brain cortex). It will likely be imperative that three-dimensional systems incorporate excellent perfusion systems to truly simulate an in vivo experience.
NEUROPHYSIOLOGY EXPERIMENTS USING MICROFLUIDIC CHIPS
19
FIGURE 1.4 Schematics showing the microscaffold system. (a) An 8 8 array of hollow microtowers with functional cross-connects along the x-direction and structural cross-connects along the y-direction. The microtowers in this schematic project 1.5 mm out the topside and backside of the Si orifice plate. (b) A 3D cross section of the microscaffold device encased in the PDMS fluid manifold. The fluid manifold allows continuous perfusion of the cells growing within the active microscaffold. Reproduced with permission from the Royal Society of Chemistry.144
Rowe et al. approached the perfusion problem from a structural engineering standpoint and actually engineered a three-dimensional scaffolding system made of SU-8 photoresist and gold electrodes.144 The design included a system of integral microchannels and ports within the major support struts, to simulate microvascular perfusion, and the entire structure was encased in a PDMS manifold for fluid delivery. Their preliminary results found that their 3D substrate successfully supported neuronal cultures and the resultant neural networks that developed showed more complexity than those grown on two-dimensional electrode arrays. Future studies planned to include electrical recordings from the gold electrodes (Figure 1.4). Regardless of whether future in vivo-type culture systems employ three-dimensional support structures built up chemically or structurally, or using a combination of these techniques, they will likely figure prominently in research that is trying to decipher cell behavior in complex geometries and communities. 1.4 NEUROPHYSIOLOGY EXPERIMENTS USING MICROFLUIDIC CHIPS 1.4.1 Cell Separation Tools One prerequisite for in vitro studies on cells of neuronal lineage is starting with the right cells. When harvested from the nervous system of donor animals, samples of cells contain a mixture of large neurons and generally smaller glial support cells. A separation process must then be used to isolate the desired cell type. Wu et al. devised
20
MICROFLUIDICS FOR NANONEUROSCIENCE
a method of microfluidic cell separation using the change in spatial distribution that occurs when fluid streams of different viscosity are mixed across an expanding channel.145 They suspended the mixture of cell types in an aqueous solution of sodium alginate that supported neuronal survival rates of greater than 90% during the separation process. They then mixed a stream of this suspension with an eluent stream traveling at a different flow rate. As the flow rate increases, the viscosity decreases since the alginate polymers become more linearly aligned with the microfluidic channel walls. As the flow rate decreases, the viscosity increases since the polymer chain bunches and intertwines with itself. If the eluent stream has a higher viscosity than the stream in which the cells are suspended, then the interface between the two streams is moved in such a way that the cell suspension stream becomes narrower and more closely applied to the channel wall. When this cell suspension stream width approaches a certain minimal value, the larger cells are picked up by the higher viscosity eluent stream and the smaller cells are left behind in the original cell stream. When these streams then encounter a branching point, the cells can be separated. The researchers were able to successfully separate neurons and glia at a rate nearing 100% when flow rates and interface distributions were stringently controlled. Stem cells that are fated to differentiate into neurons or astrocytes cannot be separated based on their size since they are indistinguishable by their morphology and size. Separation by flow cytometry is based on the elaboration of different antigens that can be fluorescently tagged, but these may not be present early in the differentiation process. Flanagan et al. devised a microfluidic chip that used the dielectric properties of stem cells to characterize their fate bias.146 Electrodes applied an alternating electric field to cells in a microfluidic channel. At low frequencies, the cells are repelled from the electrodes, but as the frequency of the switching field is increased, they are attracted to the electrodes. The frequency at which they are “trapped” between repulsion and attraction is characteristic for the cell’s fate bias, and these differentiating dielectric properties can be demonstrated prior to the development of protein markers. In this study, live cells could be distinguished from dead cells that do not “trap.” Astrocytes were trapped at 0.3 MHz, neurons trapped at 5 MHz, and neural stem cells trapped at 1 MHz. In addition, neural stem cells harvested from embryos at earlier developmental ages trap at a higher frequency than those harvested from embryos at later developmental ages, consistent with the fact that more stem cells from young embryos differentiate into neurons and more stem cells from older embryos differentiate into astrocytes. This technique can be used to measure heterogeneity in cell cultures and has several advantages over flow cytometry and FACS since it can be done on small numbers of cells, it can exclude dead cells, it is sensitive to minor differences in cells, and it needs no antibody. 1.4.2 Neuropeptide Release Neuropeptides are endogenous chemicals that play a major role in the differentiation, maturation, and communication between cells of neuronal lineage. A significant portion of neurophysiology research involves deciphering the factors involved in their
NEUROPHYSIOLOGY EXPERIMENTS USING MICROFLUIDIC CHIPS
21
release, uptake, and induced responses in local and distant cells. The effect of neuropeptides on developing neuromuscular junctions has been studied using microfluidic chips. This research is exemplified by the work of Tourovskaia et al. who used PDMS masks to apply micropatterns of cell adhesive and cell repellent molecules to isolate single myotubes in thin parallel lines.147 A microfluidic device was then placed over this, myoblasts were allowed to attach to the substrate, and streams of media containing agrin were microfluidically perfused perpendicular to the axis of the cells. Agrin is a molecule released by the tip of growing axons when they contact muscle cells. The study showed that focal application of agrin stabilized the acetylcholine receptor aggregations in the myotubes, consistent with its presumed actions involved in the early development of neuromuscular synapses (Figure 1.5). Indirect measurement of neurotransmitter release from isolated single cells was demonstrated by Huang et al.148 They used PDMS microchannels to guide single pheochromocytoma PC12 cells into a chamber etched into glass. When this cell was stimulated with nicotine, they could detect dopamine release by amperometric monitoring using a carbon fiber microelectrode. Gold-covered single cell wells in silicon chips were also used to record catecholamine release from adrenal chromaffin cells.149 PDMS microchannels were used to immobilize PC12 cells and use amperometry to record calcium-induced dopamine and norepinephrine release.150 In similar work, Sun and Gillis were able to record quantal exocytosis of catecholamines after stimulation of chromaffin cells in microfluidic channels with potassium solution.151 They recorded amperometric spikes using indium tin oxide (ITO) electrodes when the catecholamines were oxidized on the electrode surface. When trying to differentiate the complex interactions that occur between different cells in mixed-type or pure-type cultures, it is important to determine the cell’s chemical response to stimulation, in addition to its electrical and morphological responses. Although the latter responses have been more readily studied at the single cell or near-single cell level using microfluidics, the analysis of released chemicals at this scale has been more difficult to achieve, given the extremely minute concentrations of the chemicals to be studied, in addition to the fact that the exact chemical species may not be known in advance. Jo et al. designed a microfluidic chip that would allow off-line analysis of neuropeptides released in response to chemical stimulation of neurons with potassium chloride (KCl).152 They used multichambered microfluidic chips that contained a cell culture chamber functionalized with poly-L-lysine to allow attachment of Aplysia bag cell neurons. Valves were used to selectively connect this chamber to three other chambers, each functionalized with a SAM that could adsorb molecules (released neuropeptides) by hydrophobic interactions. The cell culture chamber was exposed to the KCl that activated release of the neuropeptides, and the cell culture fluid was sequentially flushed from the culture chamber into each of the SAM-containing chambers before, during, and after KCL stimulation. Once the connecting valves were closed and the solutions were allowed time to adsorb to the SAM, the PDMS was peeled from the chip, exposing the SAMs for MALDI mass spectrometry measurements and subsequent imaging. The results of the research confirmed that this methodology could successfully detect two different released neuropeptides and that the majority of the released peptides adsorbed onto the SAM
22
MICROFLUIDICS FOR NANONEUROSCIENCE
FIGURE 1.5 Synaptogenesis on a chip. (a) During development, neurons release agrin at the site of contact between nerve and muscle. (b) Fluorescence micrograph of a portion of the myotube microarray after staining the AChRs with Alexa Fluor 488-conjugated a-bungarotoxin (BTX ). Scale bar is 50 mm. (c) Three high-magnification fluorescence micrographs of myotubes stained with BTX , showing that aneural AChR clusters display intricate shapes similar to those found in vivo. (d) Phase contrast micrograph of the microfluidic device containing a ladder micropattern of myotubes during stimulation by a laminar stream of agrin (spiked with Allura red dye for visualization). The black dashed box corresponds to the area shown in (b). Reproduced from Ref. 147. Copyright 2008 Elsevier.
NEUROPHYSIOLOGY EXPERIMENTS USING MICROFLUIDIC CHIPS
23
layer and not onto the PDMS walls. This innovative combination of microfluidic control of cell bathing solution, with off-line mass spectrometry, has significant potential to study known and previously unknown chemical responses of neurons spatially and temporally. Since both the concentrations and the volumes of released neuromediators are so low, microfluidic-based on-chip analysis of these agents can represent an attractive alternative to standard laboratory techniques. Mourzina et al. devised and optimized an on-chip capillary electrophoresis system to separate neuromediators.89 They experimented with various PDMS treatments and separation buffers to improve electroosmotic pumping and decrease adsorption of the neuromediators onto the PDMS surface. With the addition of field-amplified sample stacking, they were able to achieve separation of fluorescently labeled neuropeptides (including oxytocin, serotonin, glutamic acid, and others) within tens of seconds at 110 pL volume. Fieldamplified sample stacking utilizes a principle where the analyte is dissolved in a dilute ionic solution that is sandwiched between higher concentration ionic solutions. Application of fluid flow and electrical current causes formation of a stepped electric field, resulting in migration of the analyte into the boundary area between these solutions for easier separation. This work demonstrates the utility of using microfluidic chips to process biologically relevant samples at minute scales. Along similar lines, unpublished data from other researchers (Phillips and Wellner) has demonstrated the adaptation of commercial microfluidic micromixer chips to detect proteins such as proinflammatory cytokines in tiny samples of blood or perspiration from patients with depression using recycling immunoaffinity chromatography (online communication at http://www.nibib.nih.gov/HealthEdu/eAdvances/ 30Jan09). Further refinement of these techniques will likely be forthcoming. 1.4.3 Physical and Chemical Guidance Cues The ultimate goal of most neuroscience research involves learning ways of preventing degeneration and promoting repair and regeneration of neurons and their processes. One key prerequisite for this is an understanding of how physical and chemical guidance cues affect neurite growth. This is also of great interest to individuals who study neural network design. Many studies in this field use microchannels to isolate and observe axonal responses. An early study demonstrated the relative importance of chemical guidance when neurites from chick spinal neurons that were otherwise physically confined in “v”-shaped channels and pits on a silicon nitride substrate were able to grow out of the channels if the substrate was pretreated with polylysine.53 The effects of physical cues alone were demonstrated by studying neurite elaboration by cells confined to square bottomed channels (constructed from polyimide walls placed on a glass substrate).153 Narrow channels (20–30 mm in width) caused fewer neurites to be elaborated from each cell, and each neurite was longer and more likely to be oriented parallel to the channel wall. These changes might be due to inflexibility of the cytoskeleton. The effect of isolated chemical cues is the subject of many ongoing studies. In one such study, a PDMS device with parallel stripes of channels was used to deliver
24
MICROFLUIDICS FOR NANONEUROSCIENCE
poly-L-lysine (PLL) or collagen to a substrate pretreated with sequential 3-aminopropyltriethoxysilane (APTES) and glutaraldehyde.154 This pretreatment allowed PLL or collagen to bind covalently to the substrate, so it was more stable and structurally homogeneous than those attached by simple protein adsorption. The PDMS was then removed and Aplysia neurons were applied and monitored as their neurites developed. Standard electrophysiology and mass spectrometry were used to investigate any differences between neurons cultured on patterned versus uniform layers of protein. The results showed that patterned substrates caused shorter, thicker, less branched, and slower growing neurites and caused changes in the cell’s electrical activity compared to neurons grown on uniform proteins. The effect of substance gradients on neurite extension was also specifically studied by Whitesides and colleagues.52 This group utilized the serpentine network of microfluidic channels discussed in Section 1.3.1 to study and quantify the effect of different laminin concentrations on neurite sprouting, differentiation (into dendrite or axon), and directionality from hippocampal neurons. They deposited a layer of poly-L-lysine onto channels in a plasma-treated PDMS chip and then created a gradual gradient that ranged from pure BSA to pure laminin. This treated PDMS channel was then cut from its substrate, inverted in a Petri dish, and seeded with hippocampal neurons. Cells that grew alone in the center of the gradient (center of channel) were observed and the length of their neurites was measured to determine axonal specification (axons were typically four times the length of dendrites). The results showed that approximately 60% of axons were oriented within a 120 arc in the direction of increasing laminin concentration, and although the laminin concentration did not guide the axonal growth, it did specify which early neurite would become the axon. In addition, the concentration of laminin required to influence axonal specification was determined. It is of particular importance to understand the in vitro effects of laminin since it has been shown to play a critical role in axonal pathfinding in the embryonic CNS in vivo.155 The effect of the absolute concentration of a substance on axonal growth is just one parameter that has been studied in microfluidic chips. The slope of the substance’s concentration gradient also exerts effects on axonal growth on specific types of neurons. Lang et al. demonstrated this with ephrin A5, which is a repulsive axon guidance molecule.156 They used silicon wafers with etched microfluidic channels to create multiple stripes of varying concentrations of ephrin A5. The molecules in these solutions were transferred to a PDMS stamp and ultimately into polystyrene culture dishes into which chick retinal ganglion cells originating from nasal or temporal locations on the retina were cultured. They tested the effects of both steep gradient variations and shallow gradient variations on axonal growth. They found that axons growing from neurons originating on the nasal portion of the retina do not respond to ephrin A5 gradients at all. However, axons growing from neurons originating from the temporal portion of the retina are inhibited, grow farther into shallow gradients than steep gradients, and halt their growth at a lower total ephrin A5 concentration and total exposure in shallow gradients of this molecule than in steep gradients. This research indicates the complicated inputs involved in the growth of axons of differentiated cells and the usefulness of microfluidics in deciphering the signals controlling axonal
NEUROPHYSIOLOGY EXPERIMENTS USING MICROFLUIDIC CHIPS
25
FIGURE 1.6 Temporal RGC axons stop in substrate-bound gradients produced by mFN. (a) Fluorescence images of a stepwise gradient of ephrin A5 spanning a distance of 320 mm, and the corresponding countergradient of Fc and temporal axons stained with phalloidin invading the gradient. In the original article with color images, in (b–e) phalloidin-stained axons are shown in black and antibody-stained Fc in green. (b) Temporal axons stopping in a steep ephrin A5 gradient. (c) The stop zone shifts further into the gradient in a shallow gradient. (d) Nasal axons in a steep gradient do not stop. (e) Temporal axons growing on laminin lanes without underlying gradient. For scale, see (a). With kind permission from Springer Science þ Business Media.156
responses (Figure 1.6). These researchers published a detailed protocol on their methodology, including the use of a second active protein to set up an overlapping or countergradient.157 Similarly, gradient mixers have been used to create substrate-bound gradients with multiple agents of defined concentrations and slopes.112 Li et al. used a syringe pump connected to a PDMS gradient mixer to combine laminin, chondroitin sulfate proteoglycans (CSPGs), and/or BSA to form various patterns on a glass substrate.158 After 12 h of adsorption, the PDMS superstructure was removed and DRG neurons were applied. The study showed that cells adhered more strongly to higher laminin and lower CSPG concentrations, neurites grew toward higher laminin and lower CSPG concentrations, and double opposing gradients provided the strongest guidance cues. This research confirmed that neurites can detect and respond to both the slope and the fractional concentration change of substrate-bound gradients.
26
MICROFLUIDICS FOR NANONEUROSCIENCE
In reality, it may be an oversimplification to study the effect of individual agents on neurons since it is more likely that they are programmed to respond to complex, interacting, and synergistic forces, including topography, electromagnetic fields, and chemical/biological cues. For example, when adult rat hippocampal progenitor cells were cocultured with astrocytes aligned on laminin-coated substrate grooves, there was enhanced neuronal differentiation and alignment of neurites parallel to the astrocyte processes and substrate grooves. It is presumed that the astrocytes align themselves on the grooves and then secrete soluble factors that are concentrated locally by the topography, resulting in facilitated neuronal differentiation of the progenitor cells.159 1.4.4 Electrophysiology and Microfluidics Studies on neurons frequently involve monitoring of multiple physiologic parameters, including their electrical activity, as well as their morphology and expressed proteins. Research in this field has been made easier by the availability of commercial MEAs, which typically employ a glass substrate with electrically conductive microcontacts and leads made of gold, platinum, or transparent ITO. Heuschkel et al. used an ITO MEA and engineered a microfluidic chamber on its surface by layering negative photoresist and using photolithography to pattern buried microchannels in the resist.38 Once it was processed and baked, laminin and polyornithine were applied and chick embryonic motoneurons were introduced via the microchannels. As the neurons grew, their electrical activity was monitored via the microelectrodes. Although the experiment was successful and the photoresist was found to be biocompatible, most investigators now use PDMS to fabricate microfluidic channels intended for cell culture. For example, Morin et al. aligned the wells and channels of a PDMS microfluidic chip to commercial and custom planar microelectrode array substrates.39 PolyL-lysine or laminin was applied to the chips prior to addition of chick or murine cortical neurons. These cells remained viable and electrically active for weeks, as demonstrated by optical microscopy and electrical responses to stimulation. Despite a few problems with isolating potentials from single cells, inhomogeneity of the cells in each well (neuronversus glial), and PDMS adhesion to the commercial microelectrode substrate, the authors felt that this system showed potential for the development of neuronal networks. In similar work, Claverol-Tinture et al. used PDMS chips with channels and wells over poly-L-lysine-coated planar ITO microelectrode arrays and manually placed individual neurons in the wells.40 Once the axons grew, they were able to record single cell spikes from the soma (contained in the well), or the axon (contained in the channels), depending on how the microfluidic channels were aligned on the electrodes (Figure 1.7). In follow-up studies, they were able to achieve a signalto-noise ratio of 20 dB when recording electrical spike activity of up to 300 mV amplitude from multiple sites on single neurites extending in microchannels.41 Thiebaud et al. also developed a PDMS microfluidic chamber that incorporated microelectrode arrays.42 The first step in the fabrication process involved using a PDMS microcontact stamp to deposit laminin onto an MEA substrate in parallel
NEUROPHYSIOLOGY EXPERIMENTS USING MICROFLUIDIC CHIPS
27
FIGURE 1.7 (a) Phase contrast image of a confined bipolar neuron after 12 days in vitro sprouting two neurites along a microchannel. (b) Extracellular potentials associated with an action potential and recorded by the eight microelectrodes shown in (a). (c) Raster plot showing KCl and glutamate dose responses. Reproduced with permission from Ref. 41. Copyright 2007 IEEE.
stripes whose width was consistent with the size of microelectrode arrays. A PDMS microfluidic apparatus with aligned microchannels then delivered culture medium containing neuronal cells to the laminin stripes to establish the culture. Once the cells attached, agents were injected into the parallel channels and delivered to the established lines of cells via laminar flow to study the electrophysiological effects of various pharmaceutical agents on the neurons. Commercial microelectrode arrays have also been integrated into microfluidic devices and used to study the effect of temperature changes on the electrical activity of a subpopulation of cold-sensitive cells derived from the dorsal root ganglion.44 In this research, a microfluidic chip was used to deliver polylysine over the array prior to the application of the cell suspension. There were two inlets to the chip—one
28
MICROFLUIDICS FOR NANONEUROSCIENCE
providing culture medium at 45 C, and the other providing medium at 4 C. By varying the flow rate of each input, they could rapidly (<1 s) switch the culture medium temperature flowing over cells from 35 to 16 C. Using a multichannel multiprocessor recording system, they recorded action potentials from the array of electrodes and found that certain cells consistently changed their firing rate from a mean of 0.028 spikes per second to a mean of 0.94 spikes per second in response to a switch to a colder temperature. These cells had the same morphology as the others that were not sensitive to temperature changes. This system demonstrated that the combined use of two unique microtechnologies (microfluidics and microelectrodes) could characterize and identify a special subpopulation of cells based on their electrophysiological responses. In a follow-up study, these researchers modified their microfluidic design by adding small reservoirs with flexible membrane covers to the side channels.43 This essentially introduced a “switch” that could rapidly perturb the relative flow from each input and vary the temperature flowing over the cells over a 50 ms pulse. Future physiologically relevant research will benefit from this potential to rapidly and transiently deliver agents to cultured cells on a timescale that more closely matches a cell’s innate responsiveness capabilities. 1.4.5 Growth Factor Effects As discussed in Section 1.3.1, microfluidic channels can be arranged to create gradient generators to study the effects of special factors on cell physiology. One research study examined the effect of various concentrations and combinations of growth factors (epidermal growth factor, fibroblast growth factor 2, and platelet-derived growth factor) on neural stem cell proliferation and differentiation.115 Chung et al. first demonstrated that they could successfully culture human neural stem cells in chambers that were precoated with poly-L-lysine and laminin, and kept under constant low flow (0.1 mL min1) of culture medium for at least 7 days. This low flow would help minimize autocrine and paracrine effects of secreted factors. When growth factor gradients were added, they demonstrated that neural stem cells proliferated in direct proportion to the growth factor concentration, whereas astrocytes differentiated in inverse proportion to the growth factor concentration, and all cells demonstrated increased migration toward areas with higher concentrations. The use of microfluidic gradients in this study presented a significant advantage over routine in vitro culture techniques and helped to elucidate the action of these specific factors on these cells. Wittig et al. also investigated the use of microfluidic channels to deliver graded concentrations of growth factors.160 They applied a reusable PDMS microfluidic culture medium and a factor delivery apparatus onto a standard poly-L-lysine/laminincoated Petri dish. Two channels delivering different additives in media coalesced in a “Y” shape that was placed adjacent to a neonatal spiral ganglion explant culture area. The base of the “Y” allowed growing neurites to sample two different media choices and then to decide which arm of the “Y” they preferred to grow into. They demonstrated that neurites preferred to grow toward culture medium containing neurotrophin-3 and they anticipated that this approach could be very useful in studying
NEUROPHYSIOLOGY EXPERIMENTS USING MICROFLUIDIC CHIPS
29
the various effects of growth and inhibitory factors on proliferation, neurite extension, and cell migration. In addition to allowing precise delivery of controlled concentrations of growth factors spatially, microfluidic platforms with control valves have also been used to control the timing of the delivery of these substances to cells to determine the differentiation of cells. Nakashima and Yasuda used a microfluidic control valve to release nerve growth factor (NGF) through nanopores to control the differentiation and axonal growth of adrenal pheochromocytoma cells.161 They were able to switch the microvalve on and off with controlled frequency and duty cycles to guide cellular differentiation. They anticipated that the addition of an electrode to monitor real-time cellular response to their pulsed release of growth factors would be very useful in studying the physiological responses of cells during axonal regeneration processes. 1.4.6 Gene Therapy An alternative method of delivering growth factors to cells involves the use of microfluidic methods to genetically manipulate neurons by directly delivering the DNA codes for a given growth factor to them. Houchin-Ray et al. cultured neurons on a substrate that had been microfluidically patterned with a mixture of lipoplexes and plasmid DNA that coded for NGF and green fluorescent protein.162 They were able to achieve a transfection efficiency of 25% using a vector concentration 10 times less than typically used in culture media. Neurons cultured on the patterned areas had improved survival and enhanced neurite outgrowth, indicating that the NGF DNA had been incorporated into the cells and expressed. They also determined that pretreatment of the PDMS microfluidic chip with pluronic (an amphiphilic copolymer with surfactant properties) improved transfection rates since it made the PDMS less likely to bind the cationic lipid/DNA complexes. The NGF concentration gradient could be adjusted by changing the plasmid density in the solution and the size of the microchannels in the PDMS chip used to pattern the substrate. The potential application of patterned gene delivery and expression to specific cells in culture has significant promise for studies of neural physiology, cell-to-cell interactions, and regenerative medicine. Microfluidic chips that allow fluidic isolation of parts of neurons (Section 1.4.7) have enabled selective delivery of nonviral DNA to either neurites or the cell body of neurons to study the differences in processing that occurs at these locations. This is important for eventual in vivo studies since access to both the soma and the axon may not be possible given the long lengths of many axons. Since many studies are aimed at axon regeneration after spinal cord injury, treatments may need to be specialized for the site that is accessible. Bergen and Pun illustrated this point with their research that microfluidically delivered DNA in culture medium to the isolated neurites or to the isolated soma of PC12 neuron-like cells.163 The DNA was attached to either a lipidbased carrier (lipofectamine) or PEI (poly(ethylenimine)), a polymeric nanoparticle. In general, both had 4–5 times the uptake if delivered at the soma, compared to the neurite, although the lipid-based carriers had an uptake that was 5–7 times that for the PEI carrier. Uptake seemed to be mediated by vesicle formation. When delivered to the isolated neurites, the lipoplexed DNA could be taken up, but not transported,
30
MICROFLUIDICS FOR NANONEUROSCIENCE
whereas the PEI-based DNA was taken up and retrogradely transported in a saltatory fashion, but never made it into the soma. Therefore, gene expression occurred only if the gene-complexed carrier was delivered directly to the soma, and the transfection efficiency was much higher for the lipofectamine than for the PEI. This research sheds light on the difficulties inherent in repairing a damaged spinal cord. 1.4.7 Axonal Isolation As demonstrated in the above literature review, microfluidic chambers have been used to isolate small numbers of cells of neuronal lineage and to study their individual responses to stimuli, often with the aid of on-board analytical devices. However, none of these studies were able to fluidically isolate cell segments (like axons) from their soma, or from neighboring cells of various lineages. The only method to achieve this in the past involved the use of Campenot chambers that used nerve growth factor or brain-derived neurotrophic factor to “artificially” stimulate axonal growth from macro-scaled cultures across grease layers. However, Jeon’s group at the University of California at Irvine has successfully designed and implemented a microfluidic platform that incorporates tiny grooves of adequate size and length to allow fluidic isolation of axons from the regular cell culture chamber, so that their physiology can be studied independently.164 Specifically, they designed a PDMS chip with two chambers that were separated by a series of grooves that each had dimensions of 10 mm width, 3 mm height, and 150 mm length. These grooves were used to guide neurite growth from a cell culture chamber into a second chamber that could be used to study the isolated axons. The narrowness of the grooves prevented cell bodies from penetrating them, and the length of the grooves prevented the typically shorter dendrites from emerging into the axonal isolation chamber. A key design element of the tiny grooves was their high resistance to fluid transport that allowed them to achieve temporary (15 h) fluidic isolation of the somal compartment from the axonal compartment by applying a slightly higher hydrostatic pressure in the somal compartment. On doing this, there was one-way flow only, going from the somal to the axonal compartment, in a very slow and restricted manner. This allows independent chemical manipulation of the axon, without any direct effects on the soma, unless the axon directly transports the agents to the soma in a retrograde fashion. These researchers used a patterned poly-L-lysine substrate to keep the axons aligned in parallel stripes, so that they could be more easily identified along with their respective cell body.164–166 They used several alternative tools for the patterning, including a PDMS mold with tiny channels that could wick the agent in by capillary action (micromolding in capillaries), a PDMS stamp to transfer the agent by microcontact printing, and a PDMS mask to selectively protect and preserve a uniform, preapplied, dried agent during plasma etching. In follow-up research, Jeon’s group lengthened the microgrooves to 450 mm to allow longer studies (14 days) that still isolated axons from dendrites (Figure 1.8).164,165 They used this design to investigate axonal injury, regeneration, and interactions with cocultured oligodendrocytes during myelination. In addition, they proved that their isolated compartments could permit detection of purely axonal
NEUROPHYSIOLOGY EXPERIMENTS USING MICROFLUIDIC CHIPS
31
FIGURE 1.8 The microfluidic-based culture platform directs axonal growth of CNS neurons and fluidically isolates axons. (a) The culture chamber consists of a PDMS mold containing a relief pattern of somal and axonal compartments (1.5 mm wide, 7 mm long, 100 mm high) connected by microgrooves (10 mm wide, 3 mm high). The optically transparent PDMS adheres to a polylysine-coated coverslip. Rat CNS neurons (medium gray spots) are added to the somalside reservoir and are drawn into the somal channel (black) by capillary action. Within 3–4 days, axonal growth is guided into the axonal side (light gray) through the microgrooves. (b) A volume difference between the somal side and the axonal side (50 mL) allows chemical microenvironments to be isolated to axons for over 20 h owing to the high fluidic resistance of the microgrooves. Similarly, the volume difference can be reversed to isolate a chemical microenvironment to the somal side. (c) Fluidic isolation of Texas red dextran (top panel) to the axonal compartment demonstrates that axonal or somatic microenvironments can be independently manipulated using this culture platform. Axonally restricted application of CellTracker Green (middle panel) backtracked neurons from their isolated axons. The bottom image is the merged figure. Scale bar, 100 mm. (d) Counts of radioactivity in samples from somal and axonal compartments after [35S]methionine was localized to the axonal compartment for over 20 h. Counts in the somal compartment (3.7 c.p.m. 1.5 s.e.m.) were similar to background levels. Error bars, s.e.m. (n ¼ 3). Reprinted with permission from Ref. 165. Copyright 2005 Macmillan Publishers Ltd.
32
MICROFLUIDICS FOR NANONEUROSCIENCE
mRNA, and they demonstrated changes in gene expression in the soma in response to axonal chemical and physical manipulations. This chip has now become an important tool used in research programs at different academic settings, given its potential to reveal details of neuronal pathophysiology in neurodegenerative diseases and traumatic nerve damage. When neuronal axons are damaged, the distal portion experiences a process called Wallerian degeneration, in which the proximal portion of the axon shrinks back toward the cell body. Regeneration of damaged axons is possible but seems to be hampered by many complicated and interacting factors, including glial scar tissue that prevents the regrowing axons from finding their target cells. One active inhibitory component of the scar tissue is a group of molecules composed of core proteins with carbohydrate side chains, known as CSPGs. Neuroscientists studying axonal regeneration have postulated that treatments that limited the production of these molecules at sites of nerve damage might permit axonal regrowth and reestablishment of normal function. Jeon’s group tested this hypothesis in their microfluidic chip by isolating axons in a chamber with pre-applied stripes of alternating inhibitory and permissive molecules.167 The inhibitory stripes contained these aggrecan proteins to mimic glial scars that are generated after spinal cord injury. These inhibitory areas were effectively neutralized when chondroitinase was added to the axonal chamber of the microfluidic chip. This molecule acts to dissolve the carbohydrate glycosaminoglycan side chains of the CSPGs, but left the core protein intact. Since the addition of the chondroitinase allowed axons to cross onto the CSPG stripe, they concluded that the core protein of the CSPG was not inhibitory, but the carbohydrate side chains were the active inhibitory component of the CSPG molecule (Figure 1.9). Other proteins inhibitory to axon growth have also been tested by this research laboratory. Park et al. used their axon isolation chip to test the effects of two myelinassociated proteins on axon regeneration.168 After the axons grew into the isolation chamber (about 7 days), they were severed with vacuum aspiration and their regeneration was monitored in the presence and absence of various concentrations of NOGO-66 and MAG protein. Each of these proteins decreased the length of regenerated axons by 75–80% compared to controls. Higher concentrations of NOGO lead to increased inhibition of regeneration, with the effect saturating at a concentration of 10 nM. The effect of toxins on the electrophysiology and morphology of neurons has been studied using similar axonal isolation microfluidic chips that are combined with MEA substrates. Ravula et al. mated a PDMS superstructure onto a glass substrate with a patterned MEA and recorded the spontaneous and stimulated electrical activities from neurons that they cultured in this platform.169 They were able to record action potentials from both the soma and the isolated axons when they added potassium chloride. When the sodium channel blocker tetrodotoxin was added to the axonal compartment, only axonal action potentials ceased. In follow-up work, Ravula et al. tested the effects of other chemicals on the electrophysiology of fluidically isolated neuronal soma and axons. They found that low-dose vincristine caused no effect if directly applied to the soma of the neuron, but axonal application sequentially caused a decreased excitability of the axon, an initial increase in excitability of the soma, and
DISCUSSION AND FUTURE PERSPECTIVES
33
FIGURE 1.9 Effect of chondroitinase ABC treatment on axons growing in microfluidic strip assay device. 10 DIV cortical neurons growing on aggrecan–PLL patterned strips on glass. Axons avoid inhibitor-coated areas until a drug is applied to help axons overcome the inhibition or break down the surface-bound inhibitors. Axons avoid aggrecan strips and are confined to PLL strips during entire experimental period. Striking changes in growth cone morphology and axonal projections were observed when the pattern was treated with chondroitinase ABC, an enzyme that removes the CSPGs’ side chains without degradation of the core protein. After 30 min ChABC treatment, axons are observed to randomly extend across the pattern. Higher resolution micrographs indicate that aggrecan inhibition is overcome not only in the growth cones but also in the middle of the stripes. Reprinted from Ref. 167. Copyright 2008 Elsevier.
an eventual degeneration of the axon.170 Higher dose vincristine caused degeneration if applied to either compartment. The change in electrophysiology occurred approximately 6 h after vincristine exposure and was an earlier indicator of degeneration than were morphological changes. The degradation of the electrical response to a depolarizing dose of potassium chloride is first noted in the distal axon and then progresses proximally. Eighteen hours after exposure, morphological degeneration begins and progresses at a rate of 1–2 mm per day. All the above studies indicate that microfluidic axonal isolation chips, with or without electrical monitoring ability, hold promise for high-throughput screening of many pharmaceutical agents that have effects on neuronal health and might be useful in enhancing axon regeneration. 1.5 DISCUSSION AND FUTURE PERSPECTIVES Neuroscientists have typically been very open to the use of cutting edge technology for the study of neuronal physiology and have incorporated this technology into their daily research. The challenges of applying novel micro- and nanofabricated hardware to classic neurophysiology experiments will hopefully be matched by their potential
34
MICROFLUIDICS FOR NANONEUROSCIENCE
yield. The strength of microfluidics is in the highly efficient utilization of the reductionist approach in well-defined, tightly focused environments and problems. Another advantage of microfluidics is the integrability with multiple methods of interrogation, including chemical, optical, and electrical methods. Microfluidic platforms have the ability to deliver individual cells to specific locations, and then allow study of the effects of temporally and spatially controlled environmental perturbations on isolated parts of the cells. Arrays of these platforms can be arranged to allow large parallel experiments that can multiply experimental yield. When analytical components (such as NMR coils, pH, and electrical and chemical sensors) are incorporated into the microfluidic chips, real-time information on individual live cells can be recorded and followed. It is possible that the conclusions drawn from studies of conventional cell culture populations may not be borne out at the single cell level. Determining which in vitro cellular behaviors are most consistent with in vivo realities will then become imperative since it is likely that the choice of culture techniques may influence experimental results. Initiating a microfluidic-based research program is much simpler than one might think. Most clean room fabrication facilities at universities already have the technology to create the master for the PDMS platform since it is the same as that used to create silicon wafer-based electronics. If there is no access to these services locally, commercial businesses and some universities (such as the University of California at Irvine Integrated Nanosystems Research Facility Foundry171) do offer these services for a fee. Once the master is available, the supplies and the equipment to cast the PDMS chips are common and inexpensive. For example, PDMS (sold as Sylgard 184) is available from Fisher Scientific for about $60 for a 1.1 pound kit, which will be sufficient for dozens of chips. Vacuum pumps (to degas the PDMS prior to pouring), and ovens (to bake the mold), will improve the quality of the casting, but these are not necessary for chips that lack very small features. The only other tools that may be necessary are punches to gain access to the channels in the chip, and syringe pumps, if called for in the design. Therefore, once a master is obtained, the ability to produce multiple chips is within easy reach to life scientists. For those who prefer to purchase their PDMS chips, complete microfluidic fabrication foundries (such as those located at Stanford University and California Institute of Technology) offer commercial services to build chips based on original designs sent by researchers. Plasma treatment equipment confers the advantage of temporarily altering the surface of the PDMS to make it more hydrophilic and able to irreversibly bond to the substrate. However, reversible bonds are sufficient for most low-pressure cell culture applications, and, if desired, the PDMS surface can be made hydrophilic by simple exposure to media containing 10–15% serum. Commercial multielectrode arrays and supporting electronic modules are available from many sources and can be used as the substrate for microfluidic chips. Substrates with specialized nanotopographic features can be produced by most clean room fabrication facilities. Patterned cell adhesives are easily obtained using dedicated PDMS stencils or stamps. Three-dimensional scaffolding such as collagen sponges from BD Biosciences or Inamed Biomaterials can be used within PDMS growth chambers for studies on tissue engineering within microfluidic chips.
DISCUSSION AND FUTURE PERSPECTIVES
35
Interdisciplinary collaborations between neuroscientists and engineers may offer the best chance for success for life scientists who plan to initiate a microfluidic research program. In this setting, the engineers are often happy to provide technical advice and hardware in exchange for biological applications for their technology. This may be especially fruitful for each member of the team since federal funding agencies are recognizing the importance of interdisciplinary work for innovative groundbreaking fundamental research and industrial applications. As we look toward the future, material science issues may become a critical factor for the progress of microfluidic neuroscience. The literature cited above validates the potential for microfluidics, but issues of possible chemical interactions between the PDMS and the cells or the culture medium will have to be resolved. It is known that many materials that are used in standard in vitro studies may interact with culture contents. For example, proteins are known to adsorb onto polystyrene culture flasks but the relative ratio of the culture medium volume to the polystyrene surface area usually makes the impact of this phenomenon negligible for most applications. However, molecular and fluid interactions with PDMS on tiny culture volumes will be more likely to play a role in influencing results. Potential toxic effects of the PDMS on sensitive neurons will also need to be controlled. It may be that PDMS will have to be layered with other polymers, like parylene, to limit its interaction with media. Or PDMS may have to be replaced with other polymers that are not as “porous” to water and solutes. Finally, environmental controls may have to be built into the chips so that their temperature, osmolarity, and atmosphere are preserved during manipulation and imaging of the chip. Given the platform’s small volume and lower homeostatic reserve, the heat, humidity, and carbon dioxide levels established in an incubator may otherwise change very quickly as the chip is removed for microscopic examination or media changes. The larger ratio of surface area to volume of these small culture chambers may also lead to a greater tendency toward evaporation and osmotic concentration of the media. All these issues can result in significant effects on the cell’s physiological responses and viability. So, to take advantage of the platform’s ability to precisely control the milieu of the cells it contains, we may first need to engineer a controllable environment for the platform itself. Despite these challenges, the application of microfluidic technology to appropriate in vitro neuroscience research has the potential to offer new insights and to augment ongoing conventional in vitro and in vivo investigations. As with all technology, there are certain limitations and challenges to microfluidic studies, as outlined in Section 1.2.5. The “ground-up” approach to studying cellular interactions may yield truly novel results, but caution must be exercised before generalizing information from single cell studies to either homogeneous or heterogeneous populations of cells. Moreover, as demonstrated in the field of tissue engineering, generalizing conclusions from any two-dimensional cell culture (whether microfluidic or conventional in scale) to in vivo settings may also be misleading. But, as long as we keep our perspective, we can combine the results obtained from both conventional and alternative methodologies to obtain a greater understanding of the processes we are trying to decipher.
36
MICROFLUIDICS FOR NANONEUROSCIENCE
In conclusion, the science of studying individual neuronal cells is still in its infancy, but we now have the tools needed for this endeavor in the form of microfabricated microfluidic channels and electronic sensors that provide the platform for cell proliferation, separation, differentiation, and monitoring. Newer designs also allow isolation of individual axons on these cells, which will enable study of localized axonal physiology and its effects on the cell body. Combining microfluidics with other nanotechnologies will enable truly novel experiments never previously possible. As this chapter outlines, there are many applications of microfluidics to neuroscience, and individuals who can make use of this technology may pioneer entire new areas of research, including studies of individual axons, individual synapses, or the interactions of single neurons with other isolated CNS cells (microglia, oligodendrocytes, and astrocytes). Advances in other complementary microtechnologies, such as noninvasive single cell electrical recording, monitors for other key markers of cellular physiology (such as pH and ionic currents), tools for NMR spectroscopy, mass spectrometry, and designs to allow on-chip genetic manipulation and evaluation, should allow rapid advances to be made toward understanding neuronal physiology. Once we understand how these cells operate under controlled conditions, we may be able to use this information to gain control of cell responses in disease, and design treatments and possible cures for patients suffering from neurologic diseases.
ACKNOWLEDGMENT We thank Raymond W. Glover, MD, for reviewing and editing the manuscript.
REFERENCES 1. Silva, G.A. Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system. Surg. Neurol. 2005, 63, 301–306. 2. Silva, G.A. Neuroscience nanotechnology: progress, opportunities and challenges. Nat. Rev. Neurosci. 2006, 7, 65–74. 3. Moshfeghi, A.A.; Peyman, G.A. Micro- and nanoparticulates. Adv. Drug Deliv. Rev. 2005, 57, 2047–2052. 4. Rosi, N.L.; Giljohann, D.A.; Thaxton, C.S.; Lytton-Jean, A.K.R.; Han, M.S.; Mirkin, C.A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006, 312, 1027–1030. 5. Svenson, S.; Tomalia, D.A. Dendrimers in biomedical applications—reflections on the field. Adv. Drug Deliv. Rev. 2005, 57, 2106–2129 (commentary). 6. Yokoyama, M. Drug targeting with nano-sized carrier systems. J. Artif. Organs 2005, 8, 77–84. 7. Gomez, N.; Winter, J.O.; Shieh, F.; Saunders, A.E.; Korgel, B.A.; Schmidt, C.E. Challenges in quantum dot-neuron active interfacing. Talanta 2005, 67, 462–471.
REFERENCES
37
8. Michalet, X.; Pinaud, F.F.; Bentolila, L.A.; Tsay, J.M.; Doose, S.; Li, J.J.; Sundaresan, G.; Wu, A.M.; Gambhir, S.S.; Weiss, S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307, 538–544. 9. Pinaud, F.; Michalet, X.; Bentolila, L.A.; Tsay, J.M.; Doose, S.; Li, J.J.; Iyer, G.; Weiss, S. Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials 2006, 27, 1679–1687. 10. Vu, T.Q.; Maddipati, R.; Blute, T.A.; Nehilla, B.J.; Nusblat, L.; Desai, T.A. Peptideconjugated quantum dots activate neuronal receptors and initiate downstream signaling of neurite growth. Nano Lett. 2005, 5, 603–607. 11. Winter, J.O.; Liu, T.Y.; Korgel, B.A.; Schmidt, C.E. Recognition molecule directed interfacing between semiconductor quantum dots and nerve cells. Adv. Mater. 2001, 13, 1673–1677. 12. Esplandiu, M.J.; Bittner, V.G.; Giapis, K.P.; Collier, C.P. Nanoelectrode scanning probes from fluorocarbon-coated single-walled carbon nanotubes. Nano Lett. 2004, 4, 1873–1879. 13. Albrecht, D.R.; Underhill, G.H.; Wassermann, T.B.; Sah, R.I.; Bhatia, S.N. Probing the role of multicellular organization in three-dimensional microenvironments. Nat. Methods 2006, 3, 369–375. 14. Hu, H.; Ni, Y.C.; Montana, V.; Haddon, R.C.; Parpura, V. Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Lett. 2004, 4, 507–511. 15. Mattson, M.P.; Haddon, R.C.; Rao, A.M. Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J. Mol. Neurosci. 2000, 14, 175–182. 16. Mohammed, J.S.; DeCoster, M.A.; McShane, M.J. Micropatterning of nanoengineered surfaces to study neuronal cell attachment in vitro. Biomacromolecules 2004, 5, 1745–1755. 17. Stevens, M.M.; George, J.H. Exploring and engineering the cell surface interface. Science 2005, 310, 1135–1138. 18. Tan, W.; Desai, T.A. Layer-by-layer microfluidics for biomimetic three-dimensional structures. Biomaterials 2004, 25, 1355–1364. 19. Tan, W.; Desai, T.A. Microscale multilayer cocultures for biomimetic blood vessels. J. Biomed. Mater. Res. A 72A, 2005, 146–160. 20. Dugan, L.L.; Lovett, E.G.; Quick, K.L.; Lotharius, J.; Lin, T.T.; O’Malley, K.L. Fullerenebased antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 2001, 7, 243–246. 21. Yang, F.; Murugan, R.; Ramakrishna, S.; Wang, X.; Ma, Y.X.; Wang, S. Fabrication of nano-structured porous PLLA scaffold intended for nerve tissue engineering. Biomaterials 2004, 25, 1891–1900. 22. Tiwari, S.B.; Amiji, M.M. A review of nanocarrier-based CNS delivery systems. Curr. Drug Deliv. 2006, 3, 219–232. 23. McNally, H.A.; Ben Borgens, R. Three-dimensional imaging of living and dying neurons with atomic force microscopy. J. Neurocytol. 2004, 33, 251–258. 24. McNally, H.A.; Rajwa, B.; Sturgis, J.; Robinson, J.P. Comparative three-dimensional imaging of living neurons with confocal and atomic force microscopy. J. Neurosci. Methods 2005, 142, 177–184. 25. Dahan, M.; Levi, S.; Luccardini, C.; Rostaing, P.; Riveau, B.; Triller, A. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 2003, 302, 442–445.
38
MICROFLUIDICS FOR NANONEUROSCIENCE
26. Pathak, S.; Cao, E.; Davidson, M.C.; Jin, S.H.; Silva, G.A. Quantum dot applications to neuroscience: new tools for probing neurons and glia. J. Neurosci. 2006, 26, 1893–1895. 27. Guillorn, M.A.; McKnight, T.E.; Melechko, A.; Merkulov, V.I.; Britt, P.F.; Austin, D.W.; Lowndes, D.H.; Simpson, M.L. Individually addressable vertically aligned carbon nanofiber-based electrochemical probes. J. Appl. Phys. 2002, 91, 3824–3828. 28. Patolsky, F.; Timko, B.P.; Yu, G.H.; Fang, Y.; Greytak, A.B.; Zheng, G.F.; Lieber, C.M. Detection, stimulation, and inhibition of neuronal signals with high-density nanowire transistor arrays. Science 2006, 313, 1100–1104. 29. Duffy, D.C.; McDonald, J.C.; Schueller, J.A.; Whitesides, G.M. Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal Chem. 1998, 70, 4974–4984. 30. Unger, M.A.; Chou, H.P.; Thorsen, T.; Scherer, A.; Quake, S.R. Monolithic microfabricated valves and pumps by multilayer soft lithography. Science 2000, 113–116. 31. Thorsen, T.; Maerkl, S.J.; Quake, S. Microfluidic large-scale integration. Science 2002, 298, 580–584. 32. Kartalov, E.P.; Walker, C.; Taylor, C.R.; Anderson, W.F.; Scherer, A. Microfluidic vias enable nested bioarrays and autoregulatory devices in Newtonian fluids. PNAS 2006, 103, 12280–12284. 33. Hansen, C.L.; Skordalakes, E.; Berger, J.M.; Quake, S. A robust and scalable microfluidic metering method that allows protein crystal growth by free interface diffusion. PNAS 2002, 99, 16531–16536. 34. Hansen, C.L.; Sommer, M.O.A.; Quake, S. Systematic investigation of protein phase behavior with a microfluidic formulator. PNAS 2004, 101, 14431–14436. 35. Kartalov, E.P.; Quake, S.R. Microfluidic device reads up to four consecutive base pairs in DNA sequencing-by-synthesis. Nucleic Acids Res. 2004, 2873–2879. 36. Liu, J.; Enzelberger, M.; Quake, S. A nanoliter rotary device for polymerase chain reaction. Electrophoresis 2002, 23, 1531–1536. 37. Liu, J.; Hansen, C.L.; Quake, S. Solving the “world-to-chip” interface problem with a microfluidic matrix. Anal. Chem. 2003, 75, 4718–4723. 38. Heuschkel, M.O.; Guerin, L.; Buisson, B.; Bertrand, D.; Renaud, P. Buried microchannels in photopolymer for delivering of solutions to neurons in a network. Sens. Actuators B Chem. 1998, 48, 356–361. 39. Morin, F.; Nishimura, N.; Griscom, L.; LePioufle, B.; Fujita, H.; Takamura, Y.; Tamiya, E. Constraining the connectivity of neuronal networks cultured on microelectrode arrays with microfluidic techniques: a step towards neuron-based functional chips. Biosens. Bioelectron. 2006, 21, 1093–1100. 40. Claverol-Tinture, E.; Ghirardi, M.; Fiumara, F.; Rosell, X.; Cabestany, J. Multielectrode arrays with elastomeric microstructured overlays for extracellular recordings from patterned neurons. J. Neural. Eng. 2005, 2, L1–L7. 41. Claverol-Tinture, E.; Cabestany, J.; Rosell, X. Multisite recording of extracellular potentials produced by microchannel-confined neurons in vitro. IEEE Trans. Biomed. Eng. 2007, 54, 331–335. 42. Thiebaud, P.; Lauer, L.; Knoll, W.; Offenhausser, A. PDMS device for patterned application of microfluids to neuronal cells arranged by microcontact printing. Biosens. Bioelectron. 2002, 17, 87–93.
REFERENCES
39
43. Pearce, T.M.; Williams, J.J.; Kruzel, S.P.; Gidden, M.J.; Williams, J.C. Dynamic control of extracellular environment in in vitro neural recording systems. IEEE Trans. Neural. Syst. Rehabil. Eng. 2005, 13, 207–212. 44. Pearce, T.M.; Wilson, J.A.; Oakes, S.G.; Chiu, S.Y.; Williams, J.C. Integrated microelectrode array and microfluidics for temperature clamp of sensory neurons in culture. Lab Chip 2005, 5, 97–101. 45. Grant, S.C.; Aiken, N.R.; Plant, H.D.; Gibbs, S.; Mareci, T.H.; Webb, A.G.; Blackband, S.J. NMR spectroscopy of single neurons. Magn. Reson. Med. Sci. 2000, 44, 19–22. 46. Massin, C.; Vincent, F.; Homsy, A.; Ehrmann, K.; Boero, G.; Besse, P.A.; Daridon, A.; Verpoorte, E.; de Rooij, N.F.; Popovic, R.S. Planar microcoil-based microfluidic NMR probes. J. Magn. Reson. 2003, 164, 242–255. 47. Gourley, P.L.; Copeland, R.G.; Cox, J.D.; Hendricks, J.K.; McDonald, A.E.; Peterson, S.L.; Sasaki, D.Y. Biocompatible semiconductor optoelectronics. J. Biomed. Opt. 2002, 7, 546–554. 48. Lee, K.; He, J.P.; Clement, R.; Massia, S.; Kim, B. Biocompatible benzocyclobutene (BCB)-based neural implants with micro-fluidic channel. Biosens. Bioelectron. 2004, 20, 404–407. 49. Suzuki, T.; Kotake, N.; Mabuchi, K.; Takeuchi, S. Bundled microfluidic channels for nerve regeneration electrodes. Proceedings of the 3rd International IEEE EMBS Conference on Neural Engineering, 2007, pp. 17–18. 50. Kartalov, E.P.; Zhong, J.F.; Scherer, A.; Quake, S.R.; Taylor, C.R.; Anderson, W.F. Highthroughput multi-antigen microfluidic fluorescence immunoassays. Biotechniques 2006, 40, 85–90. 51. Fu, A.Y.; Chou, H.P.; Spence, C.; Arnold, F.H.; Quake, S.R. An integrated microfabricated cell sorter. Anal. Chem. 2002, 74, 2451–2457. 52. Dertinger, S.K.W.; Jiang, X.Y.; Li, Z.Y.; Murthy, V.N.; Whitesides, G.M. Gradients of substrate-bound laminin orient axonal specification of neurons. Proc. Natl. Acad. Sci. USA 2002, 99, 12542–12547. 53. Martinoia, S.; Bove, M.; Tedesco, M.; Margesin, B.; Grattarola, M. A simple microfluidic system for patterning populations of neurons on silicon micromachined substrates. J. Neurosci. Methods 1999, 87, 35–44. 54. Wheeler, A.R.; Throndset, W.R.; Whelan, R.J.; Leach, A.M.; Zare, R.N.; Liao, Y.H.; Farrell, K.; Manger, I.D.; Daridon, A. Microfluidic device for single-cell analysis. Anal. Chem. 2003, 75, 3581–3586. 55. Lee, P.J.; Hung, P.J.; Shaw, R.; Jan, L.; Lee, L.P. Microfluidic application-specific integrated device for monitoring direct cell–cell communication via gap junctions between individual cell pairs. Appl. Phys. Lett. 2005, 86. 56. Peng, X.Y.; Li, P.C.H. A three-dimensional flow control concept for single-cell experiments on a microchip. 2. Fluorescein diacetate metabolism and calcium mobilization in a single yeast cell as stimulated by glucose and pH changes. Anal. Chem. 2004, 76, 7400–7400. 57. Peng, X.Y.; Li, P.C.H. A three-dimensional flow control concept for single-cell experiments on a microchip. 1. Cell selection, cell retention, cell culture, cell balancing, and cell scanning. Anal. Chem. 2004, 76, 5273–5281. 58. Peng, X.Y.; Li, P.C.H. A three-dimensional flow control concept for single-cell experiments on a microchip. 2. Fluorescein diacetate metabolism and calcium mobilization in
40
59.
60.
61. 62.
63.
64.
65. 66.
67.
68.
69. 70. 71. 72. 73. 74. 75. 76.
MICROFLUIDICS FOR NANONEUROSCIENCE
a single yeast cell as stimulated by glucose and pH changes. Anal. Chem. 2004, 76, 5282–5292. Rocheleau, J.V.; Walker, G.M.; Head, W.S.; McGuinness, O.P.; Piston, D.W. Microfluidic glucose stimulation reveals limited coordination of intracellular Ca2 þ activity oscillations in pancreatic islets. Proc. Natl. Acad. Sci. USA 2004, 101, 12899–12903. Ma, N.; Koelling, K.W.; Chalmers, J.J. Fabrication and use of a transient contractional flow device to quantify the sensitivity of mammalian and insect cells to hydrodynamic forces. Biotechnol. Bioeng. 2002, 80, 428–437. Gray, B.L.; Lieu, D.K.; Collins, S.D.; Smith, R.L.; Barakat, A.I. Microchannel platform for the study of endothelial cell shape and function. Biomed. Microdevices 2002, 4, 9–16. Sin, A.; Chin, K.C.; Jamil, M.F.; Kostov, Y.; Rao, G.; Shuler, M.L. The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors. Biotechnol. Prog. 2004, 20, 338–345. Rothert, A.; Deo, S.K.; Millner, L.; Puckett, L.G.; Madou, M.J.; Daunert, S. Whole-cellreporter-gene-based biosensing systems on a compact disk microfluidics platform. Anal. Biochem. 2005, 342, 11–19. Matsubara, Y.; Murakami, Y.; Kobayashi, M.; Morita, Y.; Tamiya, E. Application of onchip cell cultures for the detection of allergic response. Biosens. Bioelectron. 2004, 19, 741–747. DeBusschere, B.D.; Kovacs, G.T.A. Portable cell-based biosensor system using integrated CMOS cell-cartridges. Biosens. Bioelectron. 2001, 16, 543–556. Guo, S.X.; Bourgeois, F.; Chokshi, T.; Durr, N.J.; Hilliard, M.A.; Chronis, N.; Ben-Yakar, A. Femtosecond laser nanoaxotomy lab-on-a-chip for in vivo nerve regeneration studies. Nat. Methods 2008, 5, 531–533. Allen, P.B.; Sgro, A.E.; Chao, D.L.; Doepker, B.E.; Edgar, J.S.; Shen, K.; Chiu, D.T. Single-synapse ablation and long-term imaging in live C. elegans. J. Neurosci. Methods 2008, 173, 20–26. Ho, C.L.; Mou, T.Y.; Chiang, P.S.; Weng, C.L.; Chow, N.H. Mini chamber system for long-term maintenance and observation of cultured cells. Biotechniques 2005, 38, 267–273. Chen, C.S.; Jiang, X.Y.; Whitesides, G.M. Microengineering the environment of mammalian cells in culture. MRS Bull. 2005, 30, 194–201. Walker, G.M.; Zeringue, H.C.; Beebe, D.J. Microenvironment design considerations for cellular scale studies. Lab Chip 2004, 4, 91–97. Li, N.; Tourovskaia, A.; Folch, A. Biology on a chip: microfabrication for studying the behavior of cultured cells. Crit. Rev. Biomed. Eng. 2003, 31, 423–488. Qin, J.H.; Ye, N.N.; Liu, X.; Lin, B.C. Microfluidic devices for the analysis of apoptosis. Electrophoresis 2005, 26, 3780–3788. Vilkner, T.; Janasek, D.; Manz, A. Micro total analysis systems. Recent developments. Anal. Chem. 2004, 76, 3373–3385. Kartalov, E.P.; Anderson, W.F.; Scherer, A. The analytical approach to PDMS microfluidic technology and its biological applications. J. Nanosci. Nanotechnol. 2006, 6, 2265–2277. Sia, S.K.; Whitesides, G.M. Microfluidic devices fabricated in poly(dimethylsiloxane) for biological studies. Electrophoresis 2003, 24, 3563–3576. Park, T.H.; Shuler, M.L. Integration of cell culture and microfabrication technology. Biotechnol. Prog. 2003, 19, 243–253.
REFERENCES
41
77. Andersson, H.; van den Berg, A. Microtechnologies and nanotechnologies for single-cell analysis. Curr. Opin. Biotechnol. 2004, 15, 44–49. 78. Andersson, H.; van den Berg, A. Microfluidic devices for cellomics: a review. Sens. Actuators B Chem. 2003, 92, 315–325. 79. Andersson, H.; van den Berg, A. Microfabrication and microfluidics for tissue engineering: state of the art and future opportunities. Lab Chip 2004, 4, 98–103. 80. Pearce, T.M.; Williams, J.C. Microtechnology: meet neurobiology. Lab Chip 2007, 7, 30–40. 81. Gross, P.G.; Weiner, L.P.; Kartalov, E.P.; Scherer, A. Microfluidic techniques for studying the nervous system. Crit. Rev. Neurobiol. 2005, 17, 119–144. 82. Gross, P.G.; Kartalov, E.P.; Scherer, A.; Weiner, L.P. Applications of microfluidics for neuronal studies. J. Neurol. Sci. 2007, 252, 135–143. 83. Meyvantsson, I.; Beebe, D.J. Cell Culture Models in Microfluidic Systems. Annu. Rev. Anal. Chem. 2008, 1, 423–449. 84. Paguirigan, A.L.; Beebe, D.J. Microfluidics meet cell biology: bridging the gap by validation and application of microscale techniques for cell biological assays. Bioessays 2008, 30, 811–821. 85. Bao, N.; Wang, J.; Lu, C. Recent advances in electric analysis of cells in microfluidic systems. Anal. Bioanal. Chem. 2008, 391, 933–942. 86. Becker, H.; Gartner, C. Polymer microfabrication methods for microfluidic analytical applications. Electrophoresis 2000, 21, 12–26. 87. De Silva, M.N.; Desai, R.; Odde, D.J. Micro-patterning of animal cells on PDMS substrates in the presence of serum without use of adhesion inhibitors. Biomed. Microdevices 2004, 6, 219–222. 88. Peterson, S.L.; McDonald, A.; Gourley, P.L.; Sasaki, D.Y. Poly(dimethylsiloxane) thin films as biocompatible coatings for microfluidic devices: cell culture and flow studies with glial cells. J. Biomed. Mater. Res. A 72A, 2005, 10–18. 89. Mourzina, Y.; Kalyagin, D.; Steffen, A.; Offenhausser, A. Electrophoretic separations of neuromediators on microfluidic devices. Talanta 2006, 70, 489–498. 90. Linder, V.; Wu, H.K.; Jiang, X.Y.; Whitesides, G.M. Rapid prototyping of 2D structures with feature sizes larger than 8 mu m. Anal. Chem. 2003, 75, 2522–2527. 91. Tourovskaia, A.; Figueroa-Masot, X.; Folch, A. Differentiation-on-a-chip: a microfluidic platform for long-term cell culture studies. Lab Chip 2005, 5, 14–19. 92. Stroock, A.D.; Dertinger, S.K.; Whitesides, G.M.; Ajdari, A. Patterning flows using grooved surfaces. Anal. Chem. 2002, 74, 5306–5312. 93. Stroock, A.D.; Dertinger, S.K.W.; Ajdari, A.; Mezic, I.; Stone, H.A.; Whitesides, G.M. Chaotic mixer for microchannels. Science 2002, 295, 647–651. 94. Martines, E.; McGhee, K.; Wilkinson, C.; Curtis, A. A parallel-plate flow chamber to study initial cell adhesion on a nanofeatured surface. IEEE Trans. Nanobioscience 2004, 3, 90–95. 95. Zhu, X.; Yi Chu, L.; Chueh, B.H.; Shen, M.; Hazarika, B.; Phadke, N.; Takayama, S. Arrays of horizontally-oriented mini-reservoirs generate steady microfluidic flows for continuous perfusion cell culture and gradient generation. Analyst 2004, 129, 1026–1031. 96. Erickson, D.; Liu, X.Z.; Venditti, R.; Li, D.Q.; Krull, U.J. Electrokinetically based approach for single-nucleotide polymorphism discrimination using a microfluidic device. Anal. Chem. 2005, 77, 4000–4007.
42
MICROFLUIDICS FOR NANONEUROSCIENCE
97. Liu, J.; Enzelberger, M.; Quake, S. A nanoliter rotary device for polymerase chain reaction. Electrophoresis 2002, 23, 1531–1536. 98. Prokop, A.; Prokop, Z.; Schaffer, D.; Kozlov, E.; Wikswo, J.; Cliffel, D.; Baudenbacher, F. NanoLiterBioReactor: Long-term mammalian cell culture at nanofabricated scale. Biomed. Microdevices 2004, 6, 325–339. 99. Yang, M.; Li, C.W.; Yang, J. Cell docking and on-chip monitoring of cellular reactions with a controlled concentration gradient on a microfluidic device. Anal. Chem. 2002, 74, 3991–4001. 100. Boettcher, M.; Jaeger, M.; Kischbaum, M.; Mueller, T.; Schnelle, T.; Duschl, C. Gravitation-driven stress-reduced cell handling. Anal. Bioanal. Chem. 2008, 390, 857–863. 101. Lovchik, R.; von Arx, C.; Viviani, A.; Delamarche, E. Cellular microarrays for use with capillary-driven microfluidics. Anal. Bioanal. Chem. 2008, 390, 801–808. 102. Chang, J.C.; Brewer, G.J.; Wheeler, B.C. A modified microstamping technique enhances polylysine transfer and neuronal cell patterning. Biomaterials 2003, 24, 2863–2870. 103. Cornish, T.; Branch, D.W.; Wheeler, B.C.; Campanelli, J.T. Microcontact printing: a versatile technique for the study of synaptogenic molecules. Mol. Cell. Neurosci. 2002, 20, 140–153. 104. Tourovskaia, A.; Barber, T.; Wickes, B.T.; Hirdes, D.; Grin, B.; Castner, D.G.; Healy, K.E.; Folch, A. Micropatterns of chemisorbed cell adhesion-repellent films using oxygen plasma etching and elastomeric masks. Langmuir 2003, 19, 4754–4764. 105. Nam, Y.; Chang, J.C.; Wheeler, B.C.; Brewer, G.J. Gold-coated microelectrode array with thiol linked self-assembled monolayers for engineering neuronal cultures. IEEE Trans. Biomed. Eng. 2004, 51, 158–165. 106. Yu, H.M.; Meyvantsson, I.; Shkel, I.A.; Beebe, D.J. Diffusion dependent cell behavior in microenvironments. Lab Chip 2005, 5, 1089–1095. 107. Gu, W.; Zhu, X.Y.; Futai, N.; Cho, B.S.; Takayama, S. Computerized microfluidic cell culture using elastomeric channels and Braille displays. Proc. Natl. Acad. Sci. USA 2004, 101, 15861–15866. 108. Heo, Y.S.; Cabrera, L.M.; Song, J.W.; Futai, N.; Smith, G.D.; Takayam, S. Characterization and resolution of evaporation-mediated osmolality shifts that constrain microfluidic cell culture in poly(dimethylsiloxane) devices. Anal. Chem. 2007, 79, 1126–1134. 109. Toepke, M.W.; Beebe, D.J. PDMS absorption of small molecules and consequences in microfluidic applications. Lab Chip 2006, 6, 1484–1486. 110. Millet, L.J.; Stewart, M.E.; Sweedler, J.V.; Nuzzo, R.G.; Gillette, M.U. Microfluidic devices for culturing primary mammalian neurons at low densities. Lab Chip 2007, 7, 987–994. 111. Jeon, N.L.; Dertinger, S.K.W.; Chiu, D.T.; Choi, I.S.; Stroock, A.D.; Whitesides, G.M. Generation of solution and surface gradients using microfluidic systems. Langmuir 2000, 16, 8311–8316. 112. Dertinger, S.K.W.; Chiu, D.T.; Jeon, N.L.; Whitesides, G.M. Generation of gradients having complex shapes using microfluidic networks. Anal. Chem. 2001, 73, 1240–1246. 113. Lin, F.; Nguyen, C.M.C.; Wang, S.J.; Saadi, W.; Gross, S.P.; Jeon, N.L. Effective neutrophil chemotaxis is strongly influenced by mean IL-8 concentration. Biochem. Biophys. Res. Commun. 2004, 319, 576–581.
REFERENCES
43
114. Wang, S.J.; Saadi, W.; Lin, F.; Nguyen, C.M.C.; Jeon, N.L. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. Exp. Cell Res. 2004, 300, 180–189. 115. Chung, B.G.; Flanagan, L.A.; Rhee, S.W.; Schwartz, P.H.; Lee, A.P.; Monuki, E.S.; Jeon, N.L. Human neural stem cell growth and differentiation in a gradient-generating microfluidic device. Lab Chip 2005, 5, 401–406. 116. Hung, P.J.; Lee, P.J.; Sabounchi, P.; Lin, R.; Lee, L.P. Continuous perfusion microfluidic cell culture array for high-throughput cell-based assays. Biotechnol. Bioeng. 2005, 89, 1–8. 117. Pantoja, R.; Nagarah, J.M.; Starace, D.M.; Melosh, N.A.; Blunck, R.; Bezanilla, F.; Heath, J.R. Silicon chip-based patch-clamp electrodes integrated with PDMS microfluidics. Biosens. Bioelectron. 2004, 20, 509–517. 118. Sigworth, F.J.; Klemic, K.G. Microchip technology in ion-channel research. IEEE Trans. Nanobioscience 2005, 4, 121–127. 119. Klemic, K.G.; Klemic, J.F.; Reed, M.A.; Sigworth, F.J. Micromolded PDMS planar electrode allows patch clamp electrical recordings from cells. Biosens. Bioelectron. 2002, 17, 597–604. 120. Klemic, K.G.; Klemic, J.F.; Sigworth, F.J. An air-molding technique for fabricating PDMS planar patch-clamp electrodes. Pflugers Arch. 2005, 449, 564–572. 121. Ionescu-Zanetti, C.; Shaw, R.M.; Seo, J.G.; Jan, Y.N.; Jan, L.Y.; Lee, L.P. Mammalian electrophysiology on a microfluidic platform. Proc. Natl. Acad. Sci. USA 2005, 102, 9112–9117. 122. Lau, A.Y.; Hung, P.J.; Wu, A.R.; Lee, A.P. Open-access microfluidic patch-clamp array with raised lateral cell trapping sites. Lab Chip 2006, 6, 1510–1515. 123. Chen, C.; Folch, A. A high-performance elastomeric patch clamp chip. Lab Chip 2006, 6, 1338–1345. 124. Farinas, J.; Chow, A.W.; Wada, H.G. A microfluidic device for measuring cellular membrane potential. Anal. Biochem. 2001, 295, 138–142. 125. Mela, P.; Onclin, S.; Goedbloed, M.H.; Levi, S.; Garcia-Parajo, M.F.; van Hulst, N.F.; Ravoo, B.J.; Reinhoudt, D.N.; van den Berg, A. Monolayer-functionalized microfluidics devices for optical sensing of acidity. Lab Chip 2005, 5, 163–170. 126. Hafner, F. Cytosensor microphysiometer: technology and recent applications. Biosens. Bioelectron. 2000, 15, 149–158. 127. Brischwein, M.; Motrescu, E.R.; Cabala, E.; Otto, A.M.; Grothe, H.; Wolf, B. Functional cellular assays with multiparametric silicon sensor chips. Lab Chip 2003, 3, 234–240. 128. Zhang, X.; Yin, H.; Cooper, J.M.; Haswell, S.J. Characterization of cellular chemical dynamics using combined microfluidic and Raman techniques. Anal. Bioanal. Chem. 2008, 390, 833–840. 129. Tamaki, E.; Sato, K.; Tokeshi, M.; Aihara, M.; Kitamori, T. Single-cell analysis by a scanning thermal lens microscope with a microchip: direct monitoring of cytochrome c distribution during apoptosis process. Anal. Chem. 2002, 74, 1560–1564. 130. Huang, Y.; Rubinsky, B. Flow-through micro-electroporation chip for high efficiency single-cell genetic manipulation. Sens. Actuators A Phys. 2003, 104, 205–212. 131. Khine, M.; Lau, A.; Ionescu-Zanetti, C.; Seo, J.; Lee, L.P. A single cell electroporation chip. Lab Chip 2005, 5, 38–43.
44
MICROFLUIDICS FOR NANONEUROSCIENCE
132. Hong, J.W.; Studer, V.; Hang, G.; Anderson, W.F.; Quake, S.R. A nanoliter-scale nucleic acid processor with parallel architecture. Nat. Biotechnol. 2004, 22, 435–439. 133. Marcus, J.S.; Anderson, W.F.; Quake, S. Parallel picoliter RT-PCR assays using microfluidics. Anal. Chem. 2006, 78, 956–958. 134. Marcus, J.S.; Anderson, W.F.; Quake, S.R. Microfluidic single cell mRNA isolation and analysis. Anal. Chem. 2006, 78, 3084–3089. 135. Hong, J.W.; Chen, Y.; Anderson, W.F.; Quake, S.R. Molecular biology on a microfluidic chip. J. Phys. Condens. Matter 2006, 18, 1–11. 136. Camelliti, P.; McCulloch, A.D.; Kohl, P. Microstructured cocultures of cardiac myocytes and fibroblasts: a two-dimensional in vitro model of cardiac tissue. Microsc. Microanal. 2005, 11, 249–259. 137. Dusseiller, M.R.; Schlaepfer, D.; Koch, M.; Kroschewski, R.; Tester, M. An inverted microcontact printing method on topographically structured polystyrene chips for arrayed micro-3-D culturing of single cells. Biomaterials 2005, 26, 5917–5925. 138. Schwarz, U.S.; Bischofs, I.B. Physical determinants of cell organization in soft media. Med. Eng. Phys. 2005, 27, 763–772. 139. Discher, D.E.; Janmey, P.; Wang, Y.-l. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310, 1139–1143. 140. Turner, A.M.P.; Dowell, N.; Turner, S.W.P.; Kam, L.; Isaacson, M.; Turner, J.N.; Craighead, H.G.; Shain, W. Attachment of astroglial cells to microfabricated pillar arrays of different geometries. J. Biomed. Mater. Res. 2000, 51, 430–441. 141. Massia, S.P.; Holecko, M.M.; Ehteshami, G.R. In vitro assessment of bioactive coatings for neural implant applications. J. Biomed. Mater. Res. 68A, 2004, 177–186. 142. Recknor, J.B.; Recknor, J.C.; Sakaguchi, D.S.; Mallapragada, S.K. Oriented astroglial cell growth on micropatterned polystyrene substrates. Biomaterials 2004, 25, 2753–2767. 143. Cullen, D.K.; Vukasinovic, J.; Glezer, A.; Laplaca, M.C. Microfluidic engineered high cell density three-dimensional neural cultures. J. Neural Eng. 2007, 4, 159–172. 144. Rowe, L.; Almasri, M.; Lee, K.; Fogleman, N.; Brewer, G.J.; Nam, Y.; Wheeler, B.C.; Vukasinovic, J.; Glezer, A.; Frazier, A.B. Active 3-D microscaffold system with fluid perfusion for culturing in vitro neuronal networks. Lab Chip 2007, 7, 475–482. 145. Wu, Z.; Hjort, K.; Wicher, G.; Svenningsen, A.F. Microfluidic high viability neural cell separation using viscoelastically tuned hydrodynamic spreading. Biomed. Microdevices 2008, 10, 631–638. 146. Flanagan, L.A.; Lu, J.; Wang, L.; Marchenko, S.A.; Jeon, N.L.; Lee, A.P.; Monuki, E.S. Unique dielectric properties distinguish stem cells and their differentiated progeny. Stem Cells 2008, 26, 656–665. 147. Tourovskaia, A.; Li, N.; Folch, A. Localized acetylcholine receptor clustering dynamics in response to microfluidic focal stimulation with agrin. Biophys. J. 2008, 95, 3009–3016. 148. Huang, W.-H.; Cheng, W.; Zhang, Z.; Pang, D.-W.; Wang, Z.-L.; Cheng, J.-K.; Cui, D.-F. Transport, location and quantal release monitoring of single cells on a microfluidic device. Anal. Chem. 2004, 76, 483–488. 149. Chen, P.; Xu, B.; Tokranova, N.; Feng, X.; Castracane, J.; Gillis, K.D. Amperometric detection of quantal catecholamine secretion from individual cells on micromachined silicon chips. Anal. Chem. 2003, 75, 518–524.
REFERENCES
45
150. Li, M.W.; Spence, D.M.; Martin, R.S. A microchip-based system for immobilizing PC12 cells and amperometrically detecting catecholamines released after stimulation with calcium. Electroanalysis 2005, 17, 1171–1180. 151. Sun, X.; Gillis, K.D. On-chip amperometric measurement of quantal catecholamine release using transparent indium tin oxide electrodes. Anal. Chem. 2006, 78, 2521–2525. 152. Jo, K.; Heien, M.L.; Thompson, L.B.; Zhong, M.; Nuzzo, R.G.; Sweedler, J.V. Mass spectrometric imaging of peptide release from neuronal cells within microfluidic devices. Lab Chip 2007, 7, 1454–1460. 153. Mahoney, M.J.; Chen, R.R.; Tan, J.; Saltzman, W.M. The influence of microchannels on neurite growth and architecture. Biomaterials 2005, 26, 771–778. 154. Romanova, E.V.; Fosser, K.A.; Rubakhin, S.S.; Nuzzo, R.G.; Sweedler, J.V. Engineering the morphology and electrophysiological parameters of cultured neurons by microfluidic surface patterning. FASEB J. 2004, 18, 1267–1269. 155. Cohen, J.; Burne, J.F.; McKinlay, C.; Winter, J. The role of laminin and the laminin/ fibronectin receptor complex in the outgrowth of retinal ganglion cell axons. Dev. Biol. 1987, 122, 407–418. 156. Lang, S.; von Philipsborn, A.C.; Bernard, A.; Bonhoeffer, F.; Bastmeyer, M. Growth cone response to ephrin gradients produced by microfluidic networks. Anal. Bioanal. Chem. 2008, 390, 809–816. 157. von Philipsborn, A.C.; Lang, S.; Jiang, Z.; Bonhoeffer, F.; Bastmeyer, M. Substrate-bound protein gradients for cell culture fabricated by microfluidic networks and microcontact printing. Sci. STKE 2007, 414, 1–11. 158. Li, G.N.; Liu, J.; Hoffman-Kim, D. Multi-molecular gradients of permissive and inhibitory cues direct neurite outgrowth. Ann. Biomed. Eng. 2008, 36, 889–904. 159. Recknor, J.B.; Sakaguchi, D.S.; Mallapragada, S.K. Directed growth and selective differentiation of neural progenitor cells on micropatterned polymer substrates. Biomaterials 2006, 27, 4098–4108. 160. Wittig, J.H.; Ryan, A.F.; Asbeck, P.M. A reusable microfluidic plate with alternate-choice architecture for assessing growth preference in tissue culture. J. Neurosci. Methods 2005, 144, 79–89. 161. Nakashima, Y.; Yasuda, T. Cell differentiation guidance using chemical stimulation controlled by a microfluidic device. Sens. Actuators A Phys. 2007, 139, 252–258. 162. Houchin-Ray, T.; Whittlesey, K.J.; Shea, L.D. Spatially patterned gene delivery for localized neuron survival and neurite extension. Mol. Ther. 2007, 15, 705–712. 163. Bergen, J.M.; Pun, S.H. Analysis of the intracellular barriers encountered by nonviral gene carriers in a model of spatially controlled delivery to neurons. J. Gene Med. 2007, 10, 187–197. 164. Taylor, A.M.; Rhee, S.W.; Tu, C.H.; Cribbs, D.H.; Cotman, C.W.; Jeon, N.L. Microfluidic multicompartment device for neuroscience research. Langmuir 2003, 19, 1551–1556. 165. Taylor, A.M.; Blurton-Jones, M.; Rhee, S.W.; Cribbs, D.H.; Cotman, C.W.; Jeon, N.L. A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat. Methods 2005, 2, 599–605. 166. Rhee, S.W.; Taylor, A.M.; Tu, C.H.; Cribbs, D.H.; Cotman, C.W.; Jeon, N.L. Patterned cell culture inside microfluidic devices. Lab Chip 2005, 5, 102–107.
46
MICROFLUIDICS FOR NANONEUROSCIENCE
167. Vahidi, B.; Park, J.W.; Kim, H.J.; Jeon, N.L. Microfluidic-based strip assay for testing the effects of various surface-bound inhibitors in spinal cord injury. J. Neurosci. Methods 2008, 170, 188–196. 168. Park, J.W.; Vahidi, B.; Joon, K.H.; Rhee, S.W.; Jeon, N.L. Quantitative analysis of CNS axon regeneration using a microfluidic neuron culture device. BioChip J. 2008, 2, 44–51. 169. Ravula, S.K.; McClain, M.A.; Wang, M.S.; Glass, J.D.; Frazier, A.B. A multielectrode microcompartment culture platform for studying signal transduction in the nervous system. Lab Chip 2006, 6, 1530–1536. 170. Ravula, S.K.; Wang, M.S.; McClain, M.A.; Asress, S.A.; Frazier, B.; Glass, J.D. Spatiotemporal localization of injury potentials in DRG neurons during vincristineinduced axonal degeneration. Neurosci. Lett. 2007, 415, 34–39. 171. Minteer, S.D., Ed. Microfluidic Techniques: Reviews and Protocol, Humana Press: Totowa, NJ, 2006.
2 NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS SHALINI PRASAD AND VINDHYA KUNDURU Department of Electrical Engineering, Arizona State University, Tempe, AZ , USA
YAMINI YADAV AND MANISH BOTHARA Department of Electrical and Computer Engineering, Portland State University, Portland, OR, USA
SRIRAM MUTHUKUMAR Intel Corporation, Chandler, AZ, USA
2.1 INTRODUCTION There has been a tremendous interest in the past decade in the use of nanoporous membranes to develop sensors. These membrane-based technologies offer multiple advantages in sensing: due to the nanoporosity of membranes that enables size-based trapping of biomolecules, they can be manufactured using standard processes with tremendous quality control in membrane specifications, they are biocompatible, and they can be easily surface functionalized to ensure specificity in immobilization. This chapter reviews the advances and current state of the art in nanomembrane technology in the context of biosensing; key membrane manufacturing technologies have been reviewed and the methodologies of incorporating them into microelectronic/microfabricated platforms for developing biosensor devices have been reviewed. This chapter explains in detail the need for real-time measurement of biomolecule binding in biosensors and justification for incorporating nanoporous membranes into “lab-on-a-chip” biosensing devices. Prior to understanding the complex procedure of
Microfluidic Devices in Nanotechnology: Applications, Edited by Challa S. Kumar Copyright 2010 John Wiley & Sons, Inc.
47
48
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
construction of a membrane-based biosensor, the basic concept of a biosensor and different techniques to embed the nanoporous membrane have been reviewed. The techniques of biomolecule entrapment including encapsulation, covalent bonding, and adsorption that play an important role in determining the functionality and performance of a nanoporous membrane-based biosensor have been looked at. We have evaluated a number of applications for the nanoporous membrane-based biosensors in healthcare and environmental monitoring. A wide range of nanoporous membranes made from organic, inorganic, and hybrid nanomaterials have been examined. Methods such as anodization, ion track etching, phase separation, sol–gel rapid thermal annealing, focused ion beam, and lithography used for synthesis of nanoporous membrane have been described in this chapter. We have reviewed a range of electrochemical detection methodologies that have been most commonly adopted to perform detection with these membranes. The incorporation or integration of these nanoporous membranes into microscale platforms has been reviewed. We have also compared the multiple detection mechanisms based on constraints such as sensitivity, selectivity, time, and cost. Nanoporous membrane-based biosensors for detection of microorganism such as bacteria, pathogens, and viruses and analysis of concentration for body fluids such as glucose and cholesterol have been discussed. Finally, prospects of the development of natural and biomimetic nanomembranes have been discussed. The chapter has been organized to demonstrate the need for integration of nanoporous membranes into microfluidics with specific applications in biosensing. One of the emerging needs in the domain of biosensing is the real-time measurement or the kinetics of detection. This has a far-reaching impact on diagnostics in the areas of healthcare and the environment. The next section articulates the motivation for developing nanoporous microfluidic biosensors. The next section addresses the types of biosensors and how label-free biosensors can be developed using nanoporous membranes in conjunction with microfluidics. The next section focuses on addressing the need for nanoporous membranes for detection of both small molecules and molecular entities. The next section identifies the types of nanoporous membranes that have been used for biosensing and analyzes the merits and disadvantages of the multiple material systems. The next section focuses on methods of fabrication and processing of the nanoporous membranes and the methods of integrating them into platforms relevant to biosensing applications. The last section focuses on a number of healthcare and environmental applications that employ nanoporous microfluidic biosensors. The most distinguishing feature of this chapter is that it evaluates a new class of miniaturized lab-on-a-chip platforms—the nanoporous membrane-based microfluidic biosensors. Contemporary leading reviews focus either on microfluidics or on application for biosensors. This chapter is the first attempt to look at a new class of biosensors that have been quietly emerging in the domain of lab-on-a-chip devices. 2.2 NEED FOR REAL-TIME MEASUREMENTS Monitoring human health for early detection of disease conditions or health disorders is vital for maintaining a healthy life. Many tissues, microorganisms, organelles, cell receptors, enzymes, antibodies, nucleic acids, biomolecules, and so on help determine
BASIC CONCEPTS OF BIOSENSORS
49
the physiological state of a disease condition. In addition, analysis of food and environment for perturbants such as pesticides and river water contaminants with harmful biomolecules has also become invaluable for health diagnosis. Thus, there is an ongoing need for rapid analysis, active continuous-time monitoring systems with substantial accuracy for detecting biomolecules. A “real-time” biosensor that detects the analytes of interest in a near-continuous-time manner plays an important role in effective data generation and data processing, supporting real-time decision making, and rapid manipulation. In order to meet these multiple requirements from multiple environments, one of the standard approaches that have been adopted is developing hybrid biochemical analysis systems. These multiscale biosensors are versatile because they can monitor specific analytes from a wide range of environments at ultralow concentrations. They comprise a combination of nanomaterials integrated with microfluidic capabilities. This approach is similar to that followed by the semiconductor industry in integrated circuits. Microfluidic research involves the study of several fluid manipulation, detection, and separation techniques. Often, these different components are integrated into essential electronics to develop a complete “on-chip” analysis system. Well-established fabrication techniques are adapted from the semiconductor industry such as micromachining, injection and replica molding, soft lithography, wet etching, and photolithography. These techniques enable miniaturization of fluid handling systems to palm-held “micrototal analysis systems” or “lab-on-a-chip” devices that can perform a myriad of diagnostic and analysis tasks associated with a standard clinical laboratory assay. Hence, a lot of the present research in this area focuses on the integration of these complex requirements of real-time measurements with on-chip detection capabilities to build multifunctional biosensors. One of the innovative approaches adopted to address these requirements has been the use of nanoporous membranes embedded into microfabricated structures to generate multiscale platforms. These platforms are integrated into the appropriate microfluidics to achieve size-based trapping of analytes of interest, which are then immobilized and interrogated using a number of label-free methods that have been discussed in the following sections of the chapter. Hence, nanoporous membrane embedded with a microfluidic device provides a powerful tool for real-time measurement of “lab-on-achip” biosensors. The following section explains the basic concepts of biosensors. 2.3 BASIC CONCEPTS OF BIOSENSORS A label-free biosensor is a means of detecting biological agents such as antibodies, nucleic acids, tissues, cells, microbes, and metabolites. The working principle consists of binding bioanalytes of interest to bioreceptors, which in turn modulate the physiochemical signal associated with binding. Later, the electrochemical or optical transducer captures and converts the physiochemical signal into an electrical signal. The variation in signal such as electric potential, current, conductance, impedance, intensity and phase of the electromagnetic radiation, mass, temperature, and viscosity is monitored. The analysis of variation in one or more of these parameters quantifies the presence or absence of bioagents. This quantification is achieved without using
50
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
Electric potential Electric current Electric conductance Electric impedance Intensity and phase of EM radiation Mass Temperature Viscosity
Electrical signal
Transducer
Signal processing
Transduction
Physiochemical signal Bioreceptors Enzymes Antibody Nucleic acid Tissue Microbial Polysaccharide
Recognition
Bioanalytes
FIGURE 2.1
Biomolecular complex
Schematic prototype of a standard biosensor.
FIGURE 2.2 Integration of bioelements and transducer to construct a nanoporous membrane-based biosensor.3
fluorescent tags or labels. Figure 2.1 demonstrates a schematic diagram of biosensors. In nanoporous membrane-based biosensors shown in Figure 2.2, the porous nanomembrane acts as an intermediate layer between biological agents and the physicochemical detector component, or biological agents and transducer are combined with a nanoporous membrane to construct a biosensor. In the area of nanomaterial-based biosensor, one of the genres of nanomaterials that are incorporated in the sensors is the nanomembrane. The huge interest in nanomembranes is driven by their many desirable properties, particularly the ability to tailor the size and structure and thereby optimize signal transduction properties for sensing systems. These nanomembrane-based electrical biosensors produce signal amplification, leading to lower limit of detection. Applications in both clinical and nonclinical environments are discussed below. 2.4 APPLICATIONS OF NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS Most common applications of nanoporous membranes are self-regulated drug delivery, biomolecular separation devices, and biosensors. In biosensors, often the
APPLICATIONS OF NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
51
nanoporous membrane is incorporated for biomolecular separation. These nanoporous membrane-based microfluidic biosensors are significantly smaller in size than conventional fluid manipulation systems, rendering them portable and extremely useful in the areas of nanobiotechnology, bioanalysis, pharmaceuticals, medicine, and diagnostics. Advances in nanotechnology have impacted research in biotechnology with the development of “smart devices” capable of molecular manipulation. Microfabricated bioanalytical devices offer highly efficient platforms for genomic, proteomic, and metabolic studies. The nanoporous membrane plays an important role in fabrication of biocompatible and cost-effective lab-on-a chip devices. Moreover, analogous to the miniaturization of computer chips, bioanalytical sensors are also undergoing reduction in their size. This offers the benefit of shorter reaction speeds with faster analysis times. Multiple active sites on the microfluidic chip offer parallel operation modes, thereby resulting in multiplexed analysis and higher throughput. These membrane-based biosensors can be costeffectively produced on a large scale with a promise of higher analysis rates and better efficiency, owing to the compactness and better process control; lower analyte consumption lowers the cost incurred on expensive reagents and is environment friendly during disposal. Figure 2.3 illustrates the flowchart for different applications of biosensors. The important part of membrane-based biosensor is their thin porous membrane. The need for this nanoporous membrane is explained in following sections. 2.4.1 Need for Nanoporous Membrane Overall sensitivity of a sensor depends on signal transduction and mass transport effect. Miniaturization of a sensor increases signal-to-noise (S/N) ratio, an inherent advantage for signal transduction. It has been reported that mass transport of analytical solution through the sensor surface plays an important role in determining sensitivity.4 Detection limit for bioassays depends upon the amount of biomolecule interaction with the sensor surface. Whitman’s group at Naval Research Laboratory, Washington, DC, reported
FIGURE 2.3
Flowchart representation of a biosensor.3
52
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
that femtomolar detection limits for bioassays are likely. They predicted that the limit of detection will be due to analyte transport limitation, not due to signal transduction limitation, and without directed transport of biomolecules, individual nanoscale sensors will be limited to picomolar-order sensitivity for practical timescales.4 Total flux to the sensor was studied as a function of sensor geometry and volumetric flow. Enhancing mass transport by conventional methods of decreasing height decreased volumetric flow rate, which in turn decreased total flux of the sensor. On the other hand, directly injecting the analyte into the sensor rather than merely streaming it past increased mass transport effects, which in turn increased total flux of the sensor.4 It was found that the sensor flux could be increased by using a nanoporous membrane. Thus, the sensitivity of the sensor can be enhanced by incorporating nanoporous membrane into the microfluidic biosensors. 2.4.2 Efficient Size Sorting Membrane-based technology has been identified as a useful method for the separation of biomaterials including viruses, owing to its efficiency, ease of implementation, and cost effectiveness. Due to nanometer-sized domain, and relatively thin membrane thickness and narrow size distribution, the nanoporous membrane shows high flux, mechanical strength, and high selectivity for biomaterial separation. Comparative studies were performed between track-etched polycarbonate (PC) and anodized aluminum oxide (AAO) membranes with a uniform pore size for virus separation; it was found that the nanoporous AAO membrane yields an excellent selectivity and high solution flux. 2.4.3 Design Considerations for Molecular Sorting One of the important aspects of the porous membrane typically exploited in microfluidic devices is the sorting of biomolecules on the basis of size from different bioanalytes for downstream analysis of the bioagent on biosensor platform. Depending on size and diffusion rate, pore size is determined. Adiga et al. explained that the nanoporous membrane is evaluated in terms of porosity of the membrane that is defined by solvent flux through unit area of the membrane under a unit pressure difference.1 ! r2p Ak Lp ¼ 8h Dx where rp is the pore radius, 8h is the solvent viscosity, and (Ak/Dx) is the ratio of surface porosity to the pore length. Earlier, electrophoresis was used as a mechanism for the separation of biomolecules.5 Increasing demand of real-time measurement and miniaturization of biosensors to build a lab-on-a-chip device has led to the integration of the nanoporous membrane into the microfluidic device. Kuo et al. have built a simple, rapid prototyping of porous nanostructures inside the microchannels for the separation of
TYPES OF NANOPOROUS MATERIALS
FIGURE 2.4
53
Schematic diagram of a nanoporous structure in a microfluidic channel.6
DNA molecules.6 Periodic porous nanostructures with a cavity size of 300 nm and interconnecting pore of 30 nm were fabricated inside the microchannels. The fabrication process step using negative photoresist SU-8 is explained in Figure 2.4. First, silica colloidal is grown inside the SU-8 microchannel, then the space between colloidal crystals is filled with SU-8, which is then cured using ultraviolet light. The silica nanoparticles are finally removed using BOE, creating pores in the SU-8 structure. 2.5 TYPES OF NANOPOROUS MATERIALS Porous membranes can be broadly classified depending upon their intrinsic materials such as organic, inorganic, polymer, and composite membranes. Depending upon the barrier structure, membranes are nonporous or have micropores, mesopores, and macropores with pore diameters of <2 nm, 2–50 nm, and 50–500 nm, respectively.7 Lehrstuhl f€ur Technische Chemie II explained that porous barriers could be used for very precise continuous permselective separations based on subtle differences in size, shape, and/or functional groups.7 Many scientists are developing novel composites and polymers to tailor well-defined porous membranes in terms of pore size to increase their functionality and selectivity. Furthermore, depending on the cross section, membranes are classified as isotropic, anisotropic, bimultilayer, thin layer, or matrix of mixed composite. Yang et al. synthesized a nanoporous membrane for virus filtration with good dimensional stability under high pressures maintaining high selectivity.8 The membrane consists of a double layer. The upper layer is a nanoporous film with a pore size of 17 nm and a thickness of 160 nm, which was prepared by polystyrene-block-poly(methyl methacrylate) (PS-b-PMMA) copolymer. The lower layer consists of conventional microfiltration membrane to enhance mechanical strength. Phase separation, sol–gel method, interface reaction, stretching extrusion, track etching, and microfabrication technique can also be used for the classification of porous membranes. Inorganic membranes are made from oxides, ceramics, and metals, while the most commonly used polymeric materials are Nafion, polycarbonate, polyethylene terephthalate, or polysulfone. In comparison to polymer membranes, inorganic membranes are versatile, can be used at very high temperatures, and are much more resistant to chemical attack. Different strategies for fabricating and integrating the reviewed nanoporous membranes into sensing devices are explained briefly in the following section.
54
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
2.6 FABRICATION AND INTEGRATION OF NANOPOROUS MEMBRANES INTO MICROFLUIDIC DEVICE 2.6.1 Anodization Anodization is an “electrochemical etching” process. Traditionally, nanoporous AAO membranes are fabricated by two ways: mild anodization (MA) or hard anodization (HA). The MA method produces self-ordered pore structures with a limitation in terms of slow process; the processing time requires several days, the oxide growth rate is 2–6 mm h1, and the process requires a narrow range of processing conditions called self-ordering regimes. Being a slow process, MA is not suitable for mass production and industrial processes. Another technique that is widely found in the literature is HA. HA is performed at a high voltage by using sulfuric acid at relatively low temperatures and high current densities resulting in the rapid growth of a thick porous oxide layer of approximately 50–100 mm h1 for various applications. Comparative study shows that porous oxide films formed by HA are disoriented compared to the pores formed by MA. Moreover, they are mechanically unstable due to a strong tendency to develop cracks under the influence of even weak mechanical forces. These aspects have caused serious problems in practical application of anodic films, especially in nanotechnology research. A limitation with HA process is in controlling important structural parameters, such as pore size, interpore distance, and the aspect ratio of the nanopores of the resulting alumina membranes. A comparison between MA and HA based on porosity, interpore distance, pore diameter, and pore density is provided in Table 2.1. A schematic diagram provided in Figure 2.5 illustrates the hexagonal structural layout of AAO by the anodization method. Researchers at Max Planck Institute of Microstructure Physics in Halle have developed a novel approach for structural engineering of nanoporous alumina using a pulse anodization method with oxalic acid.9 The process sequence of the pulse anodization method is shown in Figure 2.6. In the pulse anodization method, low and high potential pulses were applied alternatively to achieve mild and hard anodization conditions, respectively. The new process is an effective way of improving mechanical stability with a thickness of >100 mm of hard anodized alumina. In addition, it also provides a unique opportunity for producing individual alumina nanotubes with uniform diameter and length by taking advantage of cracking phenomena in the hard anodization process. The interpore distances of the AAO are approximately Dint ¼ 200–300 nm that can be achieved only by mild anodization
TABLE 2.1
Comparison Between MA and HA in 0.3 N H2C2O49
Parameter Porosity (P, %) Interpore distance (Dint, nm) Pore diameter (Dp, nm) Pore density (p; pores cm2)
MA
HA
10 100 40 1.0 1010
3.3–3.4 220–300 49–59 1.3–1.9 109
FABRICATION AND INTEGRATION OF NANOPOROUS MEMBRANES
55
FIGURE 2.5 Schematic diagram demonstrating a porous oxide film produced by the anodization method.
FIGURE 2.6 Scheme for the fabrication of porous alumina with modulated pore diameters by a combination of MA and HA of a prepatterned aluminum substrate.9
56
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
FIGURE 2.7 Graph illustrating different conditions for synthesis of hard and mild anodization nanoporous membranes.9
processes. It offers substantial advantages over conventional anodization processes in terms of processing time, allowing 2500–3500% faster oxide growth with improved ordering of nanopores. Perfectly ordered alumina membranes with high aspect ratios (>1000) of uniform nanopores with periodically modulated diameters have been realized. In addition to sulfuric acid (H2SO4), oxalic acid (H2C2O4) and phosphoric acid are also used for making AAO. Figure 2.7 illustrates different conditions for the synthesis of hard and mild anodization nanoporous membranes. Shalini Prasad’s group from Portland State University demonstrated uniform formation of pores onto an alumina membrane fabricated using the anodization method.10 A combination of oxalic (0.1 M) and sulfuric acid (0.3 M) was used as an oxidizing acid. Alumina membrane fabricated had a thickness of 250 nm with a distance of separation between each pore of 10–15 nm, and the diameter of each pore was 200 mm. The volume of each pore was 8 1021 mL. The SEM characterization of AAO is shown in Figure 2.8. 2.6.2 Ion Track Etching Track etching technology consists of chemical and physical modifications of thin films induced by energetic ion irradiation.11 The ion tracking process consists of irradiation of polymeric thin foils with heavy ions and subsequent chemical etching of the particle tracks. Cylindrical, conical, funnel-like, or cigar-like pores with diameters ranging from tens of nanometers to the micrometer range can be obtained.12 To obtain nanopores, the etching is performed in an ion accelerator and controlled by monitoring etchable ion tracks of swift heavy ions. The energy of these specific ion tracks should
FABRICATION AND INTEGRATION OF NANOPOROUS MEMBRANES
57
FIGURE 2.8 Scanning electron micrographs showing the alumina nanomembrane. (a) Density of the pores is clearly visible from these micrographs. Panel (b) shows the uniformity of the pores and the size distribution of each pore. (c and d) The pore goes all the way through the membrane and creates uniform wells.
be greater than 1 MeV per nucleon. Each ion passing though the thin polymeric film produced single ion track, which subsequently represents one pore. By controlling the number of ion tracks, one can produce 109 pores cm2 to 1 pore per sample.13 A single ion is hit into a membrane to produce single pores. A metallic plate with a thickness of 0.2 mm and an aperture of 0.2 mm is inserted in front of the track-etched templates for support. A semiconductor detector is placed behind the sample to detect each ion passing through the aperture and then through the sample. At such low fluxes, the probability of an ion passing through the aperture is 1 event s1.14 This gives enough time to the automated system to switch off the beam using a fast chopper after an ion hit is detected by the detector. The next step after irradiating the polymer is chemical etching of the ion track to produce pores of desired shape, with size up to 5–100 nm. Length to diameter ratio in the range 10–1000 can be easily achieved. Chemical composition of the chemical etchants, optimum irradiation, postirradiation treatments, and etching temperature conditions determine shape, size, and density of the pores. There are two parameters that determine the shape and size of the pore: 1. vb: the bulk etch rate (etching rate for nonirradiated material). 2. vt: the track etch rate (the etching rate along the ion track). Typically, the etching results in a conical or double conical pore (depending on whetheroneorbothfacesofthefoil,respectively,areexposed totheetchingbath)withan
58
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
opening angle a: tga ¼ vb/vt. Alternatively, in the case of high-selectivity etching conditions, that is, vt vb, the shape of the pores can be approximated to be cylindrical. Polycarbonate and polyethylene terephthalate are some of the polymers used for synthesis of nanoporous membrane. Even though former polymers have lower chemical, mechanical, and thermal stabilities, both cylindrical and conical pores can be easily etched in comparison to other polymers. PC also has advantages in terms of dissolving capability into several organic solvents such as dichloromethane. Using this method, 100 nm pores were created in a PC membrane. The group of Voss, Germany, investigated asymmetric nanopores in PET and polyimide (Kapton) membranes.15 It was observed that the transient properties of the pores depend both on the chemical structure of the polymer and on the irradiation and etching procedures used. However, this method cannot be applied to metal foils, except for some special cases of amorphous “glassy” metals, because swift heavy ions passing through a metal do not generate tracks that could be etched to form holes. 2.6.3 Phase Separation The phase separation method is the most common method for preparation and production of polymeric porous membranes. There are three types of phase separation techniques that are typically used to generate a polymeric membrane, which include the wet phase separation method, the thermally induced phase separation method, and the nonsolvent-induced phase separation method. In the first method, a cast thin layer of a polymer solution is immersed in a liquid nonsolvent, which is miscible with solvent.16 The exchange of the solvent from a thin layer of polymer solution with a nonsolvent from the coagulation bath produces thermodynamic instability in ternary systems. The thermodynamic instability is resolved by separation into polymer-rich and polymer-lean phases.17 The polymer-rich phase forms a solid membrane matrix, while the polymer-lean phase leaves a porous structure by leaching out of the system. By varying the polymer concentration, the thickness of the solution and coagulation medium, and temperature, a wide variety of asymmetrical porous membranes with a very large variety of properties can be synthesized. The ternary systems most commonly comprise polymers such as cellulose acetate, polysulfone, poly(methyl methacrylate), polyamide, and polyurethane, solvents such as acetone, N,N-dimethylformamide, and acetamide, and nonsolvent such as water.18 Kawakami’s group from the Tokyo Metropolitan University fabricated threedimensional fluorinated polyimide microporous membranes of cylindrical structures by the wet phase inversion process, which is formed by a ternary system of polyimide–solvent–water.19 Moreover, microporous polystyrene and polycaprolactone (PCL) porous membranes were also synthesized by the phase separation process. PCL has several advantages, including low cost, biocompatibility, and biodegradability. Moreover, PCL is an FDA-approved material for implantable devices. Thus, it is a superior material to fabricate affordable devices. In polymeric systems, phase separation can also be induced by solvent evaporation, temperature, or addition of a nonsolvent. The process where optimization of porous
FABRICATION AND INTEGRATION OF NANOPOROUS MEMBRANES
59
property is performed by controlling the thermal conditions is called the thermally induced phase separation (TIPS) process.20 The TIPS technique has been utilized for making microporous materials such as porous membranes and foams from semicrystalline polymers. In the nonsolvent-induced phase separation method, the concentrations of polymer, solvent, and nonsolvent are highly critical for fabrication of the nanoporous membrane. Kuo’s group from the Center of Membrane Technology at Taiwan prepared a polyvinylidene fluoride (PVDF) microporous membrane by using alcohol as nonsolvent (coagulant).21 To prepare the PVDF membrane, the wet phase inversion process was carried out by using water and n-propanol as nonsolvents. An increase in the pore size of the PVDF membrane was observed with an increase in the immersion time in the n-propanol bath. Comparative studies showed that TIPS could help a homogeneous solution reach liquid–solid phase separation more quickly.22 Using this technique, phase-separated solutions spend less time in the liquid–liquid separation region. Fast solidification can avoid pore coalescence. Thus, porous membranes with high porosity can be prepared with TIPS. Moreover, nanoscale pore size can be obtained via NIPS. Therefore, nanoporous membranes with high porosity can be prepared via the combination of TIPS and NIPS. Recently, Kurt et al. developed a polymerization-induced phase separation (PIPS) technique.23 Porous membranes were developed from a monomer and solvent mixture using PIPS. This novel membrane has a potential application in flow-through biosensors based on protein or DNA microarrays. Depending on the requirements of the application, often high demands are put on specific properties such as the control over pore size, pore size distribution, morphology, and surface functionality, which is controlled by adjusting monomer concentration and UV intensity. 2.6.4 Lithography At present, novel nanoporous micromachined membranes using lithography techniques are being developed for biosensor applications. Ferrari’s group from the University of Illinois fabricated porous silicon membranes using simple standard lithography techniques. These membranes are highly reproducible, extremely stable, and have the ability to be integrated into the silicon-based platform technology. In addition, these membranes exhibit selective permeability and low biofouling. Filtration of biomolecules is desirable for biosensors. Membranes with pore sizes as small as 20 nm are available. Even so, the filtration at these dimensions is far from absolute. The use of ion track etching for the synthesis of membranes yields millipores with low porosities (<109 pores cm2) and limited pore sizes, and the pores are randomly distributed across the surface. In comparison, the anodization technique yields alumina pores of higher densities, such as 1010 pores cm2, but pore sizes greater than 20 nm, and the pore configurations and arrangements are difficult to control. The technology of micromachining allows fabrication of membranes with multiple pore configurations and arrangements. Several microfabrication methods have been used to create pore sizes in the tens of nanometers on silicon substrates using
60
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
FIGURE 2.9 Cross-sectional schematic depiction of the microfabrication process for nanoporous silicon membrane fabrication.24
photolithography and deposition/selective removal of sacrificial layers.24 Figure 2.9 demonstrates a schematic diagram for the microfabrication of nanoporous membranes with a pore thickness of 24.5 nm. In the above example of the lithography process, a nitride layer is grown onto a silicon wafer, which functions as an etch stop layer. On the top of the nitride layer, a base layer of polysilicon is deposited that acts as a structural support. The holes are then defined into the base layer by chlorine plasma. Later, thin sacrificial oxide is grown using thermal oxidation. The thickness of the sacrificial layer determines the final pore size. These pores are then completely filled with the polysilicon plug layer, which is planarization through plug layer to base. The final step is to deposit nitride layer and backside patterning. The protective, sacrificial, and etch stop layers are removed by etching in HF. Similarly, the process sequence shown above was also used by Desai’s group from the Boston University for fabrication of porous membranes with pore sizes ranging from 5 to 100 nm.25 In another method for fabrication of micro- and nanoporous membranes, pillar-like templates are used. These pillar templates are fabricated using photolithography and e-beam lithography. Grant’s group from the University of Texas at Austin built organic polystyrene (PS) and inorganic (ZnO) pillar arrays as a template and polysulfone (PSf) porous films were fabricated.26 Figure 2.10 illustrates the complete process sequence of template-based porous membrane fabrication.
FABRICATION AND INTEGRATION OF NANOPOROUS MEMBRANES
FIGURE 2.10 method.26
61
Schematic diagram for fabrication of a porous membrane using the template
2.6.5 Focus Ion Beam Etching A nanopore is most effective as a single-molecule detector when the diameter of the pore is close to the diameter of the molecule, typically 2–10 nm, being detected.27 Nanoporous membranes have pore sizes ranging from <1 to 100 nm in diameter. The focused ion beam (FIB) technique has been conventionally used for preparing nanopores in thin films.28 This technique offers very good resolution and is able to directly pattern arrays of well-defined pores. The anodization method has disadvantages in terms of fabrication of pore sizes greater than 20 nm and it is nearly impractical to etch a pore below 30 nm in diameter reproducibly in terms of size and shape using commercial FIB systems. It is possible to etch nanopores using a high-energy focused ion beam. However, Losic’s group from the University of South Australia at Adelaide, SA, overcame the system and pore size limitations and nanofabricated pore size less than 10 nm onto AAO porous membranes using the FIB technique.29 The FIB milling technique can be successfully used for removing the oxide barrier film and controlled pore opening of AAO to form a single nanopore or nanopore arrays. Figure 2.11 demonstrates the process sequence for fabricating the nanoporous membranes. Bezryadin’s group from the University of Illinois at Urbana-Champaign has demonstrated the fabrication of symmetric sub-5 nm nanopores using focused ion and electron beams.27 FIB scans reduce the size of the pore. During the sequence of ion scans, the gradual shrinking of the pore size and the change in pore geometry in a regular fashion are observed. The beam provides some mobility to the material of the membrane around the pore and allows the pores to shrink in diameter due to surface tension. This sculpting process also allows an array or a pattern consisting of multiple nanopores to be fine-tuned at the same time.
62
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
FIGURE 2.11 Schematic diagram demonstrating fabrication of a single pore to an array of nanopores onto the AAO membrane using the FIB technique.29
Similar to ion beam milling, electron beams are also used for micromachining finely precise nanopore arrays in the nitride membrane. Meller from the Boston University fabricated nanopores in thin Si3N4 films using the intense e-beam of field emission.30 Si3N4 films were formed using standard lithography techniques and low-pressure chemical vapor deposition (LPCVD). Different irradiation conditions enabled nanopore fabrication in the range of 2–20 nm with exceptional size control and greater than 0.5 nm variability, thus resulting in an effective nanopore thickness of 17 nm. Similarly, David C. Bell from the Center for Nanoscale Systems, Harvard University at Cambridge, fabricated small nanopores in SiN on the order of 1 nm diameter with great accuracy and reproducibility.31,32 2.6.6 Rapid Thermal Annealing Using the rapid thermal annealing (RTA) technique, Striemer et al. were able to fabricate ultrathin porous nanocrystalline silicon (pnc-Si) membranes.33 These pnc-Si porous membranes are approximately 10 nm in thickness. These nanomembranes are highly fragile and the technique is very complex; rapid thermal annealing is not commercially used for large-scale production. With RTA, the average pore size created varies approximately from 5 to 25 nm. The pore size distributions in pncSi membranes can be controlled through adjustment and by varying the temperature. In the RTA process, during crystallization, voids are often spontaneously formed as nanocrystals nucleate and it grows into a 15 nm thick amorphous silicon (a-Si) film. The process sequence for the fabrication of the ultrathin pnc-Si membrane is shown in Figure 2.12.
FABRICATION AND INTEGRATION OF NANOPOROUS MEMBRANES
63
FIGURE 2.12 Schematic block diagram representing formation of a nanoporous membrane using rapid thermal annealing.33
2.6.7 Sol–Gel Technique Sol–gel technology offers a cheap and quick alternative for producing bioactive porous surfaces for various biosensors. The sol–gel thin film technique offers a number of advantages including low-temperature processing, ease of fabrication, and precise microstructural and chemical control.34 Tailoring the thickness of the membrane, pore size, and density provides an additional advantage to biocompatibility. Highly porous, supercritically dried sol–gel low-density membranes formed using the sol–gel technique are called aerogels. These biocompatible membranes are commonly used in biosensors and electrochemical biosensors. Various types of inorganic aerogels such as silica, carbon, and alumina are fabricated. Similarly, inorganic aerogels such as SEAgel can also be synthesized. The starting materials used in the preparation of the sol are usually inorganic metal salts or metal organic compounds such as metal alkoxides [M(OR)n], where M represents a network forming element such as Si, Ti, Zr, Al, B, and so on and R is typically an alkyl group.35,36 The most commonly used precursors are tetramethyl orthosilicate (TMOS) and tetraethyl orthosilicate (TEOS) in the sol–gel process.37 The basic sol–gel reaction begins when metal alkoxide is mixed with water and a mutual alcoholic solvent in the presence of acid/base catalyst. Thin films can be produced on a piece of substrate by dip, spin, and spray coating. During the sol–gel transformation, the viscosity of the solution gradually increases as the sol becomes interconnected to form a rigid, porous network of gel.38 During the drying process at an ambient pressure, the solvent liquid is removed and substantial shrinkage occurs. Extracting the liquid component of a gel through supercritical drying, a highly porous
64
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
network known as an aerogel is produced. Silica aerogels are biocompatible materials mostly used for bioapplications. Power et al. from the University of Virginia at Charlottesville prepared sol–gel-based silica macroporous membranes. These porous membranes were on the order of 10–100 mm.39 These silica membranes were used to trap viral bacteria Escherichia coli (pET-gfp). Similarly, Tiwari et al. prepared a biopolymer–SiO2 nanocomposite aerogel. The resulting composite aerogel consists of a mesoporous material that was controlled by thermal curing.40 Recently, Li et al. synthesized a protein-encapsulated bioaerogel, in which a recombinant red fluorescent protein, DsRed, was chosen as a model protein.41 It was prepared using sol–gel polymerization of TEOS with an ionic liquid as the solvent and pore-forming agent. A bioaerogel formed showed high porosity. Recently, scientists from the University of Leeds, UK, for the first time explored the use of self-assembled peptide organogels and hydrogels as starting materials for the creation of new nanostructured aerogels.42 The novel aerogels impart biological-like functionality for sensing applications. Peptides such as P7-2, P9-2, P11-2, P24-2, and K2 were studied. 2.7 FUNCTIONALITY OF MEMBRANE IN BIOSENSORS Membranes with various pore sizes, lengths, morphologies, and densities have been synthesized from diverse materials for size exclusion-based separation. Specific bioagent immobilization and detection remains a great technical challenge in many biosensors. To achieve this, a material with controllable pore diameter, length, and surface chemistry is needed. Selective capture requires two steps: collection and immobilization. Membranes are well suited for this because of their enhanced probability of interaction of the surface with the liquid being analyzed. In order to create an excellent biosensor, the biological component has to be attached to transducers. This process is known as immobilization. Membrane entrapment, physical absorption, matrix entrapment, and covalent bonding are four ways to couple a biosensing element to the membrane (Table 2.2). The bioagents are bonded to the sensing element by one of these four ways. Figure 2.13 illustrates schematic block diagram demonstrating functionality of the membrane in the biosensor. The adsorption method is the simplest and involves minimal preparation. In this method, although the bonding between bioagent and sensing transducer is weak, it is extremely useful for exploratory research. The phenomenon of physical adsorption via TABLE 2.2
Different Immobilization Techniques
Immobilization technique Physical
Adsorption, entrapment, confinement, and encapsulation
Chemical
Covalent binding and cross-linking
FUNCTIONALITY OF MEMBRANE IN BIOSENSORS
65
FIGURE 2.13 Schematic block diagram demonstrating physical and chemical functionality of a nanoporous membrane in biosensors.3
van der Waals bonds is demonstrated by Prasad and coworkers from the Portland State University in nanomonitor protein biosensors.10 The AAO membrane was used to adsorb enzymes onto the sensing microelectrode array surfaces. Similarly, an antibody-based conductometric biosensor using porous filter membranes, developed by Muhammad-Tahir and Alocilja, has been shown to detect bacteria and bovine viral diarrhea virus antigens.43 In addition, Song et al. incorporated absorption techniques in biosensors to build membrane-based assay devices.44 Other forces such as hydrogen bonds, hydrophobic forces, and ionic forces are used to attach a biomaterial to the surface of the sensor. At a single instance, multiple forces can also be used in a single biosensor. However, the adsorption technique has a disadvantage: under mild conditions, through the pores the enzyme drains from the carrier and alters the change in pH or ionic strength. Entrapment of the bioagent in the nanomembrane creates a good biorecognition layer close to the transducer, which is mainly a gold microelectrode. The membrane separates the analyst and the bioelement. This facilitates a better biosensor. Kueng et al. immobilized a biorecognition element using an enzyme entrapment technique to integrate amperometric ATP microbiosensors.45 A dual microdisk electrode configuration was integrated to immobilize the enzymes at one of the microdisk electrodes. Shan et al. constructed a novel glucose biosensor by electrochemical entrapment of glucose oxidase (GOD) into porous poly(acrylonitrile-co-acrylic acid), which was
66
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
synthesized via radical polymerization of acrylonitrile and acrylic acid.46 Similarly, scientists from the Kyushu Institute of Technology in Japan used nanoporous template electrodes to enable efficient enzyme entrapment by simple physical adsorption.47 Template electrodes made of porous carbon were efficient nanomaterials for entrapment of bioagents. The integrated biosensor using entrapment provides an increased surface area and sensitivity to sense the biochemical reaction; however, the technique has also demonstrated problems such as an easy leakage, serious diffusion constraints, and lower stability48. In the microencapsulation technique, the porous entrapment scheme forms a porous encapsulation matrix around the biological analytes that helps binding to the sensor transducer. The porous membrane facilitates transfer of electrons and ions. Darder et al. demonstrated encapsulation of enzymes by alumina membranes of controlled pore sizes.49 These AAO porous membranes created by anodization were used for immobilization of the biologically active elements. Hexagonally structured AAO membranes allowed higher amounts of glucose oxidase (GOx) enzyme uptake in a thin film. This idea facilitated the construction of amperometric biosensors with the nanoporous Al2O3 membrane. Similarly, in choline biosensors, enzyme choline oxidase (ChOx) was immobilized and encapsulated in a hybrid mesoporous membrane with 12 nm pore diameter.50 Moreover, Kim et al. developed a glucose biosensor based on a sol–gel-derived zirconia/Nafion composite film as an encapsulation matrix.51 To conclude, in all these biosensors, the nanoporous structure film greatly enhances the active surface area available for protein immobilization. In covalent bonding techniques, biological elements are linked to biosensing membranes by strong covalent bonds. Sensing surfaces are treated with reactive chemical groups. De Stefano et al. created a covalent bond between the porous silicon surface and the biomolecules, which specifically recognize the unknown analytes.52 It has been demonstrated that porous silicon-based optical microsensors help detect L-glutamine from E. coli using the covalent bonding method. However, covalent bonding and cross-linking produce more stable immobilization, but may degrade the activity of enzyme by including drastic synthesis environment in the immobilization process.48 2.8 DETECTION MECHANISM Diagnostic biosensors are probably the largest area of research in the field of bionanotechnology. Over the past few years, many new ideas and technologies have been proposed in the literature. In this section, a comparative study of these detection mechanisms will be discussed. Each detection mechanism significantly differs in the design of the device, the fabrication methodology adopted for such a design, and the area of application. Each mechanism has the same goals in mind that include reducing the sensing elements to be equivalent to the size of the target species, improving the sensitivity, reducing the reagent volumes, offsetting the costs of the reagents, moving toward a real-time system to acquire the results and simultaneously getting a lower detection limit, miniaturizing the entire system, and improving
DETECTION MECHANISM
67
portability. Based on the basic principles of detection, biosensor devices can be broadly classified into two classes, namely, labeled detection and label-free detection. 2.8.1 Membrane-Based Labeled Detection A label is generally a chemical such as fluorophore, which is tagged along with the biochemical under observation for detection. In the labeled detection mechanism, as demonstrated in Figure 2.14, a biomolecule that does not react to incident light, but the chemical (label) reactive to light, is tagged to the biomolecule of interest. When the complex matrix of biomolecule and label is irradiated with light, the complex gets excited to give an output signal at the photodetector. Hence, detection of biomolecule of interest by indirect detection of the label is called labeled detection. The most popular labeled detection method is fluorescence detection and ELISA (enzymelinked immunosorbent assay). Immobilized biomolecules are emerging as popular analytical tools given their reusability and sensitivity. In a nanomembrane-based labeled detection biosensor, immobilization of the antibody is performed by simply inserting the porous nanomembrane into the reaction chamber. Membrane-based immunochemical methods are gaining wide acceptance as they offer the advantages of sensitivity, specificity, rapidity, simplicity, and cost effectiveness, which is important for routine testing. However, they have significant disadvantages that label-free detection has been striving to overcome and replace ELISA over the past decade. 2.8.2 Membrane-Based Label-Free Detection When the biomolecule can be directly detected without the help of external labels, it is called label-free detection. In the label-free mechanism, detection and quantification of the properties of interest of the biomolecule are achieved without the help of external labels. This has a huge advantage as it is possible to measure the direct interaction of the biomolecule with the substrate rather than its interaction with an
FIGURE 2.14 Schematic diagram demonstrating the labeled detection technique.
68
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
external label. It also eliminates multiple steps of attaching the label to the biomolecule and the control steps to eliminate nonspecific binding of labels. It also eliminates contamination due to external chemicals. The electrochemical or electrical method of detection is a good example of label-free detection wherein the electrical properties of the biomolecules are observed and correlated for analysis. Label-free detection has many advantages over labeled detection. It has lower cost per assay, lower contamination, higher sensitivity, and significantly shorter detection time. However, one of the important issues faced by label-free detection is the lack of throughput. Most biomolecules have different yet very similar physical characteristics when it comes to label-free detection. Because of the nature and size of the biomolecules, it was difficult to distinguish them using detection systems that were many orders of magnitude bigger. A large amount of sample volume is also required to achieve high sensitivity, which also proved impractical, as it is not possible to have tens of milliliters of blood every time the patient needs to be tested. These issues were solved with the advent of nanotechnology. With the advent of nanofabrication techniques and nanomaterials, device setups around the same size of the biomolecules could be designed. Much higher surface area of interaction with the biomolecules is possible, which enables high sensitivity in detection. Size matching of the measuring arrangement to the biomolecules significantly reduces the sample volume required and increases detection limit to very low analyte concentrations. Hence, the label-free detection technique has become the most active area of research in the field of proteomics in the past decade because of its promising trend to replace ELISA as the predominantly used technique for protein detection. Label-free nanoporous membrane-based biosensors can be classified on the basis of detection mechanism, namely, electrical detection, optical detection, and mechanical detection. Electrical biosensors can be further classified on the basis of the electrical measurement, which includes voltammetric, amperometric/coulometric, potentiometric, and impedance. 2.8.2.1 Voltammetry The current–potential relationship of an electrochemical cell provides the basis for voltammetric sensors. Amperometric sensors are also based on the current–potential relationship of the electrochemical cell, which can be considered a subclass of voltammetric sensors.53 In amperometric sensors, a fixed potential is applied to the electrochemical cell, and a corresponding current due to the reduction or oxidation reaction is obtained. This current can be used to quantify the species involved in the reaction. The key consideration of an amperometric sensor is that it operates at a fixed potential. However, a voltammetric sensor can operate in other modes such as linear or cyclic voltammetric modes. Consequently, the respective current–potential response for each mode will be different. This technique measures the current associated with electrons, which are on the surface of biomolecules during redox processes. Shimomura et al. using amperometric mechanism detected choline with enzyme immobilized in a hybrid mesoporous membrane.50 Such an ability of the hybrid mesoporous membrane F127M suggests great promise for effective immobilization of enzyme useful for electrochemical biosensors. Liu et al. developed a sensitive
DETECTION MECHANISM
69
amperometric biosensor based on gold nanoelectrode array (NEA). The gold nanoelectrode array was fabricated in the template of PC membranes.54 A conventional three-electrode system was used in all the above measurements. NEA and NEA/GOx were used as a working electrode, Ag/AgCl was used as a reference electrode, and a spiral platinum wire acted as a counter electrode. The enzyme electrode exhibits an excellent response performance to glucose with a linear range from 105 to 102 M and a fast response time of 8 s. Figure 2.15 demonstrates immobilization of the PC membrane on the Au electrode. 2.8.2.2 Potentiometry Potentiometric sensors are fundamentally based on the potential developed between two electrodes. When a redox reaction takes place at an electrode surface, a potential is developed at the electrode–electrolyte surface. This potential is found and used to characterize the activity of the species involved in the reaction. Electrodes in potentiometric sensors can be inert or active. An inert electrode merely provides the surface for an electron transfer process. However, an active electrode either donates or accepts ions in the reaction. One electrode is always used as the reference electrode to complete the circuitry for the potentiometric sensor. A noninterference half-cell reaction occurs on this electrode. Potentiometric or voltammetric techniques are generally not used for protein detection because most proteins cannot be detected based on oxidation states and redox reactions. It is quite difficult to exchange charges between proteins and a medium for a change in oxidation state. These methods are used to signify the importance of metals in detection, but are not actively used for detection in biosensors in general. Shishkanova et al. demonstrated functionalization of the PVC membrane with single-stranded oligonucleotides for a potentiometric biosensor.55 Reddy et al. estimated triglycerides by porous silicon-based potentiometric biosensors.56 Lipase, an enzyme that hydrolyzes triglycerides, was immobilized on PS and was thermally oxidized. Upon hydrolysis, the triglycerides result in the formation of fatty acids, which changes the pH of the solution. The enzyme
Au electrode
PC membrane Teflon cap
FIGURE 2.15 Integration of the PC membrane with the gold electrode.54
70
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
solution-oxidized PS–crystalline silicon structure was used to detect changes in pH during the hydrolysis of tributyrin as a shift in the capacitance–voltage (C–V) characteristics. 2.8.2.3 Impedance/Capacitance This method of detection employs true electrical parameters for detection and is based more on perturbations in the electrical components than on charge transfers or redox reactions. It calculates the amount of perturbation introduced by the biomolecule to the system more than the inherent change in the properties of the biomolecule. The most popular methodology used is electrochemical impedance spectroscopy (EIS). EIS is the plot of the overall impedance and phase between two electrodes with respect to the frequency applied to the circuit. This method of detection requires at least a twoelectrode arrangement for a closed circuit. Interdigitated electrodes or working electrode–counter electrode setups are the most popular and efficient electrode arrangements. Interdigitated electrodes offer much higher surface area of interaction than normal planar electrodes and therefore are more preferred. In a working electrode–counter electrode setup, the counter electrode is built with much higher surface area than the working electrode. This difference in surface area creates a large difference in the interaction between the electrodes and the biochemicals, thereby providing a highly sensitive detection. Using one of such two-electrode arrangements, the impedance or capacitance is measured between those electrodes. Capacitance is preferred as a parameter of detection due to its high accuracy and reliability. It can be greatly enhanced with an increase in surface area of interaction and plays a crucial role in determining selectivity. This method is well suited for detecting proteins, as it needs to measure the amount of perturbation introduced by the proteins to the system and not charge transfers or half-cell reactions. For such small protein biomolecules to perturb an electrical component, a large surface area for interaction is required. For just planar electrodes, such as planar interdigitated electrodes, there might not be enough surface area for the proteins to bind. The surface also needs to be highly sensitive to protein interaction for significant perturbation. Bothara and coworkers designed a membrane-based nanomonitor protein biosensor using an impedance and capacitive measurement technique.57Figure 2.16 shows an electric double-layer electrode on which the nanoporous structure exists. Electrons in the electrode cause the free ions in the solution to adsorb at the metal–liquid interface creating the double layer. Some of the solvated ions occupy these spaces and the proteins, which are also charged, reach close to these surfaces, which modify the double layer causing changes to the frequency at which the peaks in energy occur. Figure 2.17 illustrates a schematic diagram of an impedance/capacitance porous membrane-based biosensor. The measurement is achieved by the redox reactions at the surface for optimal charge transfer. The nonfaradaic conductance of the electrical double layer formed at the electrode surface is sensitive to reactions and is the basis of nanomonitors. This technique is advantageous since it does not require addition of any redox probes. Furthermore, conductance measurements at different bias voltages can reveal much information about dielectric and charge environment at the interface. The
DETECTION MECHANISM
71
FIGURE 2.16 Schematic diagram illustrating charge distribution across the liquid–electrode interface forming a double layer.57
nanomonitors comprise multiple sensing sites with each sensing site containing approximately a quarter million nanowells. Using the nanomonitor immunoassay technique, we were able to detect CRP and MPO with the present lower limit of detection at 10 and 20 ng mL1, respectively. The upper limit of detection for both the antigens was 100 mg mL1. The dynamic range for CRP was 100 mg mL1 to 10 ng mL1 and that for MPO was 100 mg mL1 to 20 ng mL1. 2.8.2.4 Optical Detection Optical detection techniques have been widely used in the field of biosensors for their high sensitivity. The most common examples include ELISA and fluorimetry, as discussed earlier. The detection mechanism involved is usually fluorescence or chemiluminescence. Fluorescence detection techniques are based on fluorescent markers that emit light at specific wavelengths when light is incident on it. The change in intensity of light emitted or its absolute value, as in fluorescence resonance energy transfer (FRET), determines occurrence of the binding reaction. Certain advances in this technique have been able to identify as low as single-molecule detection levels. Fluorescence-based detection has been used in chips designed for
72
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
FIGURE 2.17 The schematic diagram of an impedance/capacitance porous membranebased biosensor.57
the purpose of microarrays. These techniques are true lab-on-a-chip devices with integrated fluidic channels to direct the biomolecules. Chemiluminescence is the generation of energy in the form of light when a chemical reaction takes place. In synthetic compounds, such chemiluminescence takes place when a highly oxidized species such as peroxide emits energy during a chemical reaction. Sometimes, synthetic compounds are added to the biomolecule for detection, which in turn forms a conjugate that releases energy in the form of light. Bioluminescence is another type of luminescent technique, which has been reported by using the firefly luciferase/ luciferin as the synthetic compound. Surface plasmon resonance (SPR) is a technique that looks at the surface activity. In this technique, a longitudinal wave of a certain charge density is propagated along the surface of the metal and the dielectric. Due to the total internal reflection of light against materials such as gold or silver, the evanescent wave or field created at the surface penetrates the interface into the dense medium (metal). This evanescent light is able to couple with the free electrons on the surface, called plasmons, and this creates a resonance wave, which is recorded. Hence, in the presence of any biomolecule layer located on the surface of the metal, the SPR adsorption profile is obtained. Due to the properties of biomolecules, each SPR spectrum is different, hence making it a valid detection technique. The biggest asset
73
DETECTION MECHANISM
and the biggest drawback of optical detection system is light. Optical detection requires huge infrastructures, light sources, and other bulky instruments, making it very expensive and not portable. It is also very difficult to integrate and calibrate the light for detection. A tiny jitter in the system could make it completely inoperable and take hours for a highly skilled personnel to fix it. Specificity is also an issue with many optical detection techniques, but ELISA is considerably well established in this respect. De Stefano et al. demonstrated single-stranded DNA sensor using porous silicon surface.58 Using photochemical functionalization process, the porous silicon passivated the surface of optical biosensors. Fluorescence measurements have been used to investigate the stability of the DNA single strands bound to the nanostructured material. A dose–response curve in the 6–80 mM range for an optical label-free biosensor has been realized. Similarly, Bonanno and DeLouise demonstrated a membrane-based optical biosensor.59 The sandwich assay scheme incorporated in the sensor comprises a linking biotin/streptavidin to attach biotinylated anti-rabbit IgG receptor to detect rabbit IgG. The schematic diagram illustrating the working principle is shown in Figure 2.18. The final detection range of rabbit IgG was 0.07–3 mg mL1 (0.23–9.8 mg mm2). In the detection mechanism, a normal incident beam of white light (spot size of <13 mm2) was exposed to the sensor surface. The optical reflectance spectrum was measured. The optical shift due to specific binding interactions within the porous matrix was measured. 2.8.2.5 Mechanical Detection Mechanical detection for biochemical entities and reactions is generally through the use of nanomembrane and micro- or nanoscaled cantilever sensors. They can be further divided into mass sensors or stress sensors. Microgravimetric transducers
Target Rabbit IgG
Bioreceptor Biotin-α-rabbit IgG B
Streptavidin
B B B
B B
B
Biotin SiO2 APTMS
PSi
FIGURE 2.18 Schematic diagram of a silicon porous membrane-based optical label-free biosensor.59
74
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
monitor mass changes that occur during the binding of target analytes to the surfaceconfined recognition layer. Xue and Cui micropatterned carbon nanotube (CNT) and cantilever arrays fabricated with layer-by-layer nano-self-assembly that has application toward biosensors.60 In recent years, the areas of biomicroelectromechanical systems (BioMEMS) and nanotechnology have gained a high level of prominence and have become almost inseparable from biological applications including detection, diagnostics, therapeutics, and tissue engineering. In the nanoporous membrane-based mechanical biosensor, the porous nanomembrane acts as a filter for a bioagent in the microfluidic channel; later, the biomolecules are detected using a cantilever or a piezoelectric crystal. In a mass biosensor, change in the mass caused by chemical binding to small piezoelectric crystals is detected. Payen et al. demonstrated an MEMS rf-interrogated biosensor. Figure 2.19 demonstrated the step-by-step sequence for measuring the level of pH and eventually glucose concentration (Brix) in grapes.61 The biosensing structure consists of a microneedle, a functionalized gel, a tuned tank oscillator circuit, and a miniature antenna. A microneedle used was to puncture the organism. A two-membrane matrix was integrated into the membrane–filter system. The membrane system was used to separate the wet part of the hydrogel from the dry portion in which the tank oscillator circuit is located. The first membrane was used to allow diffusion of the grape juice into the hydrogel. The second compliant membrane was impermeable. Its function was to separate the wet region of the hydrogel from integrated circuit and antenna. A rigid porous membrane was incorporated to protect the hydrogel from biological fluids and to prevent contamination by molecules. The change in pH induces a swelling of the hydrogel. The hydrogel displacement depends on the hydrogel sensitivity and the flexible membranes. The membrane displacement induces a change in capacitance. The LC tank circuit frequency interrogation system determines the optimal frequency for data collection.
Bioelements (crop) Grapes, fruits, roots, etc.
Filter system
Fluidic delivery Microchannel Membrane matrix
Transducer
Biosensor Hydrogel
Transduction mechanism Capacitor
FIGURE 2.19
Process sequence for the detection of pH and glucose in grapes.61
POROUS MEMBRANE-BASED BIOSENSOR FOR DETECTION OF LIVING ORGANISM
75
2.9 POROUS MEMBRANE-BASED BIOSENSOR FOR DETECTION OF LIVING ORGANISM 2.9.1 E. coli Biosensor Meat products are increasingly contaminated by foodborne pathogens, thereby increasing product recalls in the United Stated. These products are contaminated from a number of sources, including the environment and the animal itself.62 E. coli serotype O157:H7 are harmful and deadliest bacteria found in meat and dairy products. These O157:H7 bacteria cause food poisoning, gastroenteritis, urinary tract infections, and neonatal meningitis. Thus, the microorganisms need to be detected at an early stage of infection in human beings. Many researchers are conducting experiments and spending billions of dollars to fabricate biosensors to detect the disease in a short time frame and with a high degree of accuracy. Wang et al. fabricated a novel nanoporous biosensor based on single-stranded DNA (ssDNA) probe functionalized AAO nanopore membranes for E. coli O157:H7 DNA detection.63 These membrane-based biosensors offered low detection limit for DNA in picomoles and rapid label-free and easy-to-use bacteria detection that holds the potential for future lab-on-a-chip devices. Similarly, disposable porous filter membranes were used by Abdel-Hamid et al. to develop a flow-through amperometric immunofiltration assay system for rapid detection of E. coli O157:H7.64 In the experiment, nylon membranes were used as a solid support for immobilization of antibodies. Two types of membranes, Biodyne B and C, were tested on which antibodies to E. coli O157:H7 were immobilized. These porous membranes were used for filtering the antigen-containing solution through the antibody-coated filter membrane. This results in excellent antigen–antibody binding, thereby significantly reducing the assay time. The effect of membrane pore sizes of 0.45, 1.2, and 3 mm determined the amount of immobilized anti-E. coli antibodies. The detection limit of E. coli O157:H7 cells is 100 cells mL1 and the working range is 100–600 cells mL1. A complete immunoassay is carried out in 30 min. Again, Liu et al. conjugated CdSe/ZnS core–shell dendron nanocrystals with the corresponding antibodies and then passed through the microporous membrane where they attached to the membrane antigen–antibody.65 The membrane antigen–antibody conjugated with the nanocrystals facilitated an efficient and stable photoluminescence. The biosensor built using this technique was used to detect not only E. coli but also hepatitis B with a limit of detection as low as 2.3 CFU mL1 and 5 ng mL1, respectively. Due to unique optical properties, nanocrystals were used as fluorescent labels. A microporous membrane was chosen for its mechanical strength and biocompatibility. The biosensor system comprises a flow chamber with an immunofilter interface with sensitive and robust dendron nanocrystals as the detection indicators. By using a matrix of the membrane, the scientists observed an increase in the efficiency of the immunoreaction between antibodies and pathogens, decrease in the detection time, and reduction in the detection limit. The pore size was optimized such that there was an excellent immunoreaction between antibodies and pathogens in a small hole and the liquid solution could be drained out. In the biosensor system, as
76
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
FIGURE 2.20 Schematic pictorial representation of a porous membrane-based biosensor for detection of E. coli bacteria.65
shown in Figure 2.20, the antibodies are immobilized onto the microporous membrane using covalent bonding. Later, the E. coli antigens are captured onto antibodies to form immunocomplexes. The immunocomplexes formed on the surface of the membrane continue to react with the dendron nanocrystal-conjugated antibodies and form “sandwich” immunocomplexes. By measuring the photoluminescence from the dendron nanocrystals, the targets, that is, E. coli antigens, are detected. Then, the nanocrystal-labeled antibody solution was injected to form a sandwich immunocomplex of immobilized antibody–E. coli O157:H7–nanocrystal-labeled antibody. The complex immunostructure using photoluminescence was measured by a spectrofluorometer. A common practice for the E. coli pathogen detection is to use an antibody-coated filter porous membrane to immobilize E. coli O157:H7, and different detection mechanism are used to detect the immunoreactions. 2.9.2 Salmonella enteritidis A commercially produced foodstuff containing raw eggs such as ice cream often gets contaminated with one of the deadliest pathogens S. enterica. These pathogens suppress the human immunity system. Therefore, scientists are developing and fabricating biosensors for detection of S. enteritidis. Zhang and Alocilja investigated a label-free DNA electrochemical biosensor for the detection of S. enteritidis.66 A nanoporous silicon-based DNA biosensor consists of a porous silicon surface, which was functionalized with DNA probes specific to the gene of S. enteritidis. Electrical property of DNA, redox indicators, and cyclic voltammetry were used for
POROUS MEMBRANE-BASED BIOSENSOR FOR DETECTION OF LIVING ORGANISM
77
the characterization of the biosensor. Porous silicon was fabricated using an anodization process in an electrochemical Teflon cell. The anodization was carried out by hydrofluoric acid. A uniform pore structure, with pore sizes ranging from 10 to 30 nm pores, was connected, and an interpore space of 10–30 nm was observed. These porous membranes were functionalized in two steps, which involved silanization of the chip surface followed by DNA probe immobilization. By immobilizing the specific DNA probe onto the PS layer, the biosensor had the ability to capture complementary DNA (cDNA). Finally, a cyclic voltammogram of target DNA concentrations on porous silicon chips was obtained. This DNA probe has high selectivity and affinity for the target DNA. The redox marker has a greater affinity for dsDNA, and therefore, a greater electrochemical response was observed when hybridization occurred. When the concentration of target DNA increased, the charge transfer between the redox marker and the PS electrode was enforced so that the peak current increased with DNA concentration. The detection limit of the PS-based label-free DNA biosensor was 1 ng mL1. 2.9.3 Virus Detection Multiple diseases are caused by a lethal submicroscopic infectious agent known as virus. In the modern world, serious diseases such as Ebola, AIDS, avian influenza, and SARS are caused by viruses. Therefore, all around the world many researchers are developing biosensors to detect viruses. Riccardi et al. designed a novel label-free electrochemical detection system of DNA hybridization for detecting hepatitis C virus.67 A porous polycarbonate membrane was integrated to detect short sequence (18-mer) target DNA after diffusion. A voltammetric microbiosensor based on immobilization of the 18-mer HCV-1 DNA probe was applied in combination with SECM line scans to evaluate hybridization of DNA fragments diffusing through a porous polycarbonate membrane. Rossi et al. were able to detect bacteriophage virus MS2 using a porous silicon biosensor.68 For immobilization of the virus, covalent bioconjugation of antibodies inside porous silicon films was carried out. By fluorescence, 2 107 plaque-forming units per milliliter (pfu mL1) were detectable. The nanoporous membrane had an average pore size of approximately 50 nm. The internal surfaces of porous silicon film are hydrogen terminated for bioconjugation chemistry. The hydrogen is then replaced by a functional organic group, which can be linked by a desired protein molecule using a cross-linker. Onto this linker, the unlabeled anti-MS2 antibodies are binded. The conjugation of either Alexa 488 to the antibodies or Alexa 532 fluorophores to MS2 viruses was carried out depending on the functionalization methods. Once again, the porous silicon surfaces were used to immobilize unlabeled anti-MS2 antibodies. The amounts of antibody and virus bound to the porous silicon surface were evaluated by fluorescence intensity at the emission maximum. Suggestions were made to improve the sensor performance by further optimization of porous layer structure and thickness. Gyurcsanyi mentioned about “passive” nanopore counters for detecting icosahedral chlorella virus viruses.69 A real-time monitoring of the antibody–virus binding was able to detect concentrations as low as 5 107 particles mL1 by a label-free technique. Reichmuth developed a lab-on-a-
78
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
chip device for rapid and portable diagnostics for detecting zoonotic diseases.70 A microchip-based electrophoretic immunoassay with an integrated nanoporous membrane incorporated into an open-channel electrophoresis and laser-induced fluorescence detection with a labeled antibody was carried out to detect influenza virus. The functionality of polymer membrane filtration eliminates the need for washing, commonly required in surface-based immunoassays, increasing the speed of the assay. Yang et al. were able to filter human rhinovirus type 14 major pathogen of the common cold in humans using nanoporous block copolymers.8 These nanoporous membranes showed excellent resistance to all organic solvents. 2.9.4 Glucose Detection For the treatment of diabetes mellitus, the amount of glucose present in a mammal’s blood is analyzed. Saha et al. fabricated a bioelectronic biosensor for the detection of glucose.71 A nanoporous cerium oxide (CeO2) thin film deposited on a platinum (Pt)coated glass plate using pulsed laser deposition (PLD) has been utilized for immobilization of glucose oxidase (GOx). Differential pulsed voltammetry (DPV) and optical measurements show that the GOx/CeO2/Pt bioelectrode exhibits linearity in glucose concentration ranging from 25 to 300 mg dL1. Immobilization of GOx onto CeO2 matrix was achieved by electrostatic interaction of positively charged CeO2 and negatively charged GOx enzyme at pH 7.0. Fourier transform infrared (FTIR), atomic force microscopy (AFM), and DPV techniques helped investigation of the CeO2/Pt electrode and GOx/CeO2/Pt bioelectrodes. Wei et al. had a novel approach for detection of glucose oxidase.72 Glucose oxidase is entrapped into a complex nanocomposite film of chitosan/nanoporous ZrO2/multiwalled carbon nanotubes (MWNTs). Nanoporous ZrO2 helped to enhance the stability of the immobilized enzyme. A wide linear response range from 8 mmol L1 to 3 mmol L1 was obtained by an amperometric glucose biosensor. The ability of CNTs to promote the electron transfer of hydrogen peroxide (H2O2) suggested a promising idea for the construction of oxidase-based amperometric biosensors. The organic–inorganic CHIT/ZrO2/ MWNT nanocomposite had an added advantage in terms of toughness of CHIT and chemical and thermal stability of nanoporous ZrO2. Another approach by Wang et al. demonstrated a nonenzymatic electrochemical glucose sensor based on nanoporous PtPb networks.73 A reproducible one-step hydrothermal method helped grow PtPb networks on Ti substrates. Voltammetry and amperometric methods are used to evaluate the electrooxidation activities of the synthesized electrodes toward nonenzymatic glucose oxidation in neutral media in the absence and presence of chloride ions. The nanoporous PtPb electrodes have strong and sensitive current responses to glucose. The excellent performance of the PtPb electrode was achieved at an optimal PtPb composition of 50%. Not only thin films with pores are used as a platform in a sensing device but also beads with pores are used as a mechanism to trap GOx. Vamvakaki and Chaniotakis utilized porous silica beads with pore sizes of 10 nm for the immobilization and stabilization of the GOx with diameters on the order of 7 nm.74 The confinement of the GOx leads to enhanced enzyme stability. Silica beads and porous polymer beads were embedded for the
POROUS MEMBRANE-BASED BIOSENSOR FOR DETECTION OF LIVING ORGANISM
79
development of novel and highly stable glucose biosensor systems. In order to construct the GOx biosensor, the beads with the immobilized enzymes were placed on platinum electrodes through Nafion membranes. The glucose biosensor used the electrochemical measurement technique, which consists of a three-electrode system of silver/silver chloride double junction reference electrode and a platinum counter electrode. Silica beads have a well-defined pore size of 10 nm and a particle size of 60–80 mesh, while polymer beads (PLRP-S) with a spherical porous structure have pore sizes of 10 and 30 nm and an average particle diameter of 50–70 mm. The comparative study showed that the response time of the free enzyme biosensors was between 30 and 60 s and that of the bead-adsorbed enzyme biosensors was between 60 and 90 s. The free GOx biosensor had a remaining activity of 60% after 70 h of continuous operation, while bead-adsorbed enzyme biosensors did not lose any of their initial activity even after 70 h of continuous operation. In addition, it was evident in the experiments that the size matching between the pore size and the molecular diameter of the enzymes is very important to achieve high enzymatic activity and prevent enzyme leaching. Ekanayake et al. enhanced the adsorption of glucose oxidase by introducing artificial porosity into polypyrrole-based glucose biosensors.75 It also enhanced the performance of the sensor in terms of increasing high enzyme loading, stability, sensitivity, reproducibility, and repeatability. The immobilization was done by physical adsorption. Glutaraldehyde was used for cross-linking, while in enzyme adsorption, the response current is increased. The reaction that produces H2O2 for sensing is shown below. GOx
Glucose þ O2 ! Gluconic acid þ H2 O2 H2 O2 ! O2 þ 2H þ þ 2e PF6 dopant helps produce microporous PPy films. This improves the porous structure and the amperometric response of the electrodes. The thickness of the nanoporous film is about 30–40 mm. PF6 dopant introduced to the PPy led to a significant improvement in sensor characteristics. Most recently, Fink et al. were able to detect glucose using a reusable enzyme-modified ion track membrane sensor.76 The enzyme glucose oxidase covalently linked to nanopores by covalent linking. The detection range of glucose concentrations is between 10 mM and 1 M. The principle for glucose sensor is described in Figure 2.21. The glucose biosensor consists of PET foils of 4 106 cm2 conical nanopores with a pore size of approximately 1.0 0.1 mm at the wide end and approximately 30 20 nm at the tip. The measurement compartment was separated by a sensing membrane and electrodes were inserted into both parts of the vessel. The voltage and transmission ion current were measured by applying sinusoidally shaped AC voltage of up to 5 Vpeak–peak operating at 1 Hz. On the basis of the current–voltage characteristics obtained, a diode-like rectification curve was obtained due to ion flow. The soluble reaction products produced due to enzyme reaction diffuse away from pore tip and avoid blocking of the pore, thereby rendering these sensors reusable. Using the
80
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
FIGURE 2.21
The pictorial representation of a glucose sensor.76
enzyme glucose oxidase (GOx) as the catalyst, the oxidation of glucose in the presence of oxygen is performed for glucose biosensing purposes. The glucose was oxidized by GOx and not by any of the other components of the device. The linearity between the measured ion current through the sensor and the applied glucose concentration was recorded. 2.9.5 Cholesterol Understanding and knowing cholesterol level in our bloodstream is extremely essential to reduce the risk of a heart attack or stroke. Li et al. have fabricated a cholesterol biosensor. Cholesterol oxidase was entrapped in a silicic sol–gel matrix.77 The half-life of the biosensor is about 35 days. The cholesterol biosensor has a high sensitivity and selectivity and can determine cholesterol oxidase ranging from 1 106 to 8 105 mol L1 with a detection limit of 1.2 107 mol L1. They also fabricated a selective cholesterol biosensor based on the composite film-modified electrode for amperometric detection.78 A concentration range of approximately 105104 mol L1 with a detection limit of 6 107 mol L1 was determined. The excellent sensitivity and selectivity were attributed to the PB/PPy layer on the biosensor. Singh et al. immobilized cholesterol oxidase (ChOx) onto zinc oxide (ZnO) nanoporous thin films grown on gold surface.79 The porous thin film was fabricated using rf magnetron sputtering. A cyclic voltammetric measurement method was used for detection of ChOx and the sensitivity of detection was in range 25–400 mg dL1. In this voltammetric method, the ChOx/ZnO/Au bioelectrode was found to detect cholesterol. Arya developed a ChOx biosensor using optical measurement. The ChOx molecule was covalently bonded to the sensing ODT electrode. The life of the ODT electrode-based biosensor was 2 months.80 Ansari et al. derived a sol–gel nanoporous cerium oxide film.81 A nanostructured cerium oxide (NS-CeO2) film deposited on the indium tin oxide (ITO)-coated glass substrate was used to detect cholesterol oxide.
POROUS MEMBRANE-BASED BIOSENSOR FOR DETECTION OF LIVING ORGANISM
81
2.9.6 New Diverse Sensors Recently, biomolecules were immobilized onto the sensing porous microelectrodes, which are used as a means of detecting bioagents. These microelectrodes are porous in nature, which help localize the bioagent for sensing. Song et al. developed a biosensor for diagnosis and monitoring of liver disease. An electrochemical array of nanoporous silicon electrodes is integrated for constructing these sensors.82 The liver plays a major role in metabolism, digestion, detoxification, and elimination of various substances from the body. Biomarkers such as cholesterol, bilirubin, and aminotransferases present in the serum help analyze the status of the liver. Using the silanization technique, sensitivities of the device were recorded to be 0.2656 mA mM1 for cholesterol, 0.15354 mA mM1 for bilirubin, 0.13698 mA (U l1)1 for alanine aminotransferase (ALT), and 0.45439 mA (U l1)1 for aspartate aminotransferase (AST). Compared to traditional analyte measurement procedures, the novel analytical device demonstrated high level of sensitivities for the analyses of multiple samples and analytes without a marked cross-interference effect. A single device containing the multiarray electrodes for sensing three different analytes is shown in Figure 2.22. A readout within minutes of application of microvolumes of a sample, reduced physical dimensions of the device, relative stability of the reagents used, and simple electronic component assembly useful for point-of-care biomarker liver analyses are some of the advantages of the liver biosensor discussed above.83 Measurement of urea in real urine samples is performed by a urea biosensor developed by Yang et al.84 The urease was immobilized onto nanoporous alumina membranes prepared by the two-step anodization method. Simple physical adsorption and cross-linking technique used for immobilization of these enzymes and piezoelectric mechanical detection mechanism were used for analysis. In the urea biosensor, urease was immobilized onto nanoporous alumina membranes, and the frequency responses of the ESPS/FIA detection system with the alumina electrode and the alumina/urease electrode were measured after the injection of 1.0 and 0.1 mM urea solutions. The catalytic reaction of the urease–urea system can be described by the equation below, thereby increasing the conductivity due to change of uncharged urea molecule to three ions. The frequency decrease is thereby attributed to the increase in conductivity. urease
NH2 CONH2 þ 2H2 O ! 2NH4 þ þ CO3 2
FIGURE 2.22
Schematic representation of a biosensor for liver diagnosis.83
82
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
The fabricated urea biosensor presented high-selectivity monitoring of urea, better reproducibility (SD ¼ 0.02, n ¼ 6), 30 s shorter response time, wider linear range from 0.5 mM to 3 mM, lower detection limit of 0.2 mM, and good longterm storage stability with about 76% of the enzymatic activity retained after 30 days. The activity of enzyme increases with increasing pore length for large pore size, while for correspondingly small pore size, enzymatic activity slightly depends on pore length.85 A nanoporous membrane can also be used to interface biological materials with a biohybrid system. Wolfrum et al. suspended nanoporous membranes as interfaces for neuronal biohybrid systems. Specification of the porosity parameters showed change in the transconductance of the nanopores and therefore helped control diffusion of molecules through the membranes. The alumina nanoporous membranes are biocompatible with both primary vertebrate and insect neurons. The thin aluminum film with 500 nm nanopores was integrated onto silicon nitride/silicon oxide to create stable suspended nanoporous Si3N4/SiO2 membranes by simple lithography anisotropic chemical silicon etching from the backside of the wafer in combination with anodization of thin aluminum films. Cells are genetically engineered and are placed on alumina membrane, which serves as a voltage-gated potassium ion channel. The cells showed adhesion and grew on the surface. The nanoporous membranes act as a cell interface and facilitate control of the cell environment with minute quantities of chemicals. 2.10 MICROFLUIDIC BIOSENSOR SYSTEMS A long-term goal in the field of microfluidics is to create integrated, portable clinical diagnostic devices for home and bedside use. Nanoporous membrane-based biosensors are integral components of a microfluidic system. This section describes the applications of microfluidic systems that have demonstrated the incorporation of nanoporous membranes to develop sensor systems. The chip used for this system is composed of an inexpensive and biocompatible polydimethylsiloxane (PDMS) layer. This overlays a Pyrex glass substrate that contains arrays of microelectrodes, which are used to detect the electrical signal in the biological environmental system. These chips consist of a microchannel to dispense or flow enzymes and analytes into the sensing area. These microfluidic biosensor systems provide low cost, portable, and high-throughput analytical systems. The approach applied for the construction of the microfluidic module provided a precise sample handling in terms of volume and flow rates, minimal dead volume at the inlet and outlet holes, that is, no sample losses during the analysis and approximately 100% waste disposal, and the ability for quick interchange of channels with different geometries and dimensions.86 Joo performed integration of a thin nanoporous platinum film into a microfluidic system for nonenzymatic electrochemical glucose sensing.87 The schematic diagram of a biosensor embedded into a microfluidic is shown in Figure 2.23.
MICROFLUIDIC BIOSENSOR SYSTEMS
83
FIGURE 2.23 Schematic representation of a microfluidic system.87
Glucose sensors cause intrinsic problems in manufacturing, storage, and distribution due to a serious, unacceptable dependence on temperature and humidity. Moreover, quality control difficulty and a short lifetime ultimately mean sizable costs. Therefore, the glucose biosensor was integrated into microfluidic systems. Programmed fluidic control of multiple reservoirs yields high-throughput analysis, automatic calibration, and multiple uses. Similarly, Metz et al. using micromachining and ion track technology fabricated polyimide microfluidic devices with integrated nanoporous filtration systems.88 Figure 2.24 illustrates a schematic block diagram of a microfluidic biosensor with embedded porous membrane. The device consists of inlet and outlet openings with the buried channels. The porous area is the filtration platform. One of the key advantages of a biosensor-based microfluidic is the limited contamination from outer atmosphere. Maeng et al. invented a novel microfluidic biosensor based on an electrical detection system for alpha-fetoprotein,89 whereas Goral et al. detected nucleic acid sequences using an electrochemical microfluidic biosensor.90 The microfluidic biosensor system was made up of PDMS and was integrated into an interdigitated ultramicroelectrode array, and microchannels were fabricated in a glass chip. Encapsulation of biosensor area into the closed system eliminated background signals to absolute nil and the IDUA responded in a highly reversible manner to the injection of various volumes and various concentrations of the electrochemical marker. Thus, the limit of detection was pushed to 1 fmol per assay and the dynamic range was 1–50 fmol. Similarly, Zaytseva et al. developed a microfluidic biosensor module with fluorescence detection for rapid and reliable identification of pathogenic organisms and
FIGURE 2.24 Schematic diagram demonstrating a polyamide microfluidic device for biosensor application.88
84
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
viruses.86 The microfluidic biosensor included a network of microchannels fabricated using soft lithography. As explained in the previous example, PDMS, which is the most commonly used polymeric substance, is used for fabricating the biomodule. Integration of the micro total analysis system into a sensing element enabled sample preparation and detection steps onto a single platform. A network of microchannels comprising the microbiosensor is modeled using computer-aided design software, nanofabricated in a silicon wafer by photolithography and etching techniques and molded into a PDMS elastomer by replica molding. In addition, Kwakye et al. developed an electrochemical microfluidic biosensor for the quantification of RNA. The concept was to demonstrate detection of dengue virus RNA.91 The detection mechanism was based on nucleic acid hybridization and liposome signal amplification. In addition, integration of a minipotentiostat, an interdigitated ultramicroelectrode array, and a microfluidic biosensor was successfully exhibited. Microchannel fluidic devices were fabricated using standard photolithography and dry etching. Using soft lithography, the microchannels were realized in PDMS covered with a glass slide consisting of interdigitated ultramicroelectrode arrays and packaged in a Plexiglas housing. Incorporating microfluidic systems yields a potentially inexpensive, portable, and disposable biosensor device that is easy to assemble and use. Yu et al. demonstrated a nanoporous impedance sensing transducer for fast bacteria patterning and detection at a low-frequency spectrum.92 A poly(ethylene glycol) (PEG) hydrogel microfluidic chip included patterned nanoporous aluminum oxide membrane (AOM) that allowed the detection limit to improve from 104 to around 102 CFU mL1, in comparison to the conventional impedance measurement system. Vargas-Bernal presented multiple topologies based on the microfluidic device in order to optimize the biosensor design for evaluation and detection of pesticides.93 The aim was to reduce the size of sample, reduce both the analytical system size and the test time, automate the operation, and finally ease the transportation. These requirements were met by using smart matrices for enzyme immobilization, microfluidic systems, more sensitive enzymes, enzymes with more specific roles, and different detecting methods. 2.11 SUMMARY AND FUTURE PERSPECTIVE In conclusion, we believe that nanoporous membrane-based microfluidic systems have a wide range of applications from development of biosensors for detection of living microorganisms that cause harmful diseases to fabrication of membrane-based drug delivery systems. These nanoporous membranes have opened a new field in the area of membrane-based biosensors. These nanoporous microfluidic membranebased biosensors not only are tested in scientific laboratory but are also being tested in clinical environments. Due to these reasons, there is a continuous need for rapid improvement in sensitivity, stability, ease of formation of solvent-free membranes, robustness, arrays, and cost. These requirements have led to various scientists exploring new methods and strategies in membrane fabrication and development. Natural membranes are now being used for fabrication of biosensors. Most common,
REFERENCES
85
naturally found nanopores membranes are lipid membranes,94 and recently, microscopic diatoms are being investigated in biosensors. These biomimetic lipid membranes consist of natural greasy molecules that are found in real membranes and some molecules that are not usually found in the body. These membranes stick tightly to metal surfaces, and this makes them rugged enough to provide a good home for membrane proteins even in industrial applications. Diatoms are microscopic, single-celled algae that possess rigid cell walls composed of hard and porous amorphous silica. Diatom biosensors are devices incorporating a biological molecular recognition component connected to a transducer capable of outputting a signal proportional to the concentration of the molecule being sensed.95 These low-cost and largely available natural materials found in microorganisms are now being investigated as transducer elements for optical biosensors or as targeting microcapsules for drug delivery.96 In addition, instead of nanoporous films, porous electrodes are being designed and fabricated for building biosensors that possess high sensitivity, outstanding selectivity, repeatability, and cost effectiveness. Researchers are discovering porous structures of any form that are biocompatible and can be embedded into a transducer for forming biosensing systems. In conclusion, there is a paradigm shift from manufactured membranes toward using natural and biomimetic membranes. REFERENCES 1. Adiga, S.; Curtiss, L.; Elam, J.; Pellin, M.; Shih, C.-C.; Shih, C.-M.; Lin, S.-J.; Su, Y.-Y.; Gittard, S.; Zhang, J.; Narayan, R. Nanoporous materials for biomedical devices. JOM J. Miner. Met. and Mater. Soc. 2008, 60, 26–32. 2. Whitesides, G.M. The origins and the future of microfluidics. Nature 2006, 442, 368–373. 3. Mohanty, S.P.; Kougianos, E. Biosensors: a tutorial review. IEEE 2006, 6, 35–40. 4. Sheehan, P.E.; Whitman, L.J. Detection limits for nanoscale biosensors. Nano Lett. 2005, 5, 803–807. 5. Cheng, K.-L.; Sheng, Y.-J.; Jiang, S.; Tsao, H.-K. Electrophoretic size separation of particles in a periodically constricted microchannel. J. Chem. Phys. 2008, 128, 101101. 6. Kuo, C.-W.; Shiu, J.-Y.; Wei, K.H.; Chen, P. Monolithic integration of well-ordered nanoporous structures in the microfluidic channels for bioseparation. J. Chromatogr. A 2007, 1162, 175–179. 7. Ulbricht, M. Advanced functional polymer membranes. Polymer 2006, 47, 2217–2262. 8. Yang, S.Y.; Jinhwan, J.P.; Moonhor, Y.; Key, R.S.; Kim, J.J.K. Virus filtration membranes prepared from nanoporous block copolymers with good dimensional stability under high pressures and excellent solvent resistance. Adv. Funct. Mater. 2008, 18, 1371–1377. 9. Lee, W.; Ji, R.; Gosele, U.; Nielsch, K. Fast fabrication of long-range ordered porous alumina membranes by hard anodization. Nat. Mater. 2006, 5, 741–747. 10. Reddy, R.K.; Bothara, M.G.; Barrett, T.W.; Carruthers, J.; Prasad, S. Nanomonitors: protein biosensors for rapid analyte analysis. IEEE Sens. J. 2008, 8, 720–723. 11. Apel, P. Track etching technique in membrane technology. Radiat. Meas. 2001, 34, 559–566.
86
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
12. Awasthi, K.; Kulshrestha, V.; Acharya, N.K.; Singh, M.; Vijay, Y.K. Ion transport through track etched polypropylene membrane. Eur. Polym. J. 2006, 42, 883–887. 13. Dobrev, D.; Neumann, R.; Angert, N.; Vetter, J. Formation of metal membranes by direct duplication of etched ion-track templates. Appl. Phys. A: Mater. Sci. Process. 2003, 76, 787–790. 14. Enculescu, I. Nanowires and nanotubes prepared using ion track membranes as templates. Digest J. Nanomater. Biostruct. 2006, 1, 15–20. 15. Siwy, Z.; Apel, P.; Dobrev, D.; Neumann, R.; Spohr, R.; Trautmann, C.; Voss, K. Ion transport through asymmetric nanopores prepared by ion track etching. Nucl. Instrum. Methods Phys. Res. B: Beam Interact. Mater. Atoms 2003, 208, 143–148. 16. Vogrin, N.; Stropnik, C.; Musil, V.; Brumen, M. The wet phase separation: the effect of cast solution thickness on the appearance of macrovoids in the membrane forming ternary cellulose acetate/acetone/water system. J. Membr. Sci. 2002, 207, 139–141. 17. Lee, H.J.; Jung, B.; Kang, Y.S.; Lee, H. Phase separation of polymer casting solution by nonsolvent vapor. J. Membr. Sci. 2004, 245, 103–112. 18. Stropnik, C.; Kaiser, V. Polymeric membranes preparation by wet phase separation: mechanisms and elementary processes. Desalination 2002, 145, 1–10. 19. Taketani, Y.; Nagaoka, S.; Kawakami, H. Fabrication of three-dimensionally ordered microporous membrane by wet phase separation. J. Appl. Polym. Sci. 2004, 92, 3016–3021. 20. Li, D.; Krantz, W.B.; Greenberg, A.R.; Sani, R.L. Membrane formation via thermally induced phase separation (TIPS): model development and validation. J. Membr. Sci. 2006, 279, 50–60. 21. Kuo, C.-Y.; Lin, H.-N.; Tsai, H.-A.; Wang, D.-M.; Lai, J.-Y. Fabrication of a high hydrophobic PVDF membrane via nonsolvent induced phase separation. Desalination 2008, 233, 40–47. 22. Fu, X.Y.; Sotani, T.; Matsuyama, H. Effect of membrane preparation method on the outer surface roughness of cellulose acetate butyrate hollow fiber membrane. Desalination 2008, 233, 10–18. 23. Kurt, R.; Simon, L.; Penterman, R.; Peeters, E.; de Koning, H.; Broer, D.J. Control over the morphology of porous polymeric membranes for flow through biosensors. J. Membr. Sci. 2008, 321, 51–60. 24. Leoni, L.; Boiarski, A.; Desai, T.A. Characterization of nanoporous membranes for immunoisolation: diffusion properties and tissue effects. Biomed. Microdevices 2002, 4, 131–139. 25. Lopez, C.A.; Fleischman, A.J.; Roy, S.; Desai, T.A. Evaluation of silicon nanoporous membranes and ECM-based microenvironments on neurosecretory cells. Biomaterials 2006, 27, 3075–3083. 26. Yan, X.; Liu, G.; Dickey, M.; Willson, C.G. Preparation of porous polymer membranes using nano- or micro-pillar arrays as templates. Polymer 2004, 45, 8469–8474. 27. Lo, C.J.; Aref, T.; Bezryadin, A. Fabrication of symmetric sub-5 nm nanopores using focused ion and electron beams. Nanotechnology 2006, 17, 3264–3267. 28. Patterson, N.; Adams, D.P.; Hodges, V.C.; Vasile, M.J.; Michael, J.R.; Kotula, P.G. Controlled fabrication of nanopores using a direct focused ion beam approach with back face particle detection. Nanotechnology 2008, 19, 1–10.
REFERENCES
87
29. Lillo, M.; Losic, D. Ion-beam pore opening of porous anodic alumina: the formation of single nanopore and nanopore arrays. Mater. Lett. 2009, 63, 457–460. 30. Kim, M.J.; McNally, B.; Murata, K.; Meller, A. Characteristics of solid-state nanometre pores fabricated using a transmission electron microscope. Nanotechnology 2007, 18, 1–5. 31. Kim, M.J.; Wanunu, M.; Bell, D.C.; Meller, A. Rapid fabrication of uniformly sized nanopores and nanopore arrays for parallel DNA analysis. Adv. Mater. 2006, 18, 3149–3153. 32. Bell, D.C. Fabrication and application of nanopores using TEM, STEM and ion beams. Microsc. Microanal. 2008, 14, 244–245. 33. Striemer, C.C.; Gaborski, T.R.; McGrath, J.L.; Fauchet, P.M. Charge- and size-based separation of macromolecules using ultrathin silicon membranes. Nature 2007, 445, 749–753. 34. Balamurugan, A.; Kannan, S.; Rajeswari, S. Structural and electrochemical behaviour of sol–gel zirconia films on 316L stainless-steel in simulated body fluid environment. Mater. Lett. 2003, 57, 4202–4205. 35. Dıaz-Garcıa, M.E.; Laınn˜o, R.B. Molecular imprinting in sol–gel materials: recent developments and applications. Microchim. Acta 2005, 149, 19–36. 36. Kumar, A.; Gupta, R. Bioactive materials for biomedical applications using sol–gel technology. Biomed. Mater. 2008, 3, 1–16. 37. Bhatia, R.B.; Brinker, C.J.; Gupta, A.K.; Singh, A.K. Aqueous sol–gel process for protein encapsulation. Chem. Mater. 2000, 12, 2434–2441. 38. Collinson, M.M. Recent trends in analytical applications of organically modified silicate materials. Trends Anal. Chem. 2002, 21, 31–39. 39. Power, M.; Hosticka, B.; Black, E.; Daitch, C.; Norris, P. Aerogels as biosensors: viral particle detection by bacteria immobilized on large pore aerogel. J. Non-Crystalline Solids 2001, 285, 303–308. 40. Tiwari, A.; Mishra, A.P.; Dhakate, S.R.; Khan, R.; Shukla, S.K. Synthesis of electrically active biopolymer–SiO2 nanocomposite aerogel. Mater. Lett. 2007, 61, 4587–4590. 41. Li, Y.K.; Chou, M.J.; Wu, T.-Y.; Jinn, T.-R.; Chen-Yang, Y.W. A novel method for preparing a protein-encapsulated bioaerogel: using a red fluorescent protein as a model. Acta Biomater. 2008, 4, 725–732. 42. Scanlon, S.; Aggeli, A.; Boden, N.; Koopmans, R.; Brydson, R.; Rayner, C.M. Peptide aerogels comprising self-assembling nanofibrils. Micro Nano Lett. 2007, 2, 24–29. 43. Yueming, Z.; Chakrabartty, S.; Muhammad-Tahir, Z.; Pal, S.; Alocilja, E.C. Spatiotemporal processing for multichannel biosensors using support vector machines. IEEE Sens. J. 2006, 6, 1644–1651. 44. Song, X.; Kaylor, R. Membrane-Based Assay Device, Kimberly-Clark Worldwide, Inc: Neenah, WI, 2002; p 24. 45. Kueng, A.; Kranz, C.; Mizaikoff, B. Imaging of ATP membrane transport with dual microdisk electrodes and scanning electrochemical microscopy. Biosens. Bioelectron. 2005, 21, 346–353. 46. Shan, D.; He, Y.; Wang, S.; Xue, H.; Zheng, H. A porous poly(acrylonitrile-co-acrylic acid) film-based glucose biosensor constructed by electrochemical entrapment. Anal. Biochem. 2006, 356, 215–221.
88
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
47. Ekanayake, E.M.I.M.; Preethichandra, D.M.G.; Kaneto, K. Fabrication and characterization of nanostructured conducting polymer electrodes for glucose biosensor applications. In Second International Conference on Industrial and Information Systems, 2007, pp. 63–66. 48. Park, J.; Kim, H.K.; Son, Y. Glucose biosensor constructed from capped conducting microtubules of PEDOT. Sens. Actuators B: Chem. 2008, 133, 244–250. 49. Darder, M.; Aranda, P.; Hernandez-Velez, M.; Manova, E.; Ruiz-Hitzky, E. Encapsulation of enzymes in alumina membranes of controlled pore size. Thin Solid Films 2006, 495, 321–326. 50. Shimomura, T.; Itoh, T.; Sumiya, T.; Mizukami, F.; Ono, M. Amperometric determination of choline with enzyme immobilized in a hybrid mesoporous membrane. Talanta 2009, 78, 217–220. 51. Kim, H.-J.; Yoon, S.H.; Choi, H.N.; Lyu, Y.-K.; Lee, W.-Y. Amperometric glucose biosensor based on sol–gel-derived zirconia/Nafion composite film as encapsulation matrix. Bull. Korean Chem. Soc. 2006, 27, 63–70. 52. De Stefano, L.; Rotiroti, L.; Rendina, I.; Moretti, L.; Scognamiglio, V.; Rossi, M.; D’Auria, S. Porous silicon-based optical microsensor for the detection of L-glutamine. Biosens. Bioelectron. 2006, 21, 1664–1667. 53. Bronzino, J.D. The Biomedical Engineering Handbook, Boca Raton, FL: CRC Press, 2000. 54. Liu, Y.; Zhu, Y.; Zeng, Y.; Xu, F. An effective amperometric biosensor based on gold nanoelectrode arrays. Nanoscale Res. Lett. 2009, 4, 210–215. 55. Shishkanova, T.V.; Volf, R.; Krondak, M.; Kral, V. Functionalization of PVC membrane with ss oligonucleotides for a potentiometric biosensor. Biosens. Bioelectron. 2007, 22, 2712–2717. 56. Reddy, R.R.K.; Basu, I.; Bhattacharya, E.; Chadha, A. Estimation of triglycerides by a porous silicon based potentiometric biosensor. Curr. Appl. Phys. 2003, 3, 155–161. 57. Reddy, R.K.K.; Prasad, S.; Barrett, T.; Carruthers, J. Electrical immunoassays toward clinical diagnostics: identification of vulnerable cardiovascular plaque. JALA 2008, 33–39. 58. De Stefano, L.; Arcari, P.; Lamberti, A.; Sanges, C.; Rotiroti, L.; Rea, I.; Rendina, I. DNA optical detection based on porous silicon technology: from biosensors to biochips. Sensors 2007, 7, 214–221. 59. Bonanno, L.; DeLouise, L. Steric crowding effects on target detection in an affinity biosensor. Langmuir 2007, 23, 5817–5823. 60. Xue, W.; Cui, T. Carbon nanotube micropatterns and cantilever arrays fabricated with layer-by-layer nano self-assembly. Sens. Actuators A: Phys. 2007, 136, 510–517. 61. Payen, S.; Walther, D.C.; Pisano, A.P. A MEMS RF-interrogated biosensor. In Third IEEE/ EMBS Special Topic Conference on Microtechnology in Medicine and Biology, 2005, pp. 76–79. 62. Alocilja, E.C. Biosensors for detecting pathogenic bacteria in the meat industry. Meat Biotechnol. 2008, 335–359. 63. Wang, L.; Liu, Q.; Hu, Z.; Zhang, Y.; Wu, C.; Yang, M.; Wang, P. A novel electrochemical biosensor based on dynamic polymerase-extending hybridization for E. coli O157:H7 DNA detection. Talanta 2009, 78, 647–652. 64. Abdel-Hamid, I.; Ivnitski, D.; Atanasov, P.; Wilkins, E. Flow-through immunofiltration assay system for rapid detection of E. coli O157:H7. Biosens. Bioelectron. 1999, 14, 309–316.
REFERENCES
89
65. Liu, Y.; Brandon, R.; Cate, M. Sensitive and rapid detection of pathogens using luminescent CdSe/ZnS dendron-nanocrystals and a porous membrane immunofilter. Anal. Chem. 2007, 79, 8796–8802. 66. Zhang, D.; Alocilja, E.C. Characterization of nanoporous silicon-based DNA biosensor for the detection of Salmonella enteritidis. IEEE Sens. J. 2008, 8, 775–780. 67. Riccardi, C. d.S.; Kranz, C.; Kowalik, J.; Yamanaka, H.; Mizaikoff, B.; Josowicz, M. Label-free DNA detection of hepatitis C virus based on modified conducting polypyrrole films at microelectrodes and atomic force microscopy tip-integrated electrodes. Anal. Chem. 2008, 80, 237–245. 68. Rossi, A.M.; Wang, L.; Reipa, V.; Murphy, T.E. Porous silicon biosensor for detection of viruses. Biosens. Bioelectron. 2007, 23, 741–745. 69. Gyurcsanyi, R.E. Chemically-modified nanopores for sensing. Trends Anal. Chem. 2008, 27, 627–639. 70. Reichmuth, D.S.; Wang, S.K.; Barrett, L.M.; Throckmorton, D.J.; Einfeld, W.; Singh, A.K. Rapid microchip-based electrophoretic immunoassays for the detection of swine influenza virus. Lab Chip 2008, 8, 1319–1324. 71. Saha, S.; Arya, S.K.; Singh, S.P.; Sreenivas, K.; Malhotra, B.D.; Gupta, V. Nanoporous cerium oxide thin film for glucose biosensor. Biosens. Bioelectron. 2009, 24, 2040–2045. 72. Wei, W.-Z.; Zhai, X.-R.; Zeng, J.-X.; Gao, Y.-P.; Gong, S.-G. New amperometric glucose biosensor by entrapping glucose oxidase into chitosan/nanoporous ZrO2/multiwalled carbon nanotubes nanocomposite film. J. Central South Univ. Technol. 2007, 14, 73–77. 73. Wang, J.; Thomas, D.F.; Chen, A. Nonenzymatic electrochemical glucose sensor based on nanoporous PtPb networks. Anal. Chem. 2008, 80, 997–1004. 74. Vamvakaki, V.; Chaniotakis, N.A. Immobilization of enzymes into nanocavities for the improvement of biosensor stability. Biosens. Bioelectron. 2007, 22, 2650–2655. 75. Ekanayake, E.M.I.M.; Preethichandra, D.M.G.; Kaneto, K. Polypyrrole nanotube array sensor for enhanced adsorption of glucose oxidase in glucose biosensors. Biosens. Bioelectron. 2007, 23, 107–113. 76. Fink, D.; Klinkovich, I.; Bukelman, O.; Marks, R.S.; Kiv, A.; Fuks, D.; Fahrner, W.R.; Alfonta, L. Glucose determination using a re-usable enzyme-modified ion track membrane sensor. Biosens. Bioelectron. 2009, 2418, 2702–2708. 77. Li, J.; Peng, T.; Peng, Y. A cholesterol biosensor based on entrapment of cholesterol oxidase in a silicic sol–gel matrix at a Prussian Blue modified electrode. Electroanalysis 2003, 15, 1031–1037. 78. Li, J.-P.; Gu, H.-N. A selective cholesterol biosensor based on composite film modified electrode for amperometric detection. J. Chin. Chem. Soc. 2006, 53, 575–582. 79. Singh, S.P.; Sunil, K.A.; Pratibha, P.; Malhotra, B.D.; Shibu, S.; Sreenivas, K.; Vinay, G. Cholesterol biosensor based on rf sputtered zinc oxide nanoporous thin film. Appl. Phys. Lett. 2007, 91, 063901. 80. Arya, S.K.; Solanki, P.R.; Singh, S.P.; Kaneto, K.; Pandey, M.K.; Datta, M.; Malhotra, B.D. Poly-(3-hexylthiophene) self-assembled monolayer based cholesterol biosensor using surface plasmon resonance technique. Biosens. Bioelectron. 2007, 22, 2516–2524. 81. Ansari, A.A.; Kaushik, A.; Solanki, P.R.; Malhotra, B.D. Sol–gel derived nanoporous cerium oxide film for application to cholesterol biosensor. Electrochem. Commun. 2008, 10, 1246–1249.
90
NANOPOROUS MEMBRANE-BASED MICROFLUIDIC BIOSENSORS
82. Song, M.-J.; Yun, D.-H.; Min, N.-K.; Hong, S.-I. Electrochemical biosensor array for liver diagnosis using silanization technique on nanoporous silicon electrode. J. Biosci. Bioeng. 2007, 103, 32–37. 83. Song, M.-J.; Yun, D.-H.; Min, N.-K.; Hong, S.-I. Electrochemical biosensor array for liver diagnosis using a silanization technique on nano-porous silicon electrode. In Nanotechnology Materials and Devices Conference, NMDC 2006, IEEE, 2006, pp. 362–363. 84. Yang, Z.; Si, S.; Dai, H.; Zhang, C. Piezoelectric urea biosensor based on immobilization of urease onto nanoporous alumina membranes. Biosens. Bioelectron. 2007, 22, 3283–3287. 85. Yang, Z.; Si, S.; Zhang, C. Study on the activity and stability of urease immobilized onto nanoporous alumina membranes. Microporous Mesoporous Mater. 2008, 111, 359–366. 86. Zaytseva, N.V.; Goral, V.N.; Montagna, R.A.; Baeumner, A.J. Development of a microfluidic biosensor module for pathogen detection. Lab Chip 2005, 5, 805–811. 87. Joo, S.; Park, S.; Chung, T.D.; Kim, H.C. Integration of a nanoporous platinum thin film into a microfluidic system for non-enzymatic electrochemical glucose sensing. Anal. Sci. 2007, 23, 277–281. 88. Metz, S.; Trautmann, C.; Bertsch, A.; Renaud, P. Polyimide microfluidic devices with integrated nanoporous filtration areas manufactured by micromachining and ion track technology. J. Micromech. Microeng. 2004, 14, 324–331. 89. Maeng, J.-H.; Lee, B.-C.; Ko, Y.-J.; Cho, W.; Ahn, Y.; Cho, N.-G.; Lee, S.-H.; Hwang, S.Y. A novel microfluidic biosensor based on an electrical detection system for alpha-fetoprotein. Biosens. Bioelectron. 2007, 23, 1319–1325. 90. Goral, V.N.; Zaytseva, N.V.; Baeumner, A.J. Electrochemical microfluidic biosensor for the detection of nucleic acid sequences. Lab Chip 2006, 6, 414–421. 91. Kwakye, S.; Goral, V.N.; Baeumner, A.J. Electrochemical microfluidic biosensor for nucleic acid detection with integrated minipotentiostat. Biosens. Bioelectron. 2006, 21, 2217–2223. 92. Yu, J.; Liu, Z.; Liu, Q.; Yuen, K.T.; Mak, A.F.T.; Yang, M.; Leung, P. A polyethylene glycol (PEG) microfluidic chip with nanostructures for bacteria rapid patterning and detection. Sens. Actuators A: Phys. 2009, 154(2), 288–294. 93. Vargas-Bernal, R. Topologies based on microfluidics of pesticides biosensors. In Proceedings of the Electronics, Robotics and Automotive Mechanics Conference, IEEE Computer Society, 2007. 94. Nikolelis, D.P.; Raftopoulou, G.; Nikoleli, G.-P.; Simantiraki, M. Stabilized lipid membrane based biosensors with incorporated enzyme for repetitive uses. Electroanalysis 2006, 18, 2467–2474. 95. Parkinson, J.; Gordon, R. Beyond micromachining: the potential of diatoms. Trends Biotechnol. 1999, 17, 190–196. 96. De Stefano, L.; Lamberti, A.; Rotiroti, L.; De Stefano, M. Interfacing the nanostructured biosilica microshells of the marine diatom Coscinodiscus wailesii with biological matter. Acta Biomater. 2008, 4, 126–130.
3 NANOPARTICLE-BASED MICROFLUIDIFIC BIOSENSORS GIOVANNA MARRAZZA Dipartimento di Chimica, Univesit a di Firenze, Via della Lastruccia, Sesto Fiorentino, Italy
3.1 INTRODUCTION Over the past decade, many important advances have been made in the use of nanotechnology for biomolecular detection. The use of nanoscale materials for biosensing has seen explosive growth in recent years following the discovery of carbon nanotubes (CNTs) by Sumio Ijima in 1991. Recently, many advances were achieved in the electrochemical and optical detection of DNA and immunoreactions, through the use of innovative detection schemes (e.g., microfluidic platform) and new materials, particularly the use of nanoparticles (NPs), nanotubes and nanowires. This advanced technology has been extended throughout the field of biosensors and biochips. Specifically, nanoparticles, made from metals, semiconductor, carbon, and polymeric materials, have been widely investigated to enhance the reaction signal of bioreceptors such as enzymes, antibodies, and oligonucleotides. Use of nanoparticle labels has proved to be particularly advantageous in sensing and biosensing applications due to the fact that single biorecognition events (i.e., DNA hybridization or immunoreaction) are typically translated into a significant effect on its optical (change of the light absorption or emission) or electrochemical properties (oxidation or reduction current) onto a transducing platform, offering novel options for bioanalysis. Moreover, the application of nanoparticles in biosensors strongly relates to their properties that derive to a certain extent from synthesis and later modifications (chemical and biological).
Microfluidic Devices in Nanotechnology: Applications, Edited by Challa S. Kumar Copyright 2010 John Wiley & Sons, Inc.
91
92
NANOPARTICLE-BASED MICROFLUIDIFIC BIOSENSORS
Although the use of NPs in bioanalysis is a recent area of research, there are many publications on their use as immobilization platform or labels for detecting numerous analytes. In the past few years, several excellent reviews have been published on the application of nanoparticles1,2 and particularly on the use of metal nanoparticles (gold nanoparticles)3,4 for the improvement of biosensing performance. Tamanaha et al.5 report an overview of the various approaches developed for magnetic labeling and detection as applied to biosensing. Moreover, nanoparticles have been applied widely to microanalytical systems (lab on a chip). For a biosensor to be used outside the laboratory, it either has to be as simple or automated with regard to sample processing and reagent addition. Automation and miniaturization of biological analytical techniques, as well as the development of on-line and remote measurement equipment, can be achieved through biosensor technology. Microfluidic systems are well recognized for their ability to move small volumes of fluids through different processes and over a sensing surface. The use of microfluidic technology presents many advantages, for example, cost reducing because of reduced fabrication expense and decreased requirements for costly reagents, reducing process and assay times that are proportional to liquid volumes. Moreover, the microfluidic devices can be realized in different steps of analytical procedure: (1) the microfluidic devices can be used for target preconcentration and target separation from other sample components, (2) the sample pretreatment (e.g., cell disruption or sample homogenization) can be performed in a microfluidic system, (3) both active and passive mixers are available for combining sample and assay reagents, (4) techniques for using solid-phase materials for separations in microflow have been identified, and finally (5) on-chip temperature control is available for temperature-dependent reactions such as PCR or simply for maintaining stability of the system in harsh environments. Therefore, microfluidic devices have found great application in the fields of biosensor technology. An overview has been published by Merkoci and coworkers on important aspects of microfluidic chip platforms as new materials for electrochemical sensing. It describes important trends in constructing detectors and their electronics on microfluidic chip platforms, the importance of selecting appropriate detector materials, and the different detection modes in